[
  {
    "chemicalName": "ERYTHROMYCIN A",
    "SMILES": "CCC1C(C(C(C(=O)C(CC(C(C(C(C(C(=O)O1)C)OC2CC(C(C(O2)C)O)(C)OC)C)OC3C(C(CC(O3)C)N(C)C)O)(C)O)C)C)O)(C)O",
    "chemicalId": "ERY",
    "InChI": "InChI=1S/C37H67NO13/c1-14-25-37(10,45)30(41)20(4)27(39)18(2)16-35(8,44)32(51-34-28(40)24(38(11)12)15-19(3)47-34)21(5)29(22(6)33(43)49-25)50-26-17-36(9,46-13)31(42)23(7)48-26/h18-26,28-32,34,40-42,44-45H,14-17H2,1-13H3/t18-,19-,20+,21+,22-,23+,24+,25-,26+,28-,29+,30-,31+,32-,34+,35-,36-,37-/m1/s1",
    "formula_weight": 0.734,
    "number_of_instances": 1,
    "drugbank_id": "DB00199",
    "drugbank_description": "Erythromycin is a bacteriostatic antibiotic drug produced by a strain of Saccharopolyspora erythraea (formerly Streptomyces erythraeus) and belongs to the macrolide group of antibiotics which consists of [Azithromycin], [Clarithromycin], [Spiramycin] and others. It was originally discovered in 1952.[L5245] Erythromycin is widely used for treating a variety of infections, including those caused by gram-positive and gram-negative bacteria.[L5245,L7261] It is available for administration in various forms, including intravenous, topical, and eye drop preparations.[L5245]",
    "InChIKey": "ULGZDMOVFRHVEP-RWJQBGPGSA-N",
    "pdbx_description": "ERYTHROMYCIN A",
    "SMILES_stereo": "CC[C@@H]1[C@@]([C@@H]([C@H](C(=O)[C@@H](C[C@@]([C@@H]([C@H]([C@@H]([C@H](C(=O)O1)C)O[C@H]2C[C@@]([C@H]([C@@H](O2)C)O)(C)OC)C)O[C@H]3[C@@H]([C@H](C[C@H](O3)C)N(C)C)O)(C)O)C)C)O)(C)O"
  },
  {
    "chemicalName": "PHOSPHOMETHYLPHOSPHONIC ACID GUANYLATE ESTER",
    "SMILES": "c1nc2c(n1C3C(C(C(O3)COP(=O)(O)OP(=O)(CP(=O)(O)O)O)O)O)N=C(NC2=O)N",
    "chemicalId": "GCP",
    "InChI": "InChI=1S/C11H18N5O13P3/c12-11-14-8-5(9(19)15-11)13-2-16(8)10-7(18)6(17)4(28-10)1-27-32(25,26)29-31(23,24)3-30(20,21)22/h2,4,6-7,10,17-18H,1,3H2,(H,23,24)(H,25,26)(H2,20,21,22)(H3,12,14,15,19)/t4-,6-,7-,10-/m1/s1",
    "formula_weight": 0.521,
    "number_of_instances": 1,
    "drugbank_id": "DB03725",
    "InChIKey": "PHBDHXOBFUBCJD-KQYNXXCUSA-N",
    "SMILES_stereo": "c1nc2c(n1[C@H]3[C@@H]([C@@H]([C@H](O3)CO[P@](=O)(O)O[P@@](=O)(CP(=O)(O)O)O)O)O)N=C(NC2=O)N",
    "pdbx_description": "PHOSPHOMETHYLPHOSPHONIC ACID GUANYLATE ESTER"
  },
  {
    "chemicalName": "N-(3-chloropyridin-2-yl)-N-[(3R)-piperidin-3-yl]-4-(3H-[1,2,3]triazolo[4,5-b]pyridin-3-yl)benzamide",
    "SMILES": "c1cc2c(nc1)n(nn2)c3ccc(cc3)C(=O)N(c4c(cccn4)Cl)C5CCCNC5",
    "chemicalId": "MVM",
    "InChI": "InChI=1S/C22H20ClN7O/c23-18-5-2-12-25-20(18)29(17-4-1-11-24-14-17)22(31)15-7-9-16(10-8-15)30-21-19(27-28-30)6-3-13-26-21/h2-3,5-10,12-13,17,24H,1,4,11,14H2/t17-/m1/s1",
    "formula_weight": 0.434,
    "number_of_instances": 1,
    "InChIKey": "FDTXHWQFIXYHCL-QGZVFWFLSA-N",
    "SMILES_stereo": "c1cc2c(nc1)n(nn2)c3ccc(cc3)C(=O)N(c4c(cccn4)Cl)[C@@H]5CCCNC5",
    "pdbx_description": "N-(3-chloropyridin-2-yl)-N-[(3R)-piperidin-3-yl]-4-(3H-[1,2,3]triazolo[4,5-b]pyridin-3-yl)benzamide"
  },
  {
    "chemicalName": "SPERMIDINE",
    "SMILES": "C(CCNCCCN)CN",
    "chemicalId": "SPD",
    "InChI": "InChI=1S/C7H19N3/c8-4-1-2-6-10-7-3-5-9/h10H,1-9H2",
    "formula_weight": 0.145,
    "number_of_instances": 3,
    "drugbank_id": "DB03566",
    "drugbank_description": "Spermidine is a polyamine formed from putrescine. It is found in almost all tissues in association with nucleic acids. It is found as a cation at all pH values, and is thought to help stabilize some membranes and nucleic acid structures. It is a precursor of spermine.",
    "InChIKey": "ATHGHQPFGPMSJY-UHFFFAOYSA-N",
    "SMILES_stereo": "C(CCNCCCN)CN",
    "pdbx_description": "SPERMIDINE"
  },
  {
    "chemicalName": "SPERMINE",
    "SMILES": "C(CCNCCCN)CNCCCN",
    "chemicalId": "SPM",
    "InChI": "InChI=1S/C10H26N4/c11-5-3-9-13-7-1-2-8-14-10-4-6-12/h13-14H,1-12H2",
    "formula_weight": 0.202,
    "number_of_instances": 5,
    "drugbank_id": "DB00127",
    "drugbank_description": "Spermine is a spermidine-derived biogenic polyamine found as a polycation at all pH values. Found in various tissues and organisms, it often acts as an essential growth factor in some bacterial species. Spermine is associated with nucleic acids, particularly in viruses, and is thought to stabilize the helical structure.",
    "InChIKey": "PFNFFQXMRSDOHW-UHFFFAOYSA-N",
    "SMILES_stereo": "C(CCNCCCN)CNCCCN",
    "pdbx_description": "SPERMINE"
  },
  {
    "chemicalName": "osmium (III) hexammine",
    "SMILES": "N[Os](N)(N)(N)(N)N",
    "chemicalId": "OHX",
    "InChI": "InChI=1S/6H2N.Os/h6*1H2;/q6*-1;+6",
    "formula_weight": 0.286,
    "number_of_instances": 930,
    "InChIKey": "OWCQTVJQFLTQTE-UHFFFAOYSA-N",
    "SMILES_stereo": "N[Os](N)(N)(N)(N)N",
    "pdbx_description": "osmium (III) hexammine"
  },
  {
    "chemicalName": "(3beta)-O~3~-[(2R)-2,6-dihydroxy-2-(2-methoxy-2-oxoethyl)-6-methylheptanoyl]cephalotaxine",
    "SMILES": "CC(C)(CCCC(CC(=O)OC)(C(=O)OC1C2c3cc4c(cc3CCN5C2(CCC5)C=C1OC)OCO4)O)O",
    "chemicalId": "HMT",
    "InChI": "InChI=1S/C29H39NO9/c1-27(2,33)8-5-10-29(34,16-23(31)36-4)26(32)39-25-22(35-3)15-28-9-6-11-30(28)12-7-18-13-20-21(38-17-37-20)14-19(18)24(25)28/h13-15,24-25,33-34H,5-12,16-17H2,1-4H3/t24-,25-,28+,29-/m1/s1",
    "formula_weight": 0.546,
    "number_of_instances": 1,
    "drugbank_id": "DB04865",
    "drugbank_description": "Omacetaxine mepesuccinate (formerly known as HHT or Homoharringtonine), is a cephalotaxine ester and protein synthesis inhibitor with established clinical activity as a single agent in hematological malignancies. Omacetaxine mepesuccinate  is synthesized from cephalotaxine, which is an extract from the leaves of the plant, Cephalotaxus species. In October 2005, omacetaxine mepesuccinate received Orphan Drug designation from the EMEA for the treatment of chronic myeloid leukemia (CML). Then in March 2006, it received Orphan Drug status from the FDA for the treatment of CML. In November 2006, omacetaxine mepesuccinate, for the treatment of CML, was granted Fast Track designation by the FDA. Most recently, in October 2012, omacetaxine mepesuccinate was marketed under the brand name Synribo and FDA approved for patients who are intolerant and/or resistant to two or more tyrosine kinase inhibitors used to treat accelerated or chronic phase CML.",
    "InChIKey": "HYFHYPWGAURHIV-JFIAXGOJSA-N",
    "pdbx_description": "(3beta)-O~3~-[(2R)-2,6-dihydroxy-2-(2-methoxy-2-oxoethyl)-6-methylheptanoyl]cephalotaxine",
    "SMILES_stereo": "CC(C)(CCC[C@@](CC(=O)OC)(C(=O)O[C@H]1[C@H]2c3cc4c(cc3CC[N@@]5[C@@]2(CCC5)C=C1OC)OCO4)O)O"
  },
  {
    "chemicalName": "Dirithromycin",
    "SMILES": "CCC1C(C2C(C(C(CC(C(C(C(C(C(=O)O1)C)OC3CC(C(C(O3)C)O)(C)OC)C)OC4C(C(CC(O4)C)N(C)C)O)(C)O)C)NC(O2)COCCOC)C)(C)O",
    "chemicalId": "DI0",
    "InChI": "InChI=1S/C42H78N2O14/c1-15-29-42(10,49)37-24(4)32(43-30(56-37)21-52-17-16-50-13)22(2)19-40(8,48)36(58-39-33(45)28(44(11)12)18-23(3)53-39)25(5)34(26(6)38(47)55-29)57-31-20-41(9,51-14)35(46)27(7)54-31/h22-37,39,43,45-46,48-49H,15-21H2,1-14H3/t22-,23-,24+,25+,26-,27+,28+,29-,30-,31+,32+,33-,34+,35+,36-,37-,39+,40-,41-,42-/m1/s1",
    "formula_weight": 0.835,
    "number_of_instances": 1,
    "drugbank_id": "DB00954",
    "drugbank_description": "Dirithromycin is a macrolide glycopeptide antibiotic used to treat many different types of bacterial infections, such as bronchitis, pneumonia, tonsillitis, and even skin infections.",
    "InChIKey": "WLOHNSSYAXHWNR-DWIOZXRMSA-N",
    "pdbx_description": "Dirithromycin",
    "SMILES_stereo": "CC[C@@H]1[C@@]([C@H]2[C@H]([C@H]([C@@H](C[C@@]([C@@H]([C@H]([C@@H]([C@H](C(=O)O1)C)O[C@H]3C[C@@]([C@H]([C@@H](O3)C)O)(C)OC)C)O[C@H]4[C@@H]([C@H](C[C@H](O4)C)N(C)C)O)(C)O)C)N[C@H](O2)COCCOC)C)(C)O"
  },
  {
    "chemicalName": "PAROMOMYCIN",
    "SMILES": "C1C(C(C(C(C1N)OC2C(C(C(C(O2)CO)O)O)N)OC3C(C(C(O3)CO)OC4C(C(C(C(O4)CN)O)O)N)O)O)N",
    "chemicalId": "PAR",
    "InChI": "InChI=1S/C23H45N5O14/c24-2-7-13(32)15(34)10(27)21(37-7)41-19-9(4-30)39-23(17(19)36)42-20-12(31)5(25)1-6(26)18(20)40-22-11(28)16(35)14(33)8(3-29)38-22/h5-23,29-36H,1-4,24-28H2/t5-,6+,7+,8-,9-,10-,11-,12+,13-,14-,15-,16-,17-,18-,19-,20-,21-,22-,23+/m1/s1",
    "formula_weight": 0.616,
    "number_of_instances": 2,
    "drugbank_id": "DB01421",
    "drugbank_description": "An oligosaccharide antibiotic produced by various streptomyces. [PubChem]",
    "InChIKey": "UOZODPSAJZTQNH-LSWIJEOBSA-N",
    "pdbx_description": "PAROMOMYCIN",
    "SMILES_stereo": "C1[C@H]([C@@H]([C@H]([C@@H]([C@H]1N)O[C@@H]2[C@@H]([C@H]([C@@H]([C@H](O2)CO)O)O)N)O[C@H]3[C@@H]([C@@H]([C@H](O3)CO)O[C@@H]4[C@@H]([C@H]([C@@H]([C@@H](O4)CN)O)O)N)O)O)N"
  },
  {
    "chemicalName": "1,4-DIAMINOBUTANE",
    "SMILES": "C(CCN)CN",
    "chemicalId": "PUT",
    "InChI": "InChI=1S/C4H12N2/c5-3-1-2-4-6/h1-6H2",
    "formula_weight": 0.088,
    "number_of_instances": 7,
    "drugbank_id": "DB01917",
    "drugbank_description": "Putrescine is a toxic diamine formed by putrefaction from the decarboxylation of arginine and ornithine. Putrescine is a solid. This compound belongs to the polyamines. These are compounds containing more than one amine group. Known drug targets of putrescine include putrescine-binding periplasmic protein, ornithine decarboxylase, and S-adenosylmethionine decarboxylase proenzyme. ",
    "InChIKey": "KIDHWZJUCRJVML-UHFFFAOYSA-N",
    "pdbx_description": "1,4-DIAMINOBUTANE",
    "SMILES_stereo": "C(CCN)CN"
  },
  {
    "chemicalName": "ADENOSINE-5'-TRIPHOSPHATE",
    "SMILES": "c1nc(c2c(n1)n(cn2)C3C(C(C(O3)COP(=O)(O)OP(=O)(O)OP(=O)(O)O)O)O)N",
    "chemicalId": "ATP",
    "InChI": "InChI=1S/C10H16N5O13P3/c11-8-5-9(13-2-12-8)15(3-14-5)10-7(17)6(16)4(26-10)1-25-30(21,22)28-31(23,24)27-29(18,19)20/h2-4,6-7,10,16-17H,1H2,(H,21,22)(H,23,24)(H2,11,12,13)(H2,18,19,20)/t4-,6-,7-,10-/m1/s1",
    "formula_weight": 0.507,
    "number_of_instances": 1,
    "drugbank_id": "DB00171",
    "drugbank_description": "An adenine nucleotide containing three phosphate groups esterified to the sugar moiety. In addition to its crucial roles in metabolism adenosine triphosphate is a neurotransmitter.",
    "InChIKey": "ZKHQWZAMYRWXGA-KQYNXXCUSA-N",
    "pdbx_description": "ADENOSINE-5'-TRIPHOSPHATE",
    "SMILES_stereo": "c1nc(c2c(n1)n(cn2)[C@H]3[C@@H]([C@@H]([C@H](O3)CO[P@@](=O)(O)O[P@](=O)(O)OP(=O)(O)O)O)O)N"
  },
  {
    "chemicalName": "GUANOSINE-5'-TRIPHOSPHATE",
    "SMILES": "c1nc2c(n1C3C(C(C(O3)COP(=O)(O)OP(=O)(O)OP(=O)(O)O)O)O)N=C(NC2=O)N",
    "chemicalId": "GTP",
    "InChI": "InChI=1S/C10H16N5O14P3/c11-10-13-7-4(8(18)14-10)12-2-15(7)9-6(17)5(16)3(27-9)1-26-31(22,23)29-32(24,25)28-30(19,20)21/h2-3,5-6,9,16-17H,1H2,(H,22,23)(H,24,25)(H2,19,20,21)(H3,11,13,14,18)/t3-,5-,6-,9-/m1/s1",
    "formula_weight": 0.523,
    "number_of_instances": 1,
    "drugbank_id": "DB04137",
    "drugbank_description": "Guanosine 5&#39;-(tetrahydrogen triphosphate). A guanine nucleotide containing three phosphate groups esterified to the sugar moiety. [PubChem]",
    "InChIKey": "XKMLYUALXHKNFT-UUOKFMHZSA-N",
    "pdbx_description": "GUANOSINE-5'-TRIPHOSPHATE",
    "SMILES_stereo": "c1nc2c(n1[C@H]3[C@@H]([C@@H]([C@H](O3)CO[P@](=O)(O)O[P@](=O)(O)OP(=O)(O)O)O)O)N=C(NC2=O)N"
  },
  {
    "chemicalName": "S-ADENOSYL-L-HOMOCYSTEINE",
    "SMILES": "c1nc(c2c(n1)n(cn2)C3C(C(C(O3)CSCCC(C(=O)O)N)O)O)N",
    "chemicalId": "SAH",
    "InChI": "InChI=1S/C14H20N6O5S/c15-6(14(23)24)1-2-26-3-7-9(21)10(22)13(25-7)20-5-19-8-11(16)17-4-18-12(8)20/h4-7,9-10,13,21-22H,1-3,15H2,(H,23,24)(H2,16,17,18)/t6-,7+,9+,10+,13+/m0/s1",
    "formula_weight": 0.384,
    "number_of_instances": 1,
    "drugbank_id": "DB01752",
    "drugbank_description": "5'-S-(3-Amino-3-carboxypropyl)-5'-thioadenosine. Formed from S-adenosylmethionine after transmethylation reactions.",
    "InChIKey": "ZJUKTBDSGOFHSH-WFMPWKQPSA-N",
    "pdbx_description": "S-ADENOSYL-L-HOMOCYSTEINE",
    "SMILES_stereo": "c1nc(c2c(n1)n(cn2)[C@H]3[C@@H]([C@@H]([C@H](O3)CSCC[C@@H](C(=O)O)N)O)O)N"
  },
  {
    "chemicalName": "ISOLEUCINE",
    "SMILES": "CCC(C)C(C(=O)O)N",
    "chemicalId": "ILE",
    "InChI": "InChI=1S/C6H13NO2/c1-3-4(2)5(7)6(8)9/h4-5H,3,7H2,1-2H3,(H,8,9)/t4-,5-/m0/s1",
    "formula_weight": 0.131,
    "number_of_instances": 2,
    "drugbank_id": "DB00167",
    "drugbank_description": "An essential branched-chain aliphatic amino acid found in many proteins. It is an isomer of leucine. It is important in hemoglobin synthesis and regulation of blood sugar and energy levels.",
    "InChIKey": "AGPKZVBTJJNPAG-WHFBIAKZSA-N",
    "SMILES_stereo": "CC[C@H](C)[C@@H](C(=O)O)N",
    "pdbx_description": "ISOLEUCINE"
  },
  {
    "chemicalName": "IRON/SULFUR CLUSTER",
    "SMILES": "[S]12[Fe]3[S]4[Fe]1[S]5[Fe]2[S]3[Fe]45",
    "chemicalId": "SF4",
    "InChI": "InChI=1S/4Fe.4S",
    "formula_weight": 0.352,
    "number_of_instances": 2,
    "InChIKey": "LJBDFODJNLIPKO-UHFFFAOYSA-N",
    "pdbx_description": "IRON/SULFUR CLUSTER",
    "SMILES_stereo": "[S]12[Fe]3[S]4[Fe]1[S]5[Fe]2[S]3[Fe]45"
  },
  {
    "chemicalName": "STREPTOMYCIN",
    "SMILES": "CC1C(C(C(O1)OC2C(C(C(C(C2O)O)NC(=N)N)O)NC(=N)N)OC3C(C(C(C(O3)CO)O)O)NC)(C=O)O",
    "chemicalId": "SRY",
    "InChI": "InChI=1S/C21H39N7O12/c1-5-21(36,4-30)16(40-17-9(26-2)13(34)10(31)6(3-29)38-17)18(37-5)39-15-8(28-20(24)25)11(32)7(27-19(22)23)12(33)14(15)35/h4-18,26,29,31-36H,3H2,1-2H3,(H4,22,23,27)(H4,24,25,28)/t5-,6-,7+,8-,9-,10-,11+,12-,13-,14+,15+,16-,17-,18-,21+/m0/s1",
    "formula_weight": 0.582,
    "number_of_instances": 1,
    "drugbank_id": "DB01082",
    "drugbank_description": "Streptomycin, an antibiotic derived from _Streptomyces griseus_, was the first aminoglycoside to be discovered and used in practice in the 1940s.[A233325,A233390] Selman Waksman and eventually Albert Schatz were recognized with the Nobel Prize in Medicine for their discovery of streptomycin and its antibacterial activity.[A233325,A232294] Although streptomycin was the first antibiotic determined to be effective against mycobacterium tuberculosis, it has fallen out of favor due to resistance and is now primarily used as adjunctive treatment in cases of multi-drug resistant tuberculosis.[A233325]",
    "InChIKey": "UCSJYZPVAKXKNQ-HZYVHMACSA-N",
    "pdbx_description": "STREPTOMYCIN",
    "SMILES_stereo": "[H]/N=C(/N)N[C@@H]1[C@H]([C@@H]([C@H]([C@@H]([C@H]1O)O)O[C@H]2[C@@H]([C@]([C@@H](O2)C)(C=O)O)O[C@H]3[C@H]([C@@H]([C@H]([C@@H](O3)CO)O)O)NC)N/C(=N[H])/N)O"
  },
  {
    "chemicalName": "NICOTINAMIDE-ADENINE-DINUCLEOTIDE",
    "SMILES": "c1cc(c[n+](c1)C2C(C(C(O2)COP(=O)([O-])OP(=O)(O)OCC3C(C(C(O3)n4cnc5c4ncnc5N)O)O)O)O)C(=O)N",
    "chemicalId": "NAD",
    "InChI": "InChI=1S/C21H27N7O14P2/c22-17-12-19(25-7-24-17)28(8-26-12)21-16(32)14(30)11(41-21)6-39-44(36,37)42-43(34,35)38-5-10-13(29)15(31)20(40-10)27-3-1-2-9(4-27)18(23)33/h1-4,7-8,10-11,13-16,20-21,29-32H,5-6H2,(H5-,22,23,24,25,33,34,35,36,37)/t10-,11-,13-,14-,15-,16-,20-,21-/m1/s1",
    "formula_weight": 0.663,
    "number_of_instances": 1,
    "drugbank_id": "DB14128",
    "drugbank_description": "A coenzyme composed of ribosylnicotinamide 5'-diphosphate coupled to adenosine 5'-phosphate by pyrophosphate linkage. It is found widely in nature and is involved in numerous enzymatic reactions in which it serves as an electron carrier by being alternately oxidized (NAD+) and reduced (NADH). (Dorland, 27th ed)",
    "InChIKey": "BAWFJGJZGIEFAR-NNYOXOHSSA-N",
    "pdbx_description": "NICOTINAMIDE-ADENINE-DINUCLEOTIDE",
    "SMILES_stereo": "c1cc(c[n+](c1)[C@H]2[C@@H]([C@@H]([C@H](O2)CO[P@@](=O)([O-])O[P@@](=O)(O)OC[C@@H]3[C@H]([C@H]([C@@H](O3)n4cnc5c4ncnc5N)O)O)O)O)C(=O)N"
  },
  {
    "chemicalName": "FE2/S2 (INORGANIC) CLUSTER",
    "SMILES": "S1[Fe]S[Fe]1",
    "chemicalId": "FES",
    "InChI": "InChI=1S/2Fe.2S",
    "formula_weight": 0.176,
    "number_of_instances": 3,
    "InChIKey": "NIXDOXVAJZFRNF-UHFFFAOYSA-N",
    "SMILES_stereo": "S1[Fe]S[Fe]1",
    "pdbx_description": "FE2/S2 (INORGANIC) CLUSTER"
  },
  {
    "chemicalName": "GUANOSINE-5'-DIPHOSPHATE",
    "SMILES": "c1nc2c(n1C3C(C(C(O3)COP(=O)(O)OP(=O)(O)O)O)O)N=C(NC2=O)N",
    "chemicalId": "GDP",
    "InChI": "InChI=1S/C10H15N5O11P2/c11-10-13-7-4(8(18)14-10)12-2-15(7)9-6(17)5(16)3(25-9)1-24-28(22,23)26-27(19,20)21/h2-3,5-6,9,16-17H,1H2,(H,22,23)(H2,19,20,21)(H3,11,13,14,18)/t3-,5-,6-,9-/m1/s1",
    "formula_weight": 0.443,
    "number_of_instances": 1,
    "drugbank_id": "DB04315",
    "drugbank_description": "A guanine nucleotide containing two phosphate groups esterified to the sugar moiety. [PubChem]",
    "InChIKey": "QGWNDRXFNXRZMB-UUOKFMHZSA-N",
    "pdbx_description": "GUANOSINE-5'-DIPHOSPHATE",
    "SMILES_stereo": "c1nc2c(n1[C@H]3[C@@H]([C@@H]([C@H](O3)CO[P@](=O)(O)OP(=O)(O)O)O)O)N=C(NC2=O)N"
  },
  {
    "chemicalName": "VALINE",
    "SMILES": "CC(C)C(C(=O)O)N",
    "chemicalId": "VAL",
    "InChI": "InChI=1S/C5H11NO2/c1-3(2)4(6)5(7)8/h3-4H,6H2,1-2H3,(H,7,8)/t4-/m0/s1",
    "formula_weight": 0.117,
    "number_of_instances": 1,
    "drugbank_id": "DB00161",
    "drugbank_description": "Valine is a branched-chain essential amino acid that has stimulant activity. It promotes muscle growth and tissue repair. It is a precursor in the penicillin biosynthetic pathway.",
    "InChIKey": "KZSNJWFQEVHDMF-BYPYZUCNSA-N",
    "SMILES_stereo": "CC(C)[C@@H](C(=O)O)N",
    "pdbx_description": "VALINE"
  },
  {
    "chemicalName": "UNKNOWN",
    "SMILES": "CCC(C(=O)O)N",
    "chemicalId": "UNK",
    "InChI": "InChI=1S/C4H9NO2/c1-2-3(5)4(6)7/h3H,2,5H2,1H3,(H,6,7)/t3-/m0/s1",
    "formula_weight": 0.103,
    "number_of_instances": 57,
    "InChIKey": "QWCKQJZIFLGMSD-VKHMYHEASA-N",
    "SMILES_stereo": "CC[C@@H](C(=O)O)N",
    "pdbx_description": "UNKNOWN"
  },
  {
    "chemicalName": "PHOSPHOAMINOPHOSPHONIC ACID-GUANYLATE ESTER",
    "SMILES": "c1nc2c(n1C3C(C(C(O3)COP(=O)(O)OP(=O)(NP(=O)(O)O)O)O)O)N=C(NC2=O)N",
    "chemicalId": "GNP",
    "InChI": "InChI=1S/C10H17N6O13P3/c11-10-13-7-4(8(19)14-10)12-2-16(7)9-6(18)5(17)3(28-9)1-27-32(25,26)29-31(23,24)15-30(20,21)22/h2-3,5-6,9,17-18H,1H2,(H,25,26)(H3,11,13,14,19)(H4,15,20,21,22,23,24)/t3-,5-,6-,9-/m1/s1",
    "formula_weight": 0.522,
    "number_of_instances": 2,
    "drugbank_id": "DB02082",
    "drugbank_description": "A non-hydrolyzable analog of GTP, in which the oxygen atom bridging the beta to the gamma phosphate is replaced by a nitrogen atom. It binds tightly to G-protein in the presence of Mg2+. The nucleotide is a potent stimulator of adenylate cyclase.",
    "InChIKey": "UQABYHGXWYXDTK-UUOKFMHZSA-N",
    "pdbx_description": "PHOSPHOAMINOPHOSPHONIC ACID-GUANYLATE ESTER",
    "SMILES_stereo": "c1nc2c(n1[C@H]3[C@@H]([C@@H]([C@H](O3)CO[P@](=O)(O)O[P@@](=O)(NP(=O)(O)O)O)O)O)N=C(NC2=O)N"
  },
  {
    "chemicalName": "ADENOSINE-5'-DIPHOSPHATE",
    "SMILES": "c1nc(c2c(n1)n(cn2)C3C(C(C(O3)COP(=O)(O)OP(=O)(O)O)O)O)N",
    "chemicalId": "ADP",
    "InChI": "InChI=1S/C10H15N5O10P2/c11-8-5-9(13-2-12-8)15(3-14-5)10-7(17)6(16)4(24-10)1-23-27(21,22)25-26(18,19)20/h2-4,6-7,10,16-17H,1H2,(H,21,22)(H2,11,12,13)(H2,18,19,20)/t4-,6-,7-,10-/m1/s1",
    "formula_weight": 0.427,
    "number_of_instances": 1,
    "drugbank_id": "DB16833",
    "InChIKey": "XTWYTFMLZFPYCI-KQYNXXCUSA-N",
    "pdbx_description": "ADENOSINE-5'-DIPHOSPHATE",
    "SMILES_stereo": "c1nc(c2c(n1)n(cn2)[C@H]3[C@@H]([C@@H]([C@H](O3)CO[P@](=O)(O)OP(=O)(O)O)O)O)N"
  },
  {
    "chemicalName": "Hygromycin A",
    "SMILES": "CC(=CC1=CC(=O)C(=CC1)OC2C(C(C(O2)C(=O)C)O)O)C(=O)NC3C(C(C4C(C3O)OCO4)O)O",
    "chemicalId": "HGR",
    "InChI": "InChI=1S/C23H29NO12/c1-8(22(32)24-13-14(27)16(29)21-20(15(13)28)33-7-34-21)5-10-3-4-12(11(26)6-10)35-23-18(31)17(30)19(36-23)9(2)25/h4-6,13-21,23,27-31H,3,7H2,1-2H3,(H,24,32)/b8-5+/t13-,14+,15-,16-,17+,18+,19-,20+,21-,23-/m1/s1",
    "formula_weight": 0.511,
    "number_of_instances": 1,
    "InChIKey": "LDTRVHIISSLXOQ-IIHALWDASA-N",
    "SMILES_stereo": "C/C(=CC1=CC(=O)C(=CC1)O[C@H]2[C@H]([C@@H]([C@H](O2)C(=O)C)O)O)/C(=O)N[C@@H]3[C@@H]([C@H]([C@@H]4[C@H]([C@@H]3O)OCO4)O)O",
    "pdbx_description": "Hygromycin A"
  },
  {
    "chemicalName": "[1R-(1.ALPHA.,3A.BETA.,4.BETA.,4A.BETA.,7.BETA.,7A.ALPHA.,8A.BETA.)]8A-[(6-DEOXY-4-O-METHYL-BETA-D-ALTROPYRANOSYLOXY)METHYL]-4-FORMYL-4,4A,5,6,7,7A,8,8A-OCTAHYDRO-7-METHYL-3-(1-METHYLETHYL)-1,4-METHANO-S-INDACENE-3A(1H)-CARBOXYLIC ACID",
    "SMILES": "CC1CCC2C1CC3(C4CC(C3(C2(C4)C=O)C(=O)O)C(C)C)COC5C(C(C(C(O5)C)OC)O)O",
    "chemicalId": "SO1",
    "InChI": "InChI=1S/C27H42O8/c1-13(2)19-8-16-9-25(11-28)18-7-6-14(3)17(18)10-26(16,27(19,25)24(31)32)12-34-23-21(30)20(29)22(33-5)15(4)35-23/h11,13-23,29-30H,6-10,12H2,1-5H3,(H,31,32)/t14-,15-,16+,17-,18-,19?,20+,21+,22-,23-,25+,26+,27+/m1/s1",
    "formula_weight": 0.495,
    "number_of_instances": 1,
    "InChIKey": "DIBGPTPYRVEPSP-OHFCZZTFSA-N",
    "SMILES_stereo": "C[C@@H]1CC[C@@H]2[C@@H]1C[C@@]3([C@H]4CC([C@@]3([C@@]2(C4)C=O)C(=O)O)C(C)C)CO[C@H]5[C@H]([C@@H]([C@@H]([C@H](O5)C)OC)O)O",
    "pdbx_description": "[1R-(1.ALPHA.,3A.BETA.,4.BETA.,4A.BETA.,7.BETA.,7A.ALPHA.,8A.BETA.)]8A-[(6-DEOXY-4-O-METHYL-BETA-D-ALTROPYRANOSYLOXY)METHYL]-4-FORMYL-4,4A,5,6,7,7A,8,8A-OCTAHYDRO-7-METHYL-3-(1-METHYLETHYL)-1,4-METHANO-S-INDACENE-3A(1H)-CARBOXYLIC ACID"
  },
  {
    "chemicalName": "emetine",
    "SMILES": "CCC1CN2CCc3cc(c(cc3C2CC1CC4c5cc(c(cc5CCN4)OC)OC)OC)OC",
    "chemicalId": "34G",
    "InChI": "InChI=1S/C29H40N2O4/c1-6-18-17-31-10-8-20-14-27(33-3)29(35-5)16-23(20)25(31)12-21(18)11-24-22-15-28(34-4)26(32-2)13-19(22)7-9-30-24/h13-16,18,21,24-25,30H,6-12,17H2,1-5H3/t18-,21-,24+,25-/m1/s1",
    "formula_weight": 0.481,
    "number_of_instances": 1,
    "InChIKey": "AUVVAXYIELKVAI-TXQMCKRASA-N",
    "SMILES_stereo": "CC[C@@H]1CN2CCc3cc(c(cc3[C@H]2C[C@H]1C[C@H]4c5cc(c(cc5CCN4)OC)OC)OC)OC",
    "pdbx_description": "emetine"
  },
  {
    "chemicalName": "PHENYLALANINE",
    "SMILES": "c1ccc(cc1)CC(C(=O)O)N",
    "chemicalId": "PHE",
    "InChI": "InChI=1S/C9H11NO2/c10-8(9(11)12)6-7-4-2-1-3-5-7/h1-5,8H,6,10H2,(H,11,12)/t8-/m0/s1",
    "formula_weight": 0.165,
    "number_of_instances": 1,
    "drugbank_id": "DB00120",
    "drugbank_description": "Phenylalanine is an essential aromatic amino acid that is a precursor of melanin, [dopamine], [noradrenalin] (norepinephrine), and [thyroxine].",
    "InChIKey": "COLNVLDHVKWLRT-QMMMGPOBSA-N",
    "SMILES_stereo": "c1ccc(cc1)C[C@@H](C(=O)O)N",
    "pdbx_description": "PHENYLALANINE"
  },
  {
    "chemicalName": "5'-GUANOSINE-DIPHOSPHATE-MONOTHIOPHOSPHATE",
    "SMILES": "c1nc2c(n1C3C(C(C(O3)COP(=O)(O)OP(=O)(O)OP(=S)(O)O)O)O)N=C(NC2=O)N",
    "chemicalId": "GSP",
    "InChI": "InChI=1S/C10H16N5O13P3S/c11-10-13-7-4(8(18)14-10)12-2-15(7)9-6(17)5(16)3(26-9)1-25-29(19,20)27-30(21,22)28-31(23,24)32/h2-3,5-6,9,16-17H,1H2,(H,19,20)(H,21,22)(H2,23,24,32)(H3,11,13,14,18)/t3-,5-,6-,9-/m1/s1",
    "formula_weight": 0.539,
    "number_of_instances": 1,
    "drugbank_id": "DB01864",
    "drugbank_description": "Guanosine 5&#39;-(trihydrogen diphosphate), monoanhydride with phosphorothioic acid. A stable GTP analog which enjoys a variety of physiological actions such as stimulation of guanine nucleotide-binding proteins, phosphoinositide hydrolysis, cyclic AMP accumulation, and activation of specific proto-oncogenes.",
    "InChIKey": "XOFLBQFBSOEHOG-UUOKFMHZSA-N",
    "pdbx_description": "5'-GUANOSINE-DIPHOSPHATE-MONOTHIOPHOSPHATE",
    "SMILES_stereo": "c1nc2c(n1[C@H]3[C@@H]([C@@H]([C@H](O3)CO[P@](=O)(O)O[P@](=O)(O)OP(=S)(O)O)O)O)N=C(NC2=O)N"
  },
  {
    "chemicalName": "(1R,2R,3S,4R,6S)-4,6-diamino-2-{[3-O-(2,6-diamino-2,6-dideoxy-beta-L-idopyranosyl)-beta-D-ribofuranosyl]oxy}-3-hydroxycyclohexyl 2-amino-2-deoxy-4,6-O-[(1R)-3-phenylpropylidene]-alpha-D-glucopyranoside",
    "SMILES": "c1ccc(cc1)CCC2OCC3C(O2)C(C(C(O3)OC4C(CC(C(C4OC5C(C(C(O5)CO)OC6C(C(C(C(O6)CN)O)O)N)O)O)N)N)N)O",
    "chemicalId": "M5Z",
    "InChI": "InChI=1S/C32H53N5O14/c33-9-15-22(40)23(41)19(36)30(45-15)50-27-16(10-38)46-32(25(27)43)51-29-21(39)13(34)8-14(35)26(29)49-31-20(37)24(42)28-17(47-31)11-44-18(48-28)7-6-12-4-2-1-3-5-12/h1-5,13-32,38-43H,6-11,33-37H2/t13-,14+,15+,16-,17-,18-,19-,20-,21+,22-,23-,24-,25-,26-,27-,28-,29-,30-,31-,32+/m1/s1",
    "formula_weight": 0.732,
    "number_of_instances": 1,
    "InChIKey": "JVOSAEIJIXVWJU-TZWNKDFKSA-N",
    "SMILES_stereo": "c1ccc(cc1)CC[C@@H]2OC[C@@H]3[C@@H](O2)[C@@H]([C@H]([C@H](O3)O[C@@H]4[C@H](C[C@H]([C@@H]([C@H]4O[C@H]5[C@@H]([C@@H]([C@H](O5)CO)O[C@@H]6[C@@H]([C@H]([C@@H]([C@@H](O6)CN)O)O)N)O)O)N)N)N)O",
    "pdbx_description": "(1R,2R,3S,4R,6S)-4,6-diamino-2-{[3-O-(2,6-diamino-2,6-dideoxy-beta-L-idopyranosyl)-beta-D-ribofuranosyl]oxy}-3-hydroxycyclohexyl 2-amino-2-deoxy-4,6-O-[(1R)-3-phenylpropylidene]-alpha-D-glucopyranoside"
  },
  {
    "chemicalName": "CHLORAMPHENICOL",
    "SMILES": "c1cc(ccc1C(C(CO)NC(=O)C(Cl)Cl)O)[N+](=O)[O-]",
    "chemicalId": "CLM",
    "InChI": "InChI=1S/C11H12Cl2N2O5/c12-10(13)11(18)14-8(5-16)9(17)6-1-3-7(4-2-6)15(19)20/h1-4,8-10,16-17H,5H2,(H,14,18)/t8-,9-/m1/s1",
    "formula_weight": 0.323,
    "number_of_instances": 1,
    "drugbank_id": "DB00446",
    "drugbank_description": "An antibiotic first isolated from cultures of _Streptomyces venezuelae_ in 1947 but now produced synthetically. It has a relatively simple structure and was the first broad-spectrum antibiotic to be discovered. It acts by interfering with bacterial protein synthesis and is mainly bacteriostatic. (From Martindale, The Extra Pharmacopoeia, 29th ed, p106)  The FDA has withdrawn all oral drug products containing chloramphenicol, due to the high risk of fatal aplastic anemia associated with this specific route of administration.[L43942,L44022]",
    "InChIKey": "WIIZWVCIJKGZOK-RKDXNWHRSA-N",
    "pdbx_description": "CHLORAMPHENICOL",
    "SMILES_stereo": "c1cc(ccc1[C@H]([C@@H](CO)NC(=O)C(Cl)Cl)O)[N+](=O)[O-]"
  },
  {
    "chemicalName": "ALANINE",
    "SMILES": "CC(C(=O)O)N",
    "chemicalId": "ALA",
    "InChI": "InChI=1S/C3H7NO2/c1-2(4)3(5)6/h2H,4H2,1H3,(H,5,6)/t2-/m0/s1",
    "formula_weight": 0.089,
    "number_of_instances": 1,
    "drugbank_id": "DB00160",
    "drugbank_description": "Alanine is a non-essential amino acid that occurs in high levels in its free state in plasma. It is produced from pyruvate by transamination. It is involved in sugar and acid metabolism, increases immunity, and provides energy for muscle tissue, brain, and the central nervous system.",
    "InChIKey": "QNAYBMKLOCPYGJ-REOHCLBHSA-N",
    "SMILES_stereo": "C[C@@H](C(=O)O)N",
    "pdbx_description": "ALANINE"
  },
  {
    "chemicalName": "ANISOMYCIN",
    "SMILES": "CC(=O)OC1C(CNC1Cc2ccc(cc2)OC)O",
    "chemicalId": "ANM",
    "InChI": "InChI=1S/C14H19NO4/c1-9(16)19-14-12(15-8-13(14)17)7-10-3-5-11(18-2)6-4-10/h3-6,12-15,17H,7-8H2,1-2H3/t12-,13+,14+/m1/s1",
    "formula_weight": 0.265,
    "number_of_instances": 1,
    "drugbank_id": "DB07374",
    "drugbank_description": "Anisomycin (sometimes known as flagecidin), is an antibiotic retrieved from the bacteria _Streptomyces griseolus_. This drug acts to inhibit bacterial protein and DNA synthesis.",
    "InChIKey": "YKJYKKNCCRKFSL-RDBSUJKOSA-N",
    "pdbx_description": "ANISOMYCIN",
    "SMILES_stereo": "CC(=O)O[C@@H]1[C@H](CN[C@@H]1Cc2ccc(cc2)OC)O"
  },
  {
    "chemicalName": "FUSIDIC ACID",
    "SMILES": "CC1C2CCC3(C(C2(CCC1O)C)C(CC4C3(CC(C4=C(CCC=C(C)C)C(=O)O)OC(=O)C)C)O)C",
    "chemicalId": "FUA",
    "InChI": "InChI=1S/C31H48O6/c1-17(2)9-8-10-20(28(35)36)26-22-15-24(34)27-29(5)13-12-23(33)18(3)21(29)11-14-30(27,6)31(22,7)16-25(26)37-19(4)32/h9,18,21-25,27,33-34H,8,10-16H2,1-7H3,(H,35,36)/b26-20-/t18-,21-,22-,23+,24+,25-,27-,29-,30-,31-/m0/s1",
    "formula_weight": 0.517,
    "number_of_instances": 2,
    "drugbank_id": "DB02703",
    "drugbank_description": "An antibiotic isolated from the fermentation broth of Fusidium coccineum. (From Merck Index, 11th ed) It acts by inhibiting translocation during protein synthesis. It is often used topically in creams and eyedrops but is available in systemic formulations including tablets and injections.",
    "InChIKey": "IECPWNUMDGFDKC-MZJAQBGESA-N",
    "pdbx_description": "FUSIDIC ACID",
    "SMILES_stereo": "C[C@H]1[C@@H]2CC[C@]3([C@H]([C@]2(CC[C@H]1O)C)[C@@H](C[C@@H]4[C@@]3(C[C@@H](/C4=C(/CCC=C(C)C)C(=O)O)OC(=O)C)C)O)C"
  },
  {
    "chemicalName": "NEOMYCIN",
    "SMILES": "C1C(C(C(C(C1N)OC2C(C(C(C(O2)CN)O)O)N)OC3C(C(C(O3)CO)OC4C(C(C(C(O4)CN)O)O)N)O)O)N",
    "chemicalId": "NMY",
    "InChI": "InChI=1S/C23H46N6O13/c24-2-7-13(32)15(34)10(28)21(37-7)40-18-6(27)1-5(26)12(31)20(18)42-23-17(36)19(9(4-30)39-23)41-22-11(29)16(35)14(33)8(3-25)38-22/h5-23,30-36H,1-4,24-29H2/t5-,6+,7-,8+,9-,10-,11-,12+,13-,14-,15-,16-,17-,18-,19-,20-,21-,22-,23+/m1/s1",
    "formula_weight": 0.615,
    "number_of_instances": 4,
    "drugbank_id": "DB00452",
    "drugbank_description": "A component of neomycin that is produced by Streptomyces fradiae. On hydrolysis it yields neamine and neobiosamine B. (From Merck Index, 11th ed)",
    "InChIKey": "PGBHMTALBVVCIT-VCIWKGPPSA-N",
    "pdbx_description": "NEOMYCIN",
    "SMILES_stereo": "C1[C@H]([C@@H]([C@H]([C@@H]([C@H]1N)O[C@@H]2[C@@H]([C@H]([C@@H]([C@H](O2)CN)O)O)N)O[C@H]3[C@@H]([C@@H]([C@H](O3)CO)O[C@@H]4[C@@H]([C@H]([C@@H]([C@@H](O4)CN)O)O)N)O)O)N"
  },
  {
    "chemicalName": "5-(2-DIETHYLAMINO-ETHANESULFONYL)-21-HYDROXY-10-ISOPROPYL-11,19-DIMETHYL-9,26-DIOXA-3,15,28-TRIAZA-TRICYCLO[23.2.1.00,255]OCTACOSA-1(27),12,17,19,25(28)-PENTAENE-2,8,14,23-TETRAONE",
    "SMILES": "CCN(CC)CCS(=O)(=O)C1CCN2C1C(=O)OC(C(C=CC(=O)NCC=CC(=CC(CC(=O)Cc3nc(co3)C2=O)O)C)C)C(C)C",
    "chemicalId": "DOL",
    "InChI": "InChI=1S/C34H50N4O9S/c1-7-37(8-2)16-17-48(44,45)28-13-15-38-31(28)34(43)47-32(22(3)4)24(6)11-12-29(41)35-14-9-10-23(5)18-25(39)19-26(40)20-30-36-27(21-46-30)33(38)42/h9-12,18,21-22,24-25,28,31-32,39H,7-8,13-17,19-20H2,1-6H3,(H,35,41)/b10-9+,12-11+,23-18+/t24-,25-,28-,31-,32-/m1/s1",
    "formula_weight": 0.691,
    "number_of_instances": 2,
    "drugbank_id": "DB01764",
    "drugbank_description": "Dalfopristin is a combination of two antibiotics (Dalfopristin and quinupristin) used to treat infections by staphylococci and by vancomycin-resistant Enterococcus faecium. It is not effective against Enterococcus faecalis infections. Dalfopristin inhibits the early phase of protein synthesis in the bacterial ribosome and quinupristin inhibits the late phase of protein synthesis.",
    "InChIKey": "SUYRLXYYZQTJHF-VMBLUXKRSA-N",
    "pdbx_description": "5-(2-DIETHYLAMINO-ETHANESULFONYL)-21-HYDROXY-10-ISOPROPYL-11,19-DIMETHYL-9,26-DIOXA-3,15,28-TRIAZA-TRICYCLO[23.2.1.00,255]OCTACOSA-1(27),12,17,19,25(28)-PENTAENE-2,8,14,23-TETRAONE",
    "SMILES_stereo": "CCN(CC)CCS(=O)(=O)[C@@H]1CCN2[C@H]1C(=O)O[C@@H]([C@@H](C=CC(=O)NC/C=C/C(=C/[C@H](CC(=O)Cc3nc(co3)C2=O)O)/C)C)C(C)C"
  },
  {
    "chemicalName": "HYGROMYCIN B",
    "SMILES": "CNC1CC(C(C(C1O)OC2C3C(C(C(O2)CO)O)OC4(O3)C(C(C(C(O4)C(CO)N)O)O)O)O)N",
    "chemicalId": "HYG",
    "InChI": "InChI=1S/C20H37N3O13/c1-23-7-2-5(21)9(26)15(10(7)27)33-19-17-16(11(28)8(4-25)32-19)35-20(36-17)18(31)13(30)12(29)14(34-20)6(22)3-24/h5-19,23-31H,2-4,21-22H2,1H3/t5-,6+,7+,8-,9+,10-,11+,12-,13-,14+,15-,16+,17-,18-,19+,20-/m1/s1",
    "formula_weight": 0.528,
    "number_of_instances": 1,
    "InChIKey": "GRRNUXAQVGOGFE-WRWUMOMGSA-N",
    "SMILES_stereo": "CN[C@H]1C[C@H]([C@@H]([C@H]([C@@H]1O)O[C@H]2[C@H]3[C@H](C([C@H](O2)CO)O)O[C@@]4(O3)[C@@H]([C@@H]([C@H]([C@@H](O4)[C@H](CO)N)O)O)O)O)N",
    "pdbx_description": "HYGROMYCIN B"
  },
  {
    "chemicalName": "BETA-L-ASPARTIC ACID",
    "SMILES": "C(C(C(=O)O)N)C(=O)O",
    "chemicalId": "IAS",
    "InChI": "InChI=1S/C4H7NO4/c5-2(4(8)9)1-3(6)7/h2H,1,5H2,(H,6,7)(H,8,9)/t2-/m0/s1",
    "formula_weight": 0.133,
    "number_of_instances": 1,
    "drugbank_id": "DB00128",
    "drugbank_description": "One of the non-essential amino acids commonly occurring in the L-form. It is found in animals and plants, especially in sugar cane and sugar beets. It may be a neurotransmitter.",
    "InChIKey": "CKLJMWTZIZZHCS-REOHCLBHSA-N",
    "SMILES_stereo": "C([C@@H](C(=O)O)N)C(=O)O",
    "pdbx_description": "BETA-L-ASPARTIC ACID"
  },
  {
    "chemicalName": "S-(2-{[N-(2-HYDROXY-4-{[HYDROXY(OXIDO)PHOSPHINO]OXY}-3,3-DIMETHYLBUTANOYL)-BETA-ALANYL]AMINO}ETHYL) DECANETHIOATE",
    "SMILES": "CCCCCCCCCC(=O)SCCNC(=O)CCNC(=O)C(C(C)(C)COP(=O)O)O",
    "chemicalId": "PM8",
    "InChI": "InChI=1S/C21H41N2O7PS/c1-4-5-6-7-8-9-10-11-18(25)32-15-14-22-17(24)12-13-23-20(27)19(26)21(2,3)16-30-31(28)29/h19,26,31H,4-16H2,1-3H3,(H,22,24)(H,23,27)(H,28,29)/t19-/m0/s1",
    "formula_weight": 0.497,
    "number_of_instances": 1,
    "InChIKey": "BPRKYNVKIAROET-IBGZPJMESA-N",
    "SMILES_stereo": "CCCCCCCCCC(=O)SCCNC(=O)CCNC(=O)[C@@H](C(C)(C)CO[P@H](=O)O)O",
    "pdbx_description": "S-(2-{[N-(2-HYDROXY-4-{[HYDROXY(OXIDO)PHOSPHINO]OXY}-3,3-DIMETHYLBUTANOYL)-BETA-ALANYL]AMINO}ETHYL) DECANETHIOATE"
  },
  {
    "chemicalName": "N-[(1S,2R,3E,5E,7S,9E,11E,13S,15R,19R)-7,13-dihydroxy-1,4,10,19-tetramethyl-17,18-dioxo-16-oxabicyclo[13.2.2]nonadeca-3,5,9,11-tetraen-2-yl]-2-oxopropanamide",
    "SMILES": "CC1C2CC(C=CC(=CCC(C=CC(=CC(C(C1=O)(C(=O)O2)C)NC(=O)C(=O)C)C)O)C)O",
    "chemicalId": "LC2",
    "InChI": "InChI=1S/C25H33NO7/c1-14-6-9-18(28)10-8-15(2)12-21(26-23(31)17(4)27)25(5)22(30)16(3)20(33-24(25)32)13-19(29)11-7-14/h6-8,10-12,16,18-21,28-29H,9,13H2,1-5H3,(H,26,31)/b10-8+,11-7+,14-6+,15-12+/t16-,18+,19-,20-,21-,25+/m1/s1",
    "formula_weight": 0.46,
    "number_of_instances": 1,
    "InChIKey": "ATDILMLBOZKFGI-JUTMVFGESA-N",
    "SMILES_stereo": "C[C@@H]1[C@H]2C[C@@H](/C=C/C(=C/C[C@@H](/C=C/C(=C/[C@H]([C@@](C1=O)(C(=O)O2)C)NC(=O)C(=O)C)/C)O)/C)O",
    "pdbx_description": "N-[(1S,2R,3E,5E,7S,9E,11E,13S,15R,19R)-7,13-dihydroxy-1,4,10,19-tetramethyl-17,18-dioxo-16-oxabicyclo[13.2.2]nonadeca-3,5,9,11-tetraen-2-yl]-2-oxopropanamide"
  },
  {
    "chemicalName": "Lankamycin",
    "SMILES": "CC1CC(C(C(O1)OC2C(CC(C(=O)C(C(C(C(OC(=O)C(C(C2C)OC3CC(C(C(O3)C)OC(=O)C)(C)OC)C)C(C)C(C)O)C)OC(=O)C)C)(C)O)C)C)OC",
    "chemicalId": "LMA",
    "InChI": "InChI=1S/C43H74O15/c1-20-18-42(13,49)38(47)26(7)36(54-30(11)45)25(6)35(22(3)28(9)44)57-40(48)27(8)37(24(5)34(20)58-41-23(4)32(50-15)17-21(2)52-41)56-33-19-43(14,51-16)39(29(10)53-33)55-31(12)46/h20-29,32-37,39,41,44,49H,17-19H2,1-16H3/t20-,21+,22+,23+,24+,25-,26+,27+,28+,29-,32-,33-,34-,35+,36-,37-,39+,41-,42-,43+/m0/s1",
    "formula_weight": 0.831,
    "number_of_instances": 1,
    "InChIKey": "FIYJFVCGASKYLV-QDYGBMDYSA-N",
    "SMILES_stereo": "C[C@@H]1C[C@@H]([C@H]([C@@H](O1)O[C@H]2[C@H](C[C@](C(=O)[C@@H]([C@H]([C@H]([C@H](OC(=O)[C@@H]([C@H]([C@@H]2C)O[C@H]3C[C@@]([C@@H]([C@@H](O3)C)OC(=O)C)(C)OC)C)[C@H](C)[C@@H](C)O)C)OC(=O)C)C)(C)O)C)C)OC",
    "pdbx_description": "Lankamycin"
  },
  {
    "chemicalName": "4'-PHOSPHOPANTETHEINE",
    "SMILES": "CC(C)(COP(=O)(O)O)C(C(=O)NCCC(=O)NCCS)O",
    "chemicalId": "PNS",
    "InChI": "InChI=1S/C11H23N2O7PS/c1-11(2,7-20-21(17,18)19)9(15)10(16)13-4-3-8(14)12-5-6-22/h9,15,22H,3-7H2,1-2H3,(H,12,14)(H,13,16)(H2,17,18,19)/t9-/m0/s1",
    "formula_weight": 0.358,
    "number_of_instances": 1,
    "drugbank_id": "DB03912",
    "InChIKey": "JDMUPRLRUUMCTL-VIFPVBQESA-N",
    "pdbx_description": "4'-PHOSPHOPANTETHEINE",
    "SMILES_stereo": "CC(C)(COP(=O)(O)O)[C@H](C(=O)NCCC(=O)NCCS)O"
  },
  {
    "chemicalName": "ZINC ION",
    "chemicalId": "ZN",
    "formula_weight": 0.065,
    "number_of_instances": 6,
    "pdbx_description": "ZINC ION"
  },
  {
    "chemicalName": "SPARSOMYCIN",
    "SMILES": "CC1=C(C(=O)NC(=O)N1)C=CC(=O)NC(CO)CS(=O)CSC",
    "chemicalId": "SPS",
    "InChI": "InChI=1S/C13H19N3O5S2/c1-8-10(12(19)16-13(20)14-8)3-4-11(18)15-9(5-17)6-23(21)7-22-2/h3-4,9,17H,5-7H2,1-2H3,(H,15,18)(H2,14,16,19,20)/b4-3+/t9-,23+/m0/s1",
    "formula_weight": 0.361,
    "number_of_instances": 2,
    "drugbank_id": "DB04222",
    "drugbank_description": "An antitumor antibiotic produced by Streptomyces sparsogenes. It inhibits protein synthesis in 70S and 80S ribosomal systems. [PubChem]",
    "InChIKey": "XKLZIVIOZDNKEQ-CLQLPEFOSA-N",
    "SMILES_stereo": "CC1=C(C(=O)NC(=O)N1)/C=C/C(=O)N[C@@H](CO)C[S@@](=O)CSC",
    "pdbx_description": "SPARSOMYCIN"
  },
  {
    "chemicalName": "MAGNESIUM ION",
    "chemicalId": "MG",
    "formula_weight": 0.024,
    "number_of_instances": 1482,
    "pdbx_description": "MAGNESIUM ION"
  },
  {
    "chemicalName": "N-[(1R,2R,3R,4S,5R)-4-[(2R,3R,6S)-6-(aminomethyl)-3-azanyl-oxan-2-yl]oxy-5-azanyl-2-[[(3S,4S,5S,6R)-5-(methylamino)-4,6-bis(oxidanyl)-2-oxabicyclo[4.1.0]heptan-3-yl]oxy]-3-oxidanyl-cyclohexyl]pyridine-3-sulfonamide",
    "SMILES": "CNC1C(C(OC2C1(C2)O)OC3C(CC(C(C3O)OC4C(CCC(O4)CN)N)N)NS(=O)(=O)c5cccnc5)O",
    "chemicalId": "HKO",
    "InChI": "InChI=1S/C24H40N6O9S/c1-28-21-18(32)23(37-16-8-24(16,21)33)39-20-15(30-40(34,35)12-3-2-6-29-10-12)7-14(27)19(17(20)31)38-22-13(26)5-4-11(9-25)36-22/h2-3,6,10-11,13-23,28,30-33H,4-5,7-9,25-27H2,1H3/t11-,13+,14+,15+,16-,17+,18-,19-,20+,21-,22+,23+,24-/m0/s1",
    "formula_weight": 0.589,
    "number_of_instances": 1,
    "InChIKey": "PLNNWXHFRHQFIG-QUYPYEIISA-N",
    "SMILES_stereo": "CN[C@H]1[C@@H]([C@H](OC2[C@]1(C2)O)O[C@@H]3[C@@H](C[C@H]([C@@H]([C@H]3O)O[C@@H]4[C@@H](CC[C@H](O4)CN)N)N)NS(=O)(=O)c5cccnc5)O",
    "pdbx_description": "N-[(1R,2R,3R,4S,5R)-4-[(2R,3R,6S)-6-(aminomethyl)-3-azanyl-oxan-2-yl]oxy-5-azanyl-2-[[(3S,4S,5S,6R)-5-(methylamino)-4,6-bis(oxidanyl)-2-oxabicyclo[4.1.0]heptan-3-yl]oxy]-3-oxidanyl-cyclohexyl]pyridine-3-sulfonamide"
  },
  {
    "chemicalName": "Mycalamide A",
    "SMILES": "CC1C(OC(CC1=C)(C(C(=O)NC2C3C(C(C(C(O3)CC(CO)O)(C)C)OC)OCO2)O)OC)C",
    "chemicalId": "MYL",
    "InChI": "InChI=1S/C24H41NO10/c1-12-9-24(31-7,35-14(3)13(12)2)19(28)21(29)25-22-18-17(32-11-33-22)20(30-6)23(4,5)16(34-18)8-15(27)10-26/h13-20,22,26-28H,1,8-11H2,2-7H3,(H,25,29)/t13-,14-,15+,16-,17+,18+,19-,20-,22-,24-/m1/s1",
    "formula_weight": 0.504,
    "number_of_instances": 1,
    "InChIKey": "IJASURGZDJYQGF-RXLGVIKCSA-N",
    "SMILES_stereo": "C[C@H]1[C@H](O[C@](CC1=C)([C@@H](C(=O)N[C@H]2[C@@H]3[C@@H]([C@H](C([C@H](O3)C[C@@H](CO)O)(C)C)OC)OCO2)O)OC)C",
    "pdbx_description": "Mycalamide A"
  },
  {
    "chemicalName": "(2~{S})-~{N}-[(2~{R})-1-[[(3~{S},6~{S},8~{S},12~{S},13~{R},16~{S},17~{R},20~{S},23~{S})-13-[(2~{S})-butan-2-yl]-20-[(4-methoxyphenyl)methyl]-6,17,21-trimethyl-3-(2-methylpropyl)-12-oxidanyl-2,5,7,10,15,19,22-heptakis(oxidanylidene)-8-propan-2-yl-9,18-dioxa-1,4,14,21-tetrazabicyclo[21.3.0]hexacosan-16-yl]amino]-4-methyl-1-oxidanylidene-pentan-2-yl]-~{N}-methyl-1-[(2~{S})-2-oxidanylpropanoyl]pyrrolidine-2-carboxamide",
    "SMILES": "CCC(C)C1C(CC(=O)OC(C(=O)C(C(=O)NC(C(=O)N2CCCC2C(=O)N(C(C(=O)OC(C(C(=O)N1)NC(=O)C(CC(C)C)N(C)C(=O)C3CCCN3C(=O)C(C)O)C)Cc4ccc(cc4)OC)C)CC(C)C)C)C(C)C)O",
    "chemicalId": "7C4",
    "InChI": "InChI=1S/C57H89N7O15/c1-15-33(8)46-44(66)29-45(67)79-49(32(6)7)48(68)34(9)50(69)58-39(26-30(2)3)54(73)64-25-17-19-41(64)56(75)62(13)43(28-37-20-22-38(77-14)23-21-37)57(76)78-36(11)47(52(71)59-46)60-51(70)42(27-31(4)5)61(12)55(74)40-18-16-24-63(40)53(72)35(10)65/h20-23,30-36,39-44,46-47,49,65-66H,15-19,24-29H2,1-14H3,(H,58,69)(H,59,71)(H,60,70)/t33-,34-,35-,36+,39-,40-,41-,42+,43-,44-,46+,47-,49-/m0/s1",
    "formula_weight": 1.112,
    "number_of_instances": 1,
    "InChIKey": "KYHUYMLIVQFXRI-SJPGYWQQSA-N",
    "SMILES_stereo": "CC[C@H](C)[C@@H]1[C@H](CC(=O)O[C@H](C(=O)[C@@H](C(=O)N[C@H](C(=O)N2CCC[C@H]2C(=O)N([C@H](C(=O)O[C@@H]([C@@H](C(=O)N1)NC(=O)[C@@H](CC(C)C)N(C)C(=O)[C@@H]3CCCN3C(=O)[C@H](C)O)C)Cc4ccc(cc4)OC)C)CC(C)C)C)C(C)C)O",
    "pdbx_description": "(2~{S})-~{N}-[(2~{R})-1-[[(3~{S},6~{S},8~{S},12~{S},13~{R},16~{S},17~{R},20~{S},23~{S})-13-[(2~{S})-butan-2-yl]-20-[(4-methoxyphenyl)methyl]-6,17,21-trimethyl-3-(2-methylpropyl)-12-oxidanyl-2,5,7,10,15,19,22-heptakis(oxidanylidene)-8-propan-2-yl-9,18-dioxa-1,4,14,21-tetrazabicyclo[21.3.0]hexacosan-16-yl]amino]-4-methyl-1-oxidanylidene-pentan-2-yl]-~{N}-methyl-1-[(2~{S})-2-oxidanylpropanoyl]pyrrolidine-2-carboxamide"
  },
  {
    "chemicalName": "Harringtonine",
    "SMILES": "CC(C)(CCC(CC(=O)OC)(C(=O)OC1C2c3cc4c(cc3CCN5C2(CCC5)C=C1OC)OCO4)O)O",
    "chemicalId": "MQ6",
    "InChI": "InChI=1S/C28H37NO9/c1-26(2,32)8-9-28(33,15-22(30)35-4)25(31)38-24-21(34-3)14-27-7-5-10-29(27)11-6-17-12-19-20(37-16-36-19)13-18(17)23(24)27/h12-14,23-24,32-33H,5-11,15-16H2,1-4H3/t23-,24-,27+,28+/m1/s1",
    "formula_weight": 0.532,
    "number_of_instances": 1,
    "InChIKey": "HAVJATCHLFRDHY-ZBVBGGFBSA-N",
    "SMILES_stereo": "CC(C)(CC[C@](CC(=O)OC)(C(=O)O[C@H]1[C@H]2c3cc4c(cc3CCN5[C@@]2(CCC5)C=C1OC)OCO4)O)O",
    "pdbx_description": "Harringtonine"
  },
  {
    "chemicalName": "DODECYL-BETA-D-MALTOSIDE",
    "SMILES": "CCCCCCCCCCCCOC1C(C(C(C(O1)CO)OC2C(C(C(C(O2)CO)O)O)O)O)O",
    "chemicalId": "LMT",
    "InChI": "InChI=1S/C24H46O11/c1-2-3-4-5-6-7-8-9-10-11-12-32-23-21(31)19(29)22(16(14-26)34-23)35-24-20(30)18(28)17(27)15(13-25)33-24/h15-31H,2-14H2,1H3/t15-,16-,17-,18+,19-,20-,21-,22-,23-,24-/m1/s1",
    "formula_weight": 0.511,
    "number_of_instances": 1,
    "InChIKey": "NLEBIOOXCVAHBD-QKMCSOCLSA-N",
    "pdbx_description": "DODECYL-BETA-D-MALTOSIDE",
    "SMILES_stereo": "CCCCCCCCCCCCO[C@H]1[C@@H]([C@H]([C@@H]([C@H](O1)CO)O[C@@H]2[C@@H]([C@H]([C@@H]([C@H](O2)CO)O)O)O)O)O"
  },
  {
    "chemicalName": "CLINDAMYCIN",
    "SMILES": "CCCC1CC(N(C1)C)C(=O)NC(C2C(C(C(C(O2)SC)O)O)O)C(C)Cl",
    "chemicalId": "CLY",
    "InChI": "InChI=1S/C18H33ClN2O5S/c1-5-6-10-7-11(21(3)8-10)17(25)20-12(9(2)19)16-14(23)13(22)15(24)18(26-16)27-4/h9-16,18,22-24H,5-8H2,1-4H3,(H,20,25)/t9-,10+,11-,12+,13-,14+,15+,16+,18+/m0/s1",
    "formula_weight": 0.425,
    "number_of_instances": 1,
    "drugbank_id": "DB01190",
    "drugbank_description": "Clindamycin is a semi-synthetic lincosamide antibiotic used in the treatment of a variety of serious infections due to susceptible microorganisms[L11599,L11596] as well as topically for acne vulgaris.[L11593] It has a relatively narrow spectrum of activity that includes anaerobic bacteria as well as gram-positive cocci and bacilli and gram-negative bacilli.[A190621] Interestingly, clindamycin appears to carry some activity against protozoans, and has been used off-label in the treatment of toxoplasmosis, malaria, and babesiosis.[A190657]  Clindamycin is derived from, and has largely replaced, [lincomycin], a naturally occurring lincosamide and the eponymous member of this antibiotic class, due to its improved properties over the parent compound. The name lincomycin is derived from Lincoln, Nebraska, where it was first isolated from _Streptomyces lincolnensis_ found in a soil sample.[A190621]",
    "InChIKey": "KDLRVYVGXIQJDK-AWPVFWJPSA-N",
    "pdbx_description": "CLINDAMYCIN",
    "SMILES_stereo": "CCC[C@@H]1C[C@H]([N@@](C1)C)C(=O)N[C@@H]([C@@H]2[C@@H]([C@@H]([C@H]([C@H](O2)SC)O)O)O)[C@H](C)Cl"
  },
  {
    "chemicalName": "(11R,12S)- Mefloquine",
    "SMILES": "c1cc2c(cc(nc2c(c1)C(F)(F)F)C(F)(F)F)C(C3CCCCN3)O",
    "chemicalId": "YMZ",
    "InChI": "InChI=1S/C17H16F6N2O/c18-16(19,20)11-5-3-4-9-10(15(26)12-6-1-2-7-24-12)8-13(17(21,22)23)25-14(9)11/h3-5,8,12,15,24,26H,1-2,6-7H2/t12-,15+/m0/s1",
    "formula_weight": 0.378,
    "number_of_instances": 2,
    "InChIKey": "XEEQGYMUWCZPDN-SWLSCSKDSA-N",
    "pdbx_description": "(11R,12S)- Mefloquine",
    "SMILES_stereo": "c1cc2c(cc(nc2c(c1)C(F)(F)F)C(F)(F)F)[C@H]([C@@H]3CCCCN3)O"
  },
  {
    "chemicalName": "TYLOSIN",
    "SMILES": "CCC1C(C=C(C=CC(=O)C(CC(C(C(C(CC(=O)O1)O)C)OC2C(C(C(C(O2)C)OC3CC(C(C(O3)C)O)(C)O)N(C)C)O)CC=O)C)C)COC4C(C(C(C(O4)C)O)OC)OC",
    "chemicalId": "TYK",
    "InChI": "InChI=1S/C46H77NO17/c1-13-33-30(22-58-45-42(57-12)41(56-11)37(52)26(5)60-45)18-23(2)14-15-31(49)24(3)19-29(16-17-48)39(25(4)32(50)20-34(51)62-33)64-44-38(53)36(47(9)10)40(27(6)61-44)63-35-21-46(8,55)43(54)28(7)59-35/h14-15,17-18,24-30,32-33,35-45,50,52-55H,13,16,19-22H2,1-12H3/b15-14+,23-18+/t24-,25+,26-,27-,28+,29+,30-,32-,33-,35+,36-,37-,38-,39-,40-,41-,42-,43+,44+,45-,46-/m1/s1",
    "formula_weight": 0.916,
    "number_of_instances": 2,
    "drugbank_id": "DB11475",
    "drugbank_description": "Tylosin is a bacteriostatic macrolide antibiotic and feed additive used in veterinary medicine. It has a broad spectrum of activity against Gram-positive organisms and a limited range of Gram-negative organisms. Tylosin is produced as a fermentation product of Streptomyces fradiae.",
    "InChIKey": "WBPYTXDJUQJLPQ-VMXQISHHSA-N",
    "pdbx_description": "TYLOSIN",
    "SMILES_stereo": "CC[C@@H]1[C@H](C=C(C=CC(=O)[C@@H](C[C@@H]([C@@H]([C@H]([C@@H](CC(=O)O1)O)C)O[C@H]2[C@@H]([C@H]([C@@H]([C@H](O2)C)O[C@H]3C[C@@]([C@H]([C@@H](O3)C)O)(C)O)N(C)C)O)CC=O)C)/C)CO[C@H]4[C@@H]([C@@H]([C@@H]([C@H](O4)C)O)OC)OC"
  },
  {
    "chemicalName": "(1S,2R,3S,4R,5S,6S)-2,3,4,5,6-PENTAHYDROXYCYCLOHEXYL 2-AMINO-4-{[CARBOXY(IMINO)METHYL]AMINO}-2,3,4,6-TETRADEOXY-ALPHA-D-ARABINO-HEXOPYRANOSIDE",
    "SMILES": "[H]N=C(C(=O)O)NC1CC(C(OC1C)OC2C(C(C(C(C2O)O)O)O)O)N",
    "chemicalId": "KSG",
    "InChI": "InChI=1S/C14H25N3O9/c1-3-5(17-12(16)13(23)24)2-4(15)14(25-3)26-11-9(21)7(19)6(18)8(20)10(11)22/h3-11,14,18-22H,2,15H2,1H3,(H2,16,17)(H,23,24)/t3-,4+,5+,6-,7+,8+,9-,10+,11+,14-/m1/s1",
    "formula_weight": 0.379,
    "number_of_instances": 2,
    "InChIKey": "PVTHJAPFENJVNC-MHRBZPPQSA-N",
    "SMILES_stereo": "[H]/N=C(/C(=O)O)N[C@H]1C[C@@H]([C@H](O[C@@H]1C)OC2[C@H]([C@H](C([C@@H]([C@H]2O)O)O)O)O)N",
    "pdbx_description": "(1S,2R,3S,4R,5S,6S)-2,3,4,5,6-PENTAHYDROXYCYCLOHEXYL 2-AMINO-4-{[CARBOXY(IMINO)METHYL]AMINO}-2,3,4,6-TETRADEOXY-ALPHA-D-ARABINO-HEXOPYRANOSIDE"
  },
  {
    "chemicalName": "FE-S-O HYBRID CLUSTER",
    "SMILES": "O1[Fe]O2[Fe]134O[Fe]356[S]4[Fe]52S6",
    "chemicalId": "FS2",
    "InChI": "InChI=1S/4Fe.3O.2S",
    "formula_weight": 0.336,
    "number_of_instances": 3,
    "InChIKey": "DEAINXNPDRNZAH-UHFFFAOYSA-N",
    "pdbx_description": "FE-S-O HYBRID CLUSTER",
    "SMILES_stereo": "O1[Fe]O2[Fe]134O[Fe]356[S]4[Fe]52S6"
  },
  {
    "chemicalName": "TRYPTOPHAN",
    "SMILES": "c1ccc2c(c1)c(c[nH]2)CC(C(=O)O)N",
    "chemicalId": "TRP",
    "InChI": "InChI=1S/C11H12N2O2/c12-9(11(14)15)5-7-6-13-10-4-2-1-3-8(7)10/h1-4,6,9,13H,5,12H2,(H,14,15)/t9-/m0/s1",
    "formula_weight": 0.204,
    "number_of_instances": 1,
    "drugbank_id": "DB00150",
    "drugbank_description": "An essential amino acid that is necessary for normal growth in infants and for nitrogen balance in adults. It is a precursor of indole alkaloids in plants. It is a precursor of serotonin (hence its use as an antidepressant and sleep aid). It can be a precursor to niacin, albeit inefficiently, in mammals.",
    "InChIKey": "QIVBCDIJIAJPQS-VIFPVBQESA-N",
    "pdbx_description": "TRYPTOPHAN",
    "SMILES_stereo": "c1ccc2c(c1)c(c[nH]2)C[C@@H](C(=O)O)N"
  },
  {
    "chemicalName": "TIGECYCLINE",
    "SMILES": "CC(C)(C)NCC(=O)Nc1cc(c2c(c1O)C(=O)C3=C(C4(C(CC3C2)C(C(=C(C4=O)C(=O)N)O)[NH+](C)C)O)O)[NH+](C)C",
    "chemicalId": "T1C",
    "InChI": "InChI=1S/C29H39N5O8/c1-28(2,3)31-11-17(35)32-15-10-16(33(4)5)13-8-12-9-14-21(34(6)7)24(38)20(27(30)41)26(40)29(14,42)25(39)18(12)23(37)19(13)22(15)36/h10,12,14,21,31,36,38-39,42H,8-9,11H2,1-7H3,(H2,30,41)(H,32,35)/p+2/t12-,14-,21-,29-/m0/s1",
    "formula_weight": 0.588,
    "number_of_instances": 7,
    "InChIKey": "FPZLLRFZJZRHSY-HJYUBDRYSA-P",
    "SMILES_stereo": "CC(C)(C)NCC(=O)Nc1cc(c2c(c1O)C(=O)C3=C([C@]4([C@@H](C[C@@H]3C2)[C@@H](C(=C(C4=O)C(=O)N)O)[NH+](C)C)O)O)[NH+](C)C",
    "pdbx_description": "TIGECYCLINE"
  },
  {
    "chemicalName": "BLASTICIDIN S",
    "SMILES": "[H]N=C(N)N(C)CCC(CC(=O)NC1C=CC(OC1C(=O)O)N2C=CC(=NC2=O)N)N",
    "chemicalId": "BLS",
    "InChI": "InChI=1S/C17H26N8O5/c1-24(16(20)21)6-4-9(18)8-12(26)22-10-2-3-13(30-14(10)15(27)28)25-7-5-11(19)23-17(25)29/h2-3,5,7,9-10,13-14H,4,6,8,18H2,1H3,(H3,20,21)(H,22,26)(H,27,28)(H2,19,23,29)/t9-,10-,13+,14-/m0/s1",
    "formula_weight": 0.422,
    "number_of_instances": 1,
    "InChIKey": "CXNPLSGKWMLZPZ-ZNIXKSQXSA-N",
    "SMILES_stereo": "[H]/N=C(N)/N(C)CC[C@@H](CC(=O)N[C@H]1C=C[C@@H](O[C@@H]1C(=O)O)N2C=CC(=NC2=O)N)N",
    "pdbx_description": "BLASTICIDIN S"
  },
  {
    "chemicalName": "Eravacycline",
    "SMILES": "CN(C)C1C2CC3Cc4c(cc(c(c4C(=C3C(=O)C2(C(=C(C1=O)C(=O)N)O)O)O)O)NC(=O)CN5CCCC5)F",
    "chemicalId": "YQM",
    "InChI": "InChI=1S/C27H31FN4O8/c1-31(2)20-13-8-11-7-12-14(28)9-15(30-16(33)10-32-5-3-4-6-32)21(34)18(12)22(35)17(11)24(37)27(13,40)25(38)19(23(20)36)26(29)39/h9,11,13,20,34-35,38,40H,3-8,10H2,1-2H3,(H2,29,39)(H,30,33)/t11-,13-,20-,27-/m0/s1",
    "formula_weight": 0.559,
    "number_of_instances": 3,
    "InChIKey": "AKLMFDDQCHURPW-ISIOAQNYSA-N",
    "SMILES_stereo": "CN(C)[C@H]1[C@@H]2C[C@@H]3Cc4c(cc(c(c4C(=C3C(=O)[C@@]2(C(=C(C1=O)C(=O)N)O)O)O)O)NC(=O)CN5CCCC5)F",
    "pdbx_description": "Eravacycline"
  },
  {
    "chemicalName": "N-carboxy-L-threonine",
    "SMILES": "CC(C(C(=O)O)NC(=O)O)O",
    "chemicalId": "U6A",
    "InChI": "InChI=1S/C5H9NO5/c1-2(7)3(4(8)9)6-5(10)11/h2-3,6-7H,1H3,(H,8,9)(H,10,11)/t2-,3+/m1/s1",
    "formula_weight": 0.163,
    "number_of_instances": 1,
    "InChIKey": "OJLPTWSLDBSLEH-GBXIJSLDSA-N",
    "pdbx_description": "N-carboxy-L-threonine",
    "SMILES_stereo": "C[C@H]([C@@H](C(=O)O)NC(=O)O)O"
  },
  {
    "chemicalName": "(4S)-2-METHYL-2,4-PENTANEDIOL",
    "SMILES": "CC(CC(C)(C)O)O",
    "chemicalId": "MPD",
    "InChI": "InChI=1S/C6H14O2/c1-5(7)4-6(2,3)8/h5,7-8H,4H2,1-3H3/t5-/m0/s1",
    "formula_weight": 0.118,
    "number_of_instances": 3,
    "drugbank_id": "DB03564",
    "InChIKey": "SVTBMSDMJJWYQN-YFKPBYRVSA-N",
    "SMILES_stereo": "C[C@@H](CC(C)(C)O)O",
    "pdbx_description": "(4S)-2-METHYL-2,4-PENTANEDIOL"
  },
  {
    "chemicalName": "ARGININE",
    "SMILES": "C(CC(C(=O)O)N)CNC(=[NH2+])N",
    "chemicalId": "ARG",
    "InChI": "InChI=1S/C6H14N4O2/c7-4(5(11)12)2-1-3-10-6(8)9/h4H,1-3,7H2,(H,11,12)(H4,8,9,10)/p+1/t4-/m0/s1",
    "formula_weight": 0.175,
    "number_of_instances": 1,
    "drugbank_id": "DB00125",
    "drugbank_description": "An essential amino acid that is physiologically active in the L-form.",
    "InChIKey": "ODKSFYDXXFIFQN-BYPYZUCNSA-O",
    "pdbx_description": "ARGININE",
    "SMILES_stereo": "C(C[C@@H](C(=O)O)N)CNC(=[NH2+])N"
  },
  {
    "chemicalName": "2-[3-(2-HYDROXY-1,1-DIHYDROXYMETHYL-ETHYLAMINO)-PROPYLAMINO]-2-HYDROXYMETHYL-PROPANE-1,3-DIOL",
    "SMILES": "C(CNC(CO)(CO)CO)CNC(CO)(CO)CO",
    "chemicalId": "B3P",
    "InChI": "InChI=1S/C11H26N2O6/c14-4-10(5-15,6-16)12-2-1-3-13-11(7-17,8-18)9-19/h12-19H,1-9H2",
    "formula_weight": 0.282,
    "number_of_instances": 1,
    "drugbank_id": "DB02676",
    "InChIKey": "HHKZCCWKTZRCCL-UHFFFAOYSA-N",
    "SMILES_stereo": "C(CNC(CO)(CO)CO)CNC(CO)(CO)CO",
    "pdbx_description": "2-[3-(2-HYDROXY-1,1-DIHYDROXYMETHYL-ETHYLAMINO)-PROPYLAMINO]-2-HYDROXYMETHYL-PROPANE-1,3-DIOL"
  },
  {
    "chemicalName": "KIRROMYCIN",
    "SMILES": "CCC(C(=O)NCC=CC=C(C)C(C(C)C1C(C(C(O1)C=CC=CC=C(C)C(=O)C2=C(C=CNC2=O)O)O)O)OC)C3(C(C(C(C(O3)C=CC=CC)(C)C)O)O)O",
    "chemicalId": "KIR",
    "InChI": "InChI=1S/C43H60N2O12/c1-9-11-13-21-31-42(6,7)38(50)39(51)43(54,57-31)28(10-2)40(52)44-23-17-16-19-26(4)36(55-8)27(5)37-35(49)34(48)30(56-37)20-15-12-14-18-25(3)33(47)32-29(46)22-24-45-41(32)53/h9,11-22,24,27-28,30-31,34-39,48-51,54H,10,23H2,1-8H3,(H,44,52)(H2,45,46,53)/b11-9-,14-12+,17-16+,20-15+,21-13+,25-18+,26-19+/t27-,28-,30-,31+,34+,35+,36-,37+,38+,39-,43-/m1/s1",
    "formula_weight": 0.797,
    "number_of_instances": 2,
    "InChIKey": "HMSYAPGFKGSXAJ-PAHGNTJYSA-N",
    "SMILES_stereo": "CC[C@H](C(=O)NCC=CC=C(/C)[C@H]([C@@H](C)[C@H]1[C@H]([C@H]([C@H](O1)C=CC=CC=C(/C)C(=O)C2=C(C=CNC2=O)O)O)O)OC)[C@@]3([C@@H]([C@@H](C([C@@H](O3)C=CC=C/C)(C)C)O)O)O",
    "pdbx_description": "KIRROMYCIN"
  },
  {
    "chemicalName": "N-{[(5S)-3-(3-fluoro-4-morpholin-4-ylphenyl)-2-oxo-1,3-oxazolidin-5-yl]methyl}acetamide",
    "SMILES": "CC(=O)NCC1CN(C(=O)O1)c2ccc(c(c2)F)N3CCOCC3",
    "chemicalId": "ZLD",
    "InChI": "InChI=1S/C16H20FN3O4/c1-11(21)18-9-13-10-20(16(22)24-13)12-2-3-15(14(17)8-12)19-4-6-23-7-5-19/h2-3,8,13H,4-7,9-10H2,1H3,(H,18,21)/t13-/m0/s1",
    "formula_weight": 0.337,
    "number_of_instances": 1,
    "drugbank_id": "DB00601",
    "drugbank_description": "Linezolid is a synthetic antibiotic which is used for the treatment of infections caused by aerobic Gram-positive bacteria. Its effects are bacteriostatic against both enterococci and staphylococci and bactericidal against most isolates of streptococci.[L32965] Linezolid exerts its antibacterial activity by inhibiting the initiation of bacterial protein synthesis - more specifically, it binds to the 23S ribosomal RNA of the 50S subunit[A11227,A199050] and, in doing so, prevents the formation of the 70S initiation complex which is essential for bacterial reproduction.  Linezolid was initially approved in 2000 and was the first member of the oxazolidinone antibiotic class.[A233425] A second member of this class, [tedizolid], was approved by the FDA in 2014 and is considered generally more effective and tolerable than its predecessor.",
    "InChIKey": "TYZROVQLWOKYKF-ZDUSSCGKSA-N",
    "SMILES_stereo": "CC(=O)NC[C@H]1CN(C(=O)O1)c2ccc(c(c2)F)N3CCOCC3",
    "pdbx_description": "N-{[(5S)-3-(3-fluoro-4-morpholin-4-ylphenyl)-2-oxo-1,3-oxazolidin-5-yl]methyl}acetamide"
  },
  {
    "chemicalName": "POTASSIUM ION",
    "chemicalId": "K",
    "formula_weight": 0.039,
    "number_of_instances": 141,
    "pdbx_description": "POTASSIUM ION"
  },
  {
    "chemicalName": "SODIUM ION",
    "chemicalId": "NA",
    "formula_weight": 0.023,
    "number_of_instances": 75,
    "pdbx_description": "SODIUM ION"
  },
  {
    "chemicalName": "CHLORIDE ION",
    "chemicalId": "CL",
    "formula_weight": 0.035,
    "number_of_instances": 22,
    "pdbx_description": "CHLORIDE ION"
  },
  {
    "chemicalName": "STRONTIUM ION",
    "chemicalId": "SR",
    "formula_weight": 0.088,
    "number_of_instances": 108,
    "pdbx_description": "STRONTIUM ION"
  },
  {
    "chemicalName": "CADMIUM ION",
    "chemicalId": "CD",
    "formula_weight": 0.112,
    "number_of_instances": 5,
    "pdbx_description": "CADMIUM ION"
  },
  {
    "chemicalName": "ACETYL GROUP",
    "chemicalId": "ACE",
    "formula_weight": 0.044,
    "number_of_instances": 1,
    "pdbx_description": "ACETYL GROUP"
  },
  {
    "chemicalName": "(3R,6R,9S,12S,15S,18S,20R,24aR)-6-[(2S)-butan-2-yl]-3,12-bis[(1R)-1-hydroxy-2-methylpropyl]-8,9,11,17,18-pentamethyl-15-[(2S)-2-methylbutyl]hexadecahydropyrido[1,2-a][1,4,7,10,13,16,19]heptaazacyclohenicosine-1,4,7,10,13,16,19(21H)-heptone",
    "SMILES": "CCC(C)CC1C(=O)N(C(C(=O)N2CCCCC2C(=O)NC(C(=O)NC(C(=O)N(C(C(=O)N(C(C(=O)N1)C(C(C)C)O)C)C)C)C(C)CC)C(C(C)C)O)C)C",
    "chemicalId": "YRB",
    "InChI": "InChI=1S/C40H71N7O9/c1-14-23(7)20-27-39(55)44(11)26(10)38(54)47-19-17-16-18-28(47)34(50)43-30(32(48)21(3)4)35(51)42-29(24(8)15-2)40(56)45(12)25(9)37(53)46(13)31(36(52)41-27)33(49)22(5)6/h21-33,48-49H,14-20H2,1-13H3,(H,41,52)(H,42,51)(H,43,50)/t23-,24-,25-,26-,27-,28+,29+,30+,31-,32+,33+/m0/s1",
    "formula_weight": 0.794,
    "number_of_instances": 1,
    "InChIKey": "XAVQUYSPPUHEAK-ASAMJPPOSA-N",
    "SMILES_stereo": "CC[C@H](C)C[C@H]1C(=O)N([C@H](C(=O)N2CCCC[C@@H]2C(=O)N[C@@H](C(=O)N[C@@H](C(=O)N([C@H](C(=O)N([C@H](C(=O)N1)[C@@H](C(C)C)O)C)C)C)[C@@H](C)CC)[C@@H](C(C)C)O)C)C",
    "pdbx_description": "(3R,6R,9S,12S,15S,18S,20R,24aR)-6-[(2S)-butan-2-yl]-3,12-bis[(1R)-1-hydroxy-2-methylpropyl]-8,9,11,17,18-pentamethyl-15-[(2S)-2-methylbutyl]hexadecahydropyrido[1,2-a][1,4,7,10,13,16,19]heptaazacyclohenicosine-1,4,7,10,13,16,19(21H)-heptone"
  },
  {
    "chemicalName": "(1S,2S,3R,4S,6R)-4,6-diamino-3-{[(2S,3R)-3-amino-6-(aminomethyl)-3,4-dihydro-2H-pyran-2-yl]oxy}-2-hydroxycyclohexyl 3-deoxy-4-C-methyl-3-(methylamino)-beta-L-arabinopyranoside",
    "SMILES": "CC1(COC(C(C1NC)O)OC2C(CC(C(C2O)OC3C(CC=C(O3)CN)N)N)N)O",
    "chemicalId": "SIS",
    "InChI": "InChI=1S/C19H37N5O7/c1-19(27)7-28-18(13(26)16(19)24-2)31-15-11(23)5-10(22)14(12(15)25)30-17-9(21)4-3-8(6-20)29-17/h3,9-18,24-27H,4-7,20-23H2,1-2H3/t9-,10+,11-,12+,13-,14-,15+,16-,17-,18-,19+/m1/s1",
    "formula_weight": 0.448,
    "number_of_instances": 1,
    "drugbank_id": "DB12604",
    "drugbank_description": "Sisomicin has been used in trials studying the treatment of Pyoderma.",
    "InChIKey": "URWAJWIAIPFPJE-YFMIWBNJSA-N",
    "pdbx_description": "(1S,2S,3R,4S,6R)-4,6-diamino-3-{[(2S,3R)-3-amino-6-(aminomethyl)-3,4-dihydro-2H-pyran-2-yl]oxy}-2-hydroxycyclohexyl 3-deoxy-4-C-methyl-3-(methylamino)-beta-L-arabinopyranoside",
    "SMILES_stereo": "C[C@@]1(CO[C@@H]([C@@H]([C@H]1NC)O)O[C@H]2[C@@H](C[C@@H]([C@H]([C@@H]2O)O[C@@H]3[C@@H](CC=C(O3)CN)N)N)N)O"
  },
  {
    "chemicalName": "SERINE",
    "SMILES": "C(C(C(=O)O)N)O",
    "chemicalId": "SER",
    "InChI": "InChI=1S/C3H7NO3/c4-2(1-5)3(6)7/h2,5H,1,4H2,(H,6,7)/t2-/m0/s1",
    "formula_weight": 0.105,
    "number_of_instances": 1,
    "drugbank_id": "DB00133",
    "drugbank_description": "A non-essential amino acid occurring in natural form as the L-isomer. It is synthesized from glycine or threonine. It is involved in the biosynthesis of purines; pyrimidines; and other amino acids.",
    "InChIKey": "MTCFGRXMJLQNBG-REOHCLBHSA-N",
    "SMILES_stereo": "C([C@@H](C(=O)O)N)O",
    "pdbx_description": "SERINE"
  },
  {
    "chemicalName": "N-[(1R,3S,4R,5S)-3-{(1R)-2-[(2R,4r,6S)-2,6-dihydroxypiperidin-4-yl]-1-hydroxyethyl}-4-hydroxy-1,5-dimethylcyclohexyl]benzamide",
    "SMILES": "CC1CC(CC(C1=O)C(CC2CC(=O)NC(=O)C2)O)(C)NC(=O)c3ccccc3",
    "chemicalId": "Z2V",
    "InChI": "InChI=1S/C22H28N2O5/c1-13-11-22(2,24-21(29)15-6-4-3-5-7-15)12-16(20(13)28)17(25)8-14-9-18(26)23-19(27)10-14/h3-7,13-14,16-17,25H,8-12H2,1-2H3,(H,24,29)(H,23,26,27)/t13-,16-,17+,22+/m0/s1",
    "formula_weight": 0.4,
    "number_of_instances": 1,
    "InChIKey": "HNMIURKVBYLOSU-NYGMARBTSA-N",
    "SMILES_stereo": "C[C@H]1C[C@@](C[C@H](C1=O)[C@@H](CC2CC(=O)NC(=O)C2)O)(C)NC(=O)c3ccccc3",
    "pdbx_description": "N-[(1R,3S,4R,5S)-3-{(1R)-2-[(2R,4r,6S)-2,6-dihydroxypiperidin-4-yl]-1-hydroxyethyl}-4-hydroxy-1,5-dimethylcyclohexyl]benzamide"
  },
  {
    "chemicalName": "APRAMYCIN",
    "SMILES": "CNC1C(C2C(CC(C(O2)OC3C(CC(C(C3O)O)N)N)N)OC1OC4C(C(C(C(O4)CO)N)O)O)O",
    "chemicalId": "AM2",
    "InChI": "InChI=1S/C21H41N5O11/c1-26-11-14(30)18-8(33-20(11)37-21-16(32)13(29)10(25)9(4-27)34-21)3-7(24)19(36-18)35-17-6(23)2-5(22)12(28)15(17)31/h5-21,26-32H,2-4,22-25H2,1H3/t5-,6+,7-,8+,9-,10-,11+,12+,13+,14-,15-,16-,17-,18+,19+,20-,21-/m1/s1",
    "formula_weight": 0.54,
    "number_of_instances": 4,
    "drugbank_id": "DB04626",
    "drugbank_description": "Apramycin is an aminoglycoside antibiotic and has a bactericidal action against many gram-negative bacteria. Apramycin is a structurally unique antibiotic that contains a bicyclic sugar moiety and a monosubstituted deoxystreptamine. It is not approved for use in humans.",
    "InChIKey": "XZNUGFQTQHRASN-XQENGBIVSA-N",
    "pdbx_description": "APRAMYCIN",
    "SMILES_stereo": "CN[C@H]1[C@H]([C@@H]2[C@H](C[C@H]([C@H](O2)O[C@@H]3[C@H](C[C@H]([C@@H]([C@H]3O)O)N)N)N)O[C@@H]1O[C@@H]4[C@@H]([C@H]([C@@H]([C@H](O4)CO)N)O)O)O"
  },
  {
    "chemicalName": "(1R,2S,3S,4R,6R)-4,6-diamino-2-{[3-O-(2,6-diamino-2,6-dideoxy-alpha-L-altropyranosyl)-beta-L-arabinofuranosyl]oxy}-3-hydroxycyclohexyl 2-amino-2-deoxy-alpha-D-allopyranoside",
    "SMILES": "C1C(C(C(C(C1N)OC2C(C(C(C(O2)CO)O)O)N)OC3C(C(C(O3)CO)OC4C(C(C(C(O4)CN)O)O)N)O)O)N",
    "chemicalId": "B6M",
    "InChI": "InChI=1S/C23H45N5O14/c24-2-7-13(32)15(34)10(27)21(37-7)41-19-9(4-30)39-23(17(19)36)42-20-12(31)5(25)1-6(26)18(20)40-22-11(28)16(35)14(33)8(3-29)38-22/h5-23,29-36H,1-4,24-28H2/t5-,6-,7+,8-,9+,10-,11-,12+,13+,14-,15-,16+,17-,18-,19+,20+,21+,22-,23-/m1/s1",
    "formula_weight": 0.616,
    "number_of_instances": 1,
    "InChIKey": "UOZODPSAJZTQNH-JMVAARTISA-N",
    "SMILES_stereo": "C1[C@H]([C@@H]([C@@H]([C@@H]([C@@H]1N)O[C@@H]2[C@@H]([C@@H]([C@@H]([C@H](O2)CO)O)O)N)O[C@@H]3[C@@H]([C@H]([C@@H](O3)CO)O[C@H]4[C@@H]([C@H]([C@H]([C@@H](O4)CN)O)O)N)O)O)N",
    "pdbx_description": "(1R,2S,3S,4R,6R)-4,6-diamino-2-{[3-O-(2,6-diamino-2,6-dideoxy-alpha-L-altropyranosyl)-beta-L-arabinofuranosyl]oxy}-3-hydroxycyclohexyl 2-amino-2-deoxy-alpha-D-allopyranoside"
  },
  {
    "chemicalName": "PROLINE",
    "SMILES": "C1CC(NC1)C(=O)O",
    "chemicalId": "PRO",
    "InChI": "InChI=1S/C5H9NO2/c7-5(8)4-2-1-3-6-4/h4,6H,1-3H2,(H,7,8)/t4-/m0/s1",
    "formula_weight": 0.115,
    "number_of_instances": 4,
    "drugbank_id": "DB00172",
    "drugbank_description": "Proline is one of the twenty amino acids used in living organisms as the building blocks of proteins. Proline is sometimes called an imino acid, although the IUPAC definition of an imine requires a carbon-nitrogen double bond. Proline is a non-essential amino acid that is synthesized from glutamic acid. It is an essential component of collagen and is important for proper functioning of joints and tendons.",
    "InChIKey": "ONIBWKKTOPOVIA-BYPYZUCNSA-N",
    "SMILES_stereo": "C1C[C@H](NC1)C(=O)O",
    "pdbx_description": "PROLINE"
  },
  {
    "chemicalName": "beta-D-galactopyranose",
    "SMILES": "C(C1C(C(C(C(O1)O)O)O)O)O",
    "chemicalId": "GAL",
    "InChI": "InChI=1S/C6H12O6/c7-1-2-3(8)4(9)5(10)6(11)12-2/h2-11H,1H2/t2-,3+,4+,5-,6-/m1/s1",
    "formula_weight": 0.18,
    "number_of_instances": 1,
    "InChIKey": "WQZGKKKJIJFFOK-FPRJBGLDSA-N",
    "pdbx_description": "beta-D-galactopyranose",
    "SMILES_stereo": "C([C@@H]1[C@@H]([C@@H]([C@H]([C@@H](O1)O)O)O)O)O"
  },
  {
    "chemicalName": "EDEINE B",
    "SMILES": "[H]N=C(CCCCNCCCNC(=O)CNC(=O)CC(C(CCCC(C(=O)O)NC(=O)C(CN)NC(=O)C(CNC(=O)CC(c1ccc(cc1)O)N)O)N)O)N",
    "chemicalId": "EDE",
    "InChI": "InChI=1S/C34H59N11O10/c35-17-25(45-33(53)27(48)18-42-29(49)15-23(37)20-8-10-21(46)11-9-20)32(52)44-24(34(54)55)6-3-5-22(36)26(47)16-30(50)43-19-31(51)41-14-4-13-40-12-2-1-7-28(38)39/h8-11,22-27,40,46-48H,1-7,12-19,35-37H2,(H3,38,39)(H,41,51)(H,42,49)(H,43,50)(H,44,52)(H,45,53)(H,54,55)/t22-,23-,24+,25-,26+,27-/m0/s1",
    "formula_weight": 0.782,
    "number_of_instances": 1,
    "InChIKey": "WEPSNLBXXUYQJF-LQXCWRENSA-N",
    "SMILES_stereo": "[H]/N=C(CCCCNCCCNC(=O)CNC(=O)C[C@H]([C@H](CCC[C@H](C(=O)O)NC(=O)[C@H](CN)NC(=O)[C@H](CNC(=O)C[C@@H](c1ccc(cc1)O)N)O)N)O)/N",
    "pdbx_description": "EDEINE B"
  },
  {
    "chemicalName": "PHOSPHOAMINOPHOSPHONIC ACID-ADENYLATE ESTER",
    "SMILES": "c1nc(c2c(n1)n(cn2)C3C(C(C(O3)COP(=O)(O)OP(=O)(NP(=O)(O)O)O)O)O)N",
    "chemicalId": "ANP",
    "InChI": "InChI=1S/C10H17N6O12P3/c11-8-5-9(13-2-12-8)16(3-14-5)10-7(18)6(17)4(27-10)1-26-31(24,25)28-30(22,23)15-29(19,20)21/h2-4,6-7,10,17-18H,1H2,(H,24,25)(H2,11,12,13)(H4,15,19,20,21,22,23)/t4-,6-,7-,10-/m1/s1",
    "formula_weight": 0.506,
    "number_of_instances": 2,
    "InChIKey": "PVKSNHVPLWYQGJ-KQYNXXCUSA-N",
    "SMILES_stereo": "c1nc(c2c(n1)n(cn2)[C@H]3[C@@H]([C@@H]([C@H](O3)CO[P@](=O)(O)O[P@@](=O)(NP(=O)(O)O)O)O)O)N",
    "pdbx_description": "PHOSPHOAMINOPHOSPHONIC ACID-ADENYLATE ESTER"
  },
  {
    "chemicalName": "(1R,2R,3S,4R,6S)-4,6-diamino-2-{[3-O-(2,6-diamino-2,6-dideoxy-beta-L-idopyranosyl)-beta-D-ribofuranosyl]oxy}-3-hydroxyc yclohexyl 2-amino-2,4-dideoxy-4-propyl-alpha-D-glucopyranoside",
    "SMILES": "CCCC1C(OC(C(C1O)N)OC2C(CC(C(C2OC3C(C(C(O3)CO)OC4C(C(C(C(O4)CN)O)O)N)O)O)N)N)CO",
    "chemicalId": "LUJ",
    "InChI": "InChI=1S/C26H51N5O13/c1-2-3-8-12(6-32)40-24(14(30)16(8)34)42-21-10(29)4-9(28)17(35)23(21)44-26-20(38)22(13(7-33)41-26)43-25-15(31)19(37)18(36)11(5-27)39-25/h8-26,32-38H,2-7,27-31H2,1H3/t8-,9-,10+,11+,12-,13-,14-,15-,16+,17+,18-,19-,20-,21-,22-,23-,24-,25-,26+/m1/s1",
    "formula_weight": 0.642,
    "number_of_instances": 6,
    "InChIKey": "GSHRTHLCTXGYPA-RNNXBIGMSA-N",
    "SMILES_stereo": "CCC[C@@H]1[C@H](O[C@@H]([C@@H]([C@H]1O)N)O[C@@H]2[C@H](C[C@H]([C@@H]([C@H]2O[C@H]3[C@@H]([C@@H]([C@H](O3)CO)O[C@@H]4[C@@H]([C@H]([C@@H]([C@@H](O4)CN)O)O)N)O)O)N)N)CO",
    "pdbx_description": "(1R,2R,3S,4R,6S)-4,6-diamino-2-{[3-O-(2,6-diamino-2,6-dideoxy-beta-L-idopyranosyl)-beta-D-ribofuranosyl]oxy}-3-hydroxyc yclohexyl 2-amino-2,4-dideoxy-4-propyl-alpha-D-glucopyranoside"
  },
  {
    "chemicalName": "PUROMYCIN",
    "SMILES": "CN(C)c1c2c(ncn1)n(cn2)C3C(C(C(O3)CO)NC(=O)C(Cc4ccc(cc4)OC)N)O",
    "chemicalId": "PUY",
    "InChI": "InChI=1S/C22H29N7O5/c1-28(2)19-17-20(25-10-24-19)29(11-26-17)22-18(31)16(15(9-30)34-22)27-21(32)14(23)8-12-4-6-13(33-3)7-5-12/h4-7,10-11,14-16,18,22,30-31H,8-9,23H2,1-3H3,(H,27,32)/t14-,15+,16+,18+,22+/m0/s1",
    "formula_weight": 0.472,
    "number_of_instances": 1,
    "drugbank_id": "DB08437",
    "drugbank_description": "Puromycin is an antibiotic that prevents bacterial protein translation. It is utilized as a selective agent in laboratory cell cultures. Puromycin is toxic to both prokaryotic and eukaryotic cells, resulting in significant cell death at appropriate doses.",
    "InChIKey": "RXWNCPJZOCPEPQ-NVWDDTSBSA-N",
    "pdbx_description": "PUROMYCIN",
    "SMILES_stereo": "CN(C)c1c2c(ncn1)n(cn2)[C@H]3[C@@H]([C@@H]([C@H](O3)CO)NC(=O)[C@H](Cc4ccc(cc4)OC)N)O"
  },
  {
    "chemicalName": "TETRACYCLINE",
    "SMILES": "CC1(c2cccc(c2C(=O)C3=C(C4(C(CC31)C(C(=C(C4=O)C(=O)N)O)N(C)C)O)O)O)O",
    "chemicalId": "TAC",
    "InChI": "InChI=1S/C22H24N2O8/c1-21(31)8-5-4-6-11(25)12(8)16(26)13-9(21)7-10-15(24(2)3)17(27)14(20(23)30)19(29)22(10,32)18(13)28/h4-6,9-10,15,25,27-28,31-32H,7H2,1-3H3,(H2,23,30)/t9-,10-,15-,21+,22-/m0/s1",
    "formula_weight": 0.444,
    "number_of_instances": 1,
    "drugbank_id": "DB00759",
    "drugbank_description": "Tetracycline is a broad spectrum polyketide antibiotic produced by the Streptomyces genus of Actinobacteria. It exerts a bacteriostatic effect on bacteria by binding reversible to the bacterial 30S ribosomal subunit and blocking incoming aminoacyl tRNA from binding to the ribosome acceptor site. It also binds to some extent to the bacterial 50S ribosomal subunit and may alter the cytoplasmic membrane causing intracellular components to leak from bacterial cells.  The FDA withdrew its approval for the use of all liquid oral drug products formulated for pediatric use containing tetracycline in a concentration greater than 25 mg/ml.[L43942] Other formulations of tetracycline continue to be used.",
    "InChIKey": "OFVLGDICTFRJMM-WESIUVDSSA-N",
    "pdbx_description": "TETRACYCLINE",
    "SMILES_stereo": "C[C@]1(c2cccc(c2C(=O)C3=C([C@]4([C@@H](C[C@@H]31)C(C(=C(C4=O)C(=O)N)O)N(C)C)O)O)O)O"
  },
  {
    "chemicalName": "1-cyclopropyl-7-[(4-{[3-({(3aR,4R,7R,8S,9S,10R,11R,13R,14E,15S,15aR)-10-{[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy}-4-ethyl-11-methoxy-3a,7,9,11,13,15-hexamethyl-14-[({3-[5-(methylcarbamoyl)pyridin-3-yl]prop-2-yn-1-yl}oxy)imino]-2,6-dioxododecahydro-2H,4H-[1,3]dioxolo[4,5-c]oxacyclotetradecin-8-yl}oxy)-3-oxopropyl]amino}butyl)amino]-6-fluoro-4-oxo-1,4-dihydroquinoline-3-carboxylic acid (non-preferred name)",
    "SMILES": "CCC1C2(C(C(C(=NOCC#Cc3cc(cnc3)C(=O)NC)C(CC(C(C(C(C(C(=O)O1)C)OC(=O)CCNCCCCNc4cc5c(cc4F)C(=O)C(=CN5C6CC6)C(=O)O)C)OC7C(C(CC(O7)C)N(C)C)O)(C)OC)C)C)OC(=O)O2)C",
    "chemicalId": "A1AEZ",
    "InChI": "InChI=1S/C61H84FN7O16/c1-13-47-61(8)54(84-59(77)85-61)35(4)49(67-79-24-16-17-38-26-39(31-65-30-38)55(73)63-9)33(2)29-60(7,78-12)53(83-58-51(72)46(68(10)11)25-34(3)80-58)36(5)52(37(6)57(76)81-47)82-48(70)20-23-64-21-14-15-22-66-44-28-45-41(27-43(44)62)50(71)42(56(74)75)32-69(45)40-18-19-40/h26-28,30-37,40,46-47,51-54,58,64,66,72H,13-15,18-25,29H2,1-12H3,(H,63,73)(H,74,75)/b67-49+/t33-,34-,35+,36+,37-,46+,47-,51-,52+,53-,54-,58+,60-,61-/m1/s1",
    "formula_weight": 1.19,
    "number_of_instances": 2,
    "InChIKey": "QSECVVVQBOHDAY-AALAPHBKSA-N",
    "pdbx_description": "1-cyclopropyl-7-[(4-{[3-({(3aR,4R,7R,8S,9S,10R,11R,13R,14E,15S,15aR)-10-{[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy}-4-ethyl-11-methoxy-3a,7,9,11,13,15-hexamethyl-14-[({3-[5-(methylcarbamoyl)pyridin-3-yl]prop-2-yn-1-yl}oxy)imino]-2,6-dioxododecahydro-2H,4H-[1,3]dioxolo[4,5-c]oxacyclotetradecin-8-yl}oxy)-3-oxopropyl]amino}butyl)amino]-6-fluoro-4-oxo-1,4-dihydroquinoline-3-carboxylic acid (non-preferred name)",
    "SMILES_stereo": "CC[C@@H]1[C@@]2([C@@H]([C@H](/C(=N/OCC#Cc3cc(cnc3)C(=O)NC)/[C@@H](C[C@@]([C@@H]([C@H]([C@@H]([C@H](C(=O)O1)C)OC(=O)CCNCCCCNc4cc5c(cc4F)C(=O)C(=CN5C6CC6)C(=O)O)C)O[C@H]7[C@@H]([C@H](C[C@H](O7)C)N(C)C)O)(C)OC)C)C)OC(=O)O2)C"
  },
  {
    "chemicalName": "SELENOCYSTEINE",
    "SMILES": "C(C(C(=O)O)N)[SeH]",
    "chemicalId": "SEC",
    "InChI": "InChI=1S/C3H7NO2Se/c4-2(1-7)3(5)6/h2,7H,1,4H2,(H,5,6)/t2-/m0/s1",
    "formula_weight": 0.168,
    "number_of_instances": 1,
    "drugbank_id": "DB02345",
    "drugbank_description": "A naturally occurring amino acid in both eukaryotic and prokaryotic organisms. It is found in tRNAs and in the catalytic site of some enzymes. The genes for glutathione peroxidase and formate dehydrogenase contain the TGA codon, which codes for this amino acid. [PubChem]",
    "InChIKey": "ZKZBPNGNEQAJSX-REOHCLBHSA-N",
    "SMILES_stereo": "C([C@@H](C(=O)O)N)[SeH]",
    "pdbx_description": "SELENOCYSTEINE"
  },
  {
    "chemicalName": "GUANOSINE-5',3'-TETRAPHOSPHATE",
    "SMILES": "c1nc2c(n1C3C(C(C(O3)COP(=O)(O)OP(=O)(O)O)OP(=O)(O)OP(=O)(O)O)O)N=C(NC2=O)N",
    "chemicalId": "G4P",
    "InChI": "InChI=1S/C10H17N5O17P4/c11-10-13-7-4(8(17)14-10)12-2-15(7)9-5(16)6(30-36(26,27)32-34(21,22)23)3(29-9)1-28-35(24,25)31-33(18,19)20/h2-3,5-6,9,16H,1H2,(H,24,25)(H,26,27)(H2,18,19,20)(H2,21,22,23)(H3,11,13,14,17)/t3-,5-,6-,9-/m1/s1",
    "formula_weight": 0.603,
    "number_of_instances": 1,
    "drugbank_id": "DB04022",
    "drugbank_description": "Guanosine tetraphosphate is a guanine nucleotide containing four phosphate groups. Two phosphate groups are esterified to the sugar moiety in the 5' position and the other two in the 2' or 3' position. This nucleotide serves as a messenger to turn off the synthesis of ribosomal RNA when amino acids are not available for protein synthesis.",
    "InChIKey": "BUFLLCUFNHESEH-UUOKFMHZSA-N",
    "pdbx_description": "GUANOSINE-5',3'-TETRAPHOSPHATE",
    "SMILES_stereo": "c1nc2c(n1[C@H]3[C@@H]([C@@H]([C@H](O3)CO[P@](=O)(O)OP(=O)(O)O)O[P@](=O)(O)OP(=O)(O)O)O)N=C(NC2=O)N"
  },
  {
    "chemicalName": "ASPARTIC ACID",
    "SMILES": "C(C(C(=O)O)N)C(=O)O",
    "chemicalId": "ASP",
    "InChI": "InChI=1S/C4H7NO4/c5-2(4(8)9)1-3(6)7/h2H,1,5H2,(H,6,7)(H,8,9)/t2-/m0/s1",
    "formula_weight": 0.133,
    "number_of_instances": 1,
    "drugbank_id": "DB00128",
    "drugbank_description": "One of the non-essential amino acids commonly occurring in the L-form. It is found in animals and plants, especially in sugar cane and sugar beets. It may be a neurotransmitter.",
    "InChIKey": "CKLJMWTZIZZHCS-REOHCLBHSA-N",
    "SMILES_stereo": "C([C@@H](C(=O)O)N)C(=O)O",
    "pdbx_description": "ASPARTIC ACID"
  },
  {
    "chemicalName": "Streptothricin F",
    "SMILES": "C1C(C2C(C(=O)N1)N=C(N2)NC3C(C(C(C(O3)CO)OC(=O)N)O)NC(=O)CC(CCCN)N)O",
    "chemicalId": "OI9",
    "InChI": "InChI=1S/C19H34N8O8/c20-3-1-2-7(21)4-10(30)24-13-14(31)15(35-18(22)33)9(6-28)34-17(13)27-19-25-11-8(29)5-23-16(32)12(11)26-19/h7-9,11-15,17,28-29,31H,1-6,20-21H2,(H2,22,33)(H,23,32)(H,24,30)(H2,25,26,27)/t7-,8+,9+,11+,12-,13+,14-,15-,17+/m0/s1",
    "formula_weight": 0.503,
    "number_of_instances": 2,
    "InChIKey": "NRAUADCLPJTGSF-VLSXYIQESA-N",
    "pdbx_description": "Streptothricin F",
    "SMILES_stereo": "C1[C@H]([C@@H]2[C@@H](C(=O)N1)N=C(N2)N[C@H]3[C@@H]([C@@H]([C@H]([C@H](O3)CO)OC(=O)N)O)NC(=O)C[C@H](CCCN)N)O"
  },
  {
    "chemicalName": "PHOSPHOTHIOPHOSPHORIC ACID-ADENYLATE ESTER",
    "SMILES": "c1nc(c2c(n1)n(cn2)C3C(C(C(O3)COP(=O)(O)OP(=O)(O)OP(=S)(O)O)O)O)N",
    "chemicalId": "AGS",
    "InChI": "InChI=1S/C10H16N5O12P3S/c11-8-5-9(13-2-12-8)15(3-14-5)10-7(17)6(16)4(25-10)1-24-28(18,19)26-29(20,21)27-30(22,23)31/h2-4,6-7,10,16-17H,1H2,(H,18,19)(H,20,21)(H2,11,12,13)(H2,22,23,31)/t4-,6-,7-,10-/m1/s1",
    "formula_weight": 0.523,
    "number_of_instances": 11,
    "drugbank_id": "DB02930",
    "drugbank_description": "A nucleoside triphosphate analogue that is ATP in which one of the oxygens attached to 3-phosphate group is replaced by sulfur.",
    "InChIKey": "NLTUCYMLOPLUHL-KQYNXXCUSA-N",
    "pdbx_description": "PHOSPHOTHIOPHOSPHORIC ACID-ADENYLATE ESTER",
    "SMILES_stereo": "c1nc(c2c(n1)n(cn2)[C@H]3[C@@H]([C@@H]([C@H](O3)COP(=O)(O)OP(=O)(O)OP(=S)(O)O)O)O)N"
  },
  {
    "chemicalName": "Pactamycin",
    "SMILES": "Cc1cccc(c1C(=O)OCC2(C(C(C(C2(C)O)(C(C)O)NC(=O)N(C)C)N)Nc3cccc(c3)C(=O)C)O)O",
    "chemicalId": "PCY",
    "InChI": "InChI=1S/C28H38N4O8/c1-15-9-7-12-20(35)21(15)24(36)40-14-27(39)23(30-19-11-8-10-18(13-19)16(2)33)22(29)28(17(3)34,26(27,4)38)31-25(37)32(5)6/h7-13,17,22-23,30,34-35,38-39H,14,29H2,1-6H3,(H,31,37)/t17-,22-,23-,26-,27+,28-/m0/s1",
    "formula_weight": 0.559,
    "number_of_instances": 2,
    "InChIKey": "WVIUOSJLUCTGFK-JUJPXXQGSA-N",
    "SMILES_stereo": "Cc1cccc(c1C(=O)OC[C@]2([C@H]([C@@H]([C@]([C@@]2(C)O)([C@H](C)O)NC(=O)N(C)C)N)Nc3cccc(c3)C(=O)C)O)O",
    "pdbx_description": "Pactamycin"
  },
  {
    "chemicalName": "Dibekacin",
    "SMILES": "C1CC(C(OC1CN)OC2C(CC(C(C2O)OC3C(C(C(C(O3)CO)O)N)O)N)N)N",
    "chemicalId": "84D",
    "InChI": "InChI=1S/C18H37N5O8/c19-4-6-1-2-7(20)17(28-6)30-15-8(21)3-9(22)16(14(15)27)31-18-13(26)11(23)12(25)10(5-24)29-18/h6-18,24-27H,1-5,19-23H2/t6-,7+,8-,9+,10+,11-,12+,13+,14-,15+,16-,17+,18+/m0/s1",
    "formula_weight": 0.452,
    "number_of_instances": 13,
    "drugbank_id": "DB13270",
    "drugbank_description": "Dibekacin is an aminoglycoside antibiotic marketed in Japan [L5623].",
    "InChIKey": "JJCQSGDBDPYCEO-XVZSLQNASA-N",
    "pdbx_description": "Dibekacin",
    "SMILES_stereo": "C1C[C@H]([C@H](O[C@@H]1CN)O[C@@H]2[C@H](C[C@H]([C@@H]([C@H]2O)O[C@@H]3[C@@H]([C@H]([C@@H]([C@H](O3)CO)O)N)O)N)N)N"
  },
  {
    "chemicalName": "GENETICIN",
    "SMILES": "CC(C1C(C(C(C(O1)OC2C(CC(C(C2O)OC3C(C(C(CO3)(C)O)NC)O)N)N)N)O)O)O",
    "chemicalId": "GET",
    "InChI": "InChI=1S/C20H40N4O10/c1-6(25)14-11(27)10(26)9(23)18(32-14)33-15-7(21)4-8(22)16(12(15)28)34-19-13(29)17(24-3)20(2,30)5-31-19/h6-19,24-30H,4-5,21-23H2,1-3H3/t6-,7+,8-,9-,10-,11+,12+,13-,14-,15-,16+,17-,18-,19-,20+/m1/s1",
    "formula_weight": 0.497,
    "number_of_instances": 2,
    "drugbank_id": "DB04263",
    "drugbank_description": "Geneticin (also known as G418) is an aminoglycoside antibiotic similar in structure to gentamicin B1, produced by Micromonospora rhodorangea. Geneticin blocks polypeptide synthesis by inhibiting the elongation step in both prokaryotic and eukaryotic cells and is commonly used in laboratory research to select genetically engineered cells. Resistance to Geneticin is conferred by the neo gene from Tn5 encoding an aminoglycoside 3‘-phosphotransferase, APH 3‘ II.",
    "InChIKey": "BRZYSWJRSDMWLG-DJWUNRQOSA-N",
    "pdbx_description": "GENETICIN",
    "SMILES_stereo": "C[C@H]([C@@H]1[C@H]([C@@H]([C@H]([C@H](O1)O[C@@H]2[C@H](C[C@H]([C@@H]([C@H]2O)O[C@@H]3[C@@H]([C@H]([C@@](CO3)(C)O)NC)O)N)N)N)O)O)O"
  },
  {
    "chemicalName": "TELITHROMYCIN",
    "SMILES": "CCC1C2(C(C(C(=O)C(CC(C(C(C(=O)C(C(=O)O1)C)C)OC3C(C(CC(O3)C)N(C)C)O)(C)OC)C)C)N(C(=O)O2)CCCCn4cc(nc4)c5cccnc5)C",
    "chemicalId": "TEL",
    "InChI": "InChI=1S/C43H65N5O10/c1-12-33-43(8)37(48(41(53)58-43)19-14-13-18-47-23-31(45-24-47)30-16-15-17-44-22-30)27(4)34(49)25(2)21-42(7,54-11)38(28(5)35(50)29(6)39(52)56-33)57-40-36(51)32(46(9)10)20-26(3)55-40/h15-17,22-29,32-33,36-38,40,51H,12-14,18-21H2,1-11H3/t25-,26-,27+,28+,29-,32+,33-,36-,37-,38-,40+,42-,43-/m1/s1",
    "formula_weight": 0.812,
    "number_of_instances": 2,
    "drugbank_id": "DB00976",
    "drugbank_description": "Telithromycin, a semi-synthetic erythromycin derivative, belongs to a new chemical class of antibiotics called ketolides. Ketolides have been recently added to the macrolide-lincosamide-streptogramin class of antibiotics. Similar to the macrolide antibiotics, telithromycin prevents bacterial growth by interfering with bacterial protein synthesis. Telithromycin binds to the 50S subunit of the 70S bacterial ribosome and blocks further peptide elongation. Binding occurs simultaneously at to two domains of 23S RNA of the 50S ribosomal subunit, domain II and V, where older macrolides bind only to one. It is used to treat mild to moderate respiratory infections.",
    "InChIKey": "LJVAJPDWBABPEJ-PNUFFHFMSA-N",
    "pdbx_description": "TELITHROMYCIN",
    "SMILES_stereo": "CC[C@@H]1[C@@]2([C@@H]([C@H](C(=O)[C@@H](C[C@@]([C@@H]([C@H](C(=O)[C@H](C(=O)O1)C)C)O[C@H]3[C@@H]([C@H](C[C@H](O3)C)N(C)C)O)(C)OC)C)C)N(C(=O)O2)CCCCn4cc(nc4)c5cccnc5)C"
  },
  {
    "chemicalName": "Contezolid",
    "SMILES": "c1conc1NCC2CN(C(=O)O2)c3cc(c(c(c3F)F)N4CCC(=O)C=C4)F",
    "chemicalId": "ZC0",
    "InChI": "InChI=1S/C18H15F3N4O4/c19-12-7-13(15(20)16(21)17(12)24-4-1-10(26)2-5-24)25-9-11(29-18(25)27)8-22-14-3-6-28-23-14/h1,3-4,6-7,11H,2,5,8-9H2,(H,22,23)/t11-/m0/s1",
    "formula_weight": 0.408,
    "number_of_instances": 1,
    "drugbank_id": "DB12796",
    "drugbank_description": "MRX-I has been used in trials studying the treatment of Bacterial Infections.",
    "InChIKey": "SULYVXZZUMRQAX-NSHDSACASA-N",
    "pdbx_description": "Contezolid",
    "SMILES_stereo": "c1conc1NC[C@H]2CN(C(=O)O2)c3cc(c(c(c3F)F)N4CCC(=O)C=C4)F"
  },
  {
    "chemicalName": "(2R,3R,4R,5R)-2-((1S,2S,3R,4S,6R)-4,6-DIAMINO-3-((2R,3R,6S)-3-AMINO-6-(AMINOMETHYL)-TETRAHYDRO-2H-PYRAN-2-YLOXY)-2-HYDR OXYCYCLOHEXYLOXY)-5-METHYL-4-(METHYLAMINO)-TETRAHYDRO-2H-PYRAN-3,5-DIOL",
    "SMILES": "CC1(COC(C(C1NC)O)OC2C(CC(C(C2O)OC3C(CCC(O3)CN)N)N)N)O",
    "chemicalId": "LLL",
    "InChI": "InChI=1S/C19H39N5O7/c1-19(27)7-28-18(13(26)16(19)24-2)31-15-11(23)5-10(22)14(12(15)25)30-17-9(21)4-3-8(6-20)29-17/h8-18,24-27H,3-7,20-23H2,1-2H3/t8-,9+,10-,11+,12-,13+,14+,15-,16+,17+,18+,19-/m0/s1",
    "formula_weight": 0.45,
    "number_of_instances": 4,
    "drugbank_id": "DB04729",
    "InChIKey": "VEGXETMJINRLTH-BOZYPMBZSA-N",
    "SMILES_stereo": "C[C@@]1(CO[C@@H]([C@@H]([C@H]1NC)O)O[C@H]2[C@@H](C[C@@H]([C@H]([C@@H]2O)O[C@@H]3[C@@H](CC[C@H](O3)CN)N)N)N)O",
    "pdbx_description": "(2R,3R,4R,5R)-2-((1S,2S,3R,4S,6R)-4,6-DIAMINO-3-((2R,3R,6S)-3-AMINO-6-(AMINOMETHYL)-TETRAHYDRO-2H-PYRAN-2-YLOXY)-2-HYDR OXYCYCLOHEXYLOXY)-5-METHYL-4-(METHYLAMINO)-TETRAHYDRO-2H-PYRAN-3,5-DIOL"
  },
  {
    "chemicalName": "alpha-D-mannopyranose",
    "SMILES": "C(C1C(C(C(C(O1)O)O)O)O)O",
    "chemicalId": "MAN",
    "InChI": "InChI=1S/C6H12O6/c7-1-2-3(8)4(9)5(10)6(11)12-2/h2-11H,1H2/t2-,3-,4+,5+,6+/m1/s1",
    "formula_weight": 0.18,
    "number_of_instances": 2,
    "InChIKey": "WQZGKKKJIJFFOK-PQMKYFCFSA-N",
    "pdbx_description": "alpha-D-mannopyranose",
    "SMILES_stereo": "C([C@@H]1[C@H]([C@@H]([C@@H]([C@H](O1)O)O)O)O)O"
  },
  {
    "chemicalName": "TC007",
    "SMILES": "C1C(C(C(C(C1N)OC2C(C(C(C(O2)CN)O)O)N)OC3C(C(C(C(O3)CO)O)N)O)O)N",
    "chemicalId": "8UZ",
    "InChI": "InChI=1S/C18H37N5O10/c19-2-6-12(27)13(28)9(23)17(30-6)32-15-5(21)1-4(20)10(25)16(15)33-18-14(29)8(22)11(26)7(3-24)31-18/h4-18,24-29H,1-3,19-23H2/t4-,5+,6-,7-,8+,9-,10+,11-,12-,13-,14-,15-,16-,17-,18+/m1/s1",
    "formula_weight": 0.484,
    "number_of_instances": 4,
    "InChIKey": "NFBWMUNZOXWDAP-BXZIPUBNSA-N",
    "SMILES_stereo": "C1[C@H]([C@@H]([C@H]([C@@H]([C@H]1N)O[C@@H]2[C@@H]([C@H]([C@@H]([C@H](O2)CN)O)O)N)O[C@H]3[C@@H]([C@H]([C@@H]([C@H](O3)CO)O)N)O)O)N",
    "pdbx_description": "TC007"
  },
  {
    "chemicalName": "URIDINE 5'-TRIPHOSPHATE",
    "SMILES": "C1=CN(C(=O)NC1=O)C2C(C(C(O2)COP(=O)(O)OP(=O)(O)OP(=O)(O)O)O)O",
    "chemicalId": "UTP",
    "InChI": "InChI=1S/C9H15N2O15P3/c12-5-1-2-11(9(15)10-5)8-7(14)6(13)4(24-8)3-23-28(19,20)26-29(21,22)25-27(16,17)18/h1-2,4,6-8,13-14H,3H2,(H,19,20)(H,21,22)(H,10,12,15)(H2,16,17,18)/t4-,6-,7-,8-/m1/s1",
    "formula_weight": 0.484,
    "number_of_instances": 1,
    "drugbank_id": "DB04005",
    "drugbank_description": "Uridine 5&#39;-(tetrahydrogen triphosphate). A uracil nucleotide containing three phosphate groups esterified to the sugar moiety.",
    "InChIKey": "PGAVKCOVUIYSFO-XVFCMESISA-N",
    "pdbx_description": "URIDINE 5'-TRIPHOSPHATE",
    "SMILES_stereo": "C1=CN(C(=O)NC1=O)[C@H]2[C@@H]([C@@H]([C@H](O2)CO[P@@](=O)(O)O[P@@](=O)(O)OP(=O)(O)O)O)O"
  },
  {
    "chemicalName": "FLAVIN-ADENINE DINUCLEOTIDE",
    "SMILES": "Cc1cc2c(cc1C)N(C3=NC(=O)NC(=O)C3=N2)CC(C(C(COP(=O)(O)OP(=O)(O)OCC4C(C(C(O4)n5cnc6c5ncnc6N)O)O)O)O)O",
    "chemicalId": "FAD",
    "InChI": "InChI=1S/C27H33N9O15P2/c1-10-3-12-13(4-11(10)2)35(24-18(32-12)25(42)34-27(43)33-24)5-14(37)19(39)15(38)6-48-52(44,45)51-53(46,47)49-7-16-20(40)21(41)26(50-16)36-9-31-17-22(28)29-8-30-23(17)36/h3-4,8-9,14-16,19-21,26,37-41H,5-7H2,1-2H3,(H,44,45)(H,46,47)(H2,28,29,30)(H,34,42,43)/t14-,15+,16+,19-,20+,21+,26+/m0/s1",
    "formula_weight": 0.786,
    "number_of_instances": 1,
    "drugbank_id": "DB03147",
    "drugbank_description": "A condensation product of riboflavin and adenosine diphosphate. The coenzyme of various aerobic dehydrogenases, e.g., D-amino acid oxidase and L-amino acid oxidase. (Lehninger, Principles of Biochemistry, 1982, p972) Flavin adenine dinucleotide is approved for use in Japan under the trade name Adeflavin as an ophthalmic treatment for vitamin B2 deficiency.",
    "InChIKey": "VWWQXMAJTJZDQX-UYBVJOGSSA-N",
    "pdbx_description": "FLAVIN-ADENINE DINUCLEOTIDE",
    "SMILES_stereo": "Cc1cc2c(cc1C)N(C3=NC(=O)NC(=O)C3=N2)C[C@@H]([C@@H]([C@@H](CO[P@@](=O)(O)O[P@](=O)(O)OC[C@@H]4[C@H]([C@H]([C@@H](O4)n5cnc6c5ncnc6N)O)O)O)O)O"
  },
  {
    "chemicalName": "Flopristin",
    "SMILES": "CC1C=CC(=O)NCC=CC(=CC(CC(Cc2nc(co2)C(=O)N3CCCC3C(=O)OC1C(C)C)F)O)C",
    "chemicalId": "VIF",
    "InChI": "InChI=1S/C28H38FN3O6/c1-17(2)26-19(4)9-10-24(34)30-11-5-7-18(3)13-21(33)14-20(29)15-25-31-22(16-37-25)27(35)32-12-6-8-23(32)28(36)38-26/h5,7,9-10,13,16-17,19-21,23,26,33H,6,8,11-12,14-15H2,1-4H3,(H,30,34)/b7-5+,10-9+,18-13+/t19-,20-,21-,23-,26-/m1/s1",
    "formula_weight": 0.532,
    "number_of_instances": 2,
    "InChIKey": "DFSJQGCLWZVMOD-IQIMCDJDSA-N",
    "SMILES_stereo": "C[C@@H]1/C=C/C(=O)NC/C=C/C(=C/[C@H](C[C@H](Cc2nc(co2)C(=O)N3CCC[C@@H]3C(=O)O[C@@H]1C(C)C)F)O)/C",
    "pdbx_description": "Flopristin"
  },
  {
    "chemicalName": "3-aminopyridine-4-carboxamide",
    "SMILES": "c1cncc(c1C(=O)N)N",
    "chemicalId": "YRW",
    "InChI": "InChI=1S/C6H7N3O/c7-5-3-9-2-1-4(5)6(8)10/h1-3H,7H2,(H2,8,10)",
    "formula_weight": 0.137,
    "number_of_instances": 1,
    "InChIKey": "MRZUGOPPUMNHGA-UHFFFAOYSA-N",
    "SMILES_stereo": "c1cncc(c1C(=O)N)N",
    "pdbx_description": "3-aminopyridine-4-carboxamide"
  },
  {
    "chemicalName": "3'-amino-3'-deoxyadenosine 5'-(dihydrogen phosphate)",
    "SMILES": "c1nc(c2c(n1)n(cn2)C3C(C(C(O3)COP(=O)(O)O)N)O)N",
    "chemicalId": "8AN",
    "InChI": "InChI=1S/C10H15N6O6P/c11-5-4(1-21-23(18,19)20)22-10(7(5)17)16-3-15-6-8(12)13-2-14-9(6)16/h2-5,7,10,17H,1,11H2,(H2,12,13,14)(H2,18,19,20)/t4-,5-,7-,10-/m1/s1",
    "formula_weight": 0.346,
    "number_of_instances": 2,
    "InChIKey": "WIVGZDLLXCRANL-QYYRPYCUSA-N",
    "SMILES_stereo": "c1nc(c2c(n1)n(cn2)[C@H]3[C@@H]([C@@H]([C@H](O3)COP(=O)(O)O)N)O)N",
    "pdbx_description": "3'-amino-3'-deoxyadenosine 5'-(dihydrogen phosphate)"
  },
  {
    "chemicalName": "LYSINE",
    "SMILES": "C(CC[NH3+])CC(C(=O)O)N",
    "chemicalId": "LYS",
    "InChI": "InChI=1S/C6H14N2O2/c7-4-2-1-3-5(8)6(9)10/h5H,1-4,7-8H2,(H,9,10)/p+1/t5-/m0/s1",
    "formula_weight": 0.147,
    "number_of_instances": 1,
    "drugbank_id": "DB00123",
    "drugbank_description": "Lysine (abbreviated as Lys or K) is an α-amino acid with the chemical formula HO2CCH(NH2)(CH2)4NH2. This amino acid is an essential amino acid, which means that humans cannot synthesize it. Its codons are AAA and AAG. Lysine is a base, as are arginine and histidine. The ε-amino group acts as a site for hydrogen binding and a general base in catalysis. Common posttranslational modifications include methylation of the ε-amino group, giving methyl-, dimethyl-, and trimethyllysine. The latter occurs in calmodulin. Other posttranslational modifications include acetylation. Collagen contains hydroxylysine which is derived from lysine by lysyl hydroxylase. O-Glycosylation of lysine residues in the endoplasmic reticulum or Golgi apparatus is used to mark certain proteins for secretion from the cell.",
    "InChIKey": "KDXKERNSBIXSRK-YFKPBYRVSA-O",
    "SMILES_stereo": "C(CC[NH3+])C[C@@H](C(=O)O)N",
    "pdbx_description": "LYSINE"
  },
  {
    "chemicalName": "7-[4-[3-[[(1~{S},2~{R},5~{R},6~{S},7~{S},8~{R},9~{R},11~{R},13~{R},14~{R})-8-[(2~{S},3~{R},4~{S},6~{R})-4-(dimethylamino)-6-methyl-3-oxidanyl-oxan-2-yl]oxy-2-ethyl-9-methoxy-1,5,7,9,11,13-hexamethyl-4,12,16-tris(oxidanylidene)-3,17-dioxa-15-azabicyclo[12.3.0]heptadecan-6-yl]oxycarbonylamino]propoxy]but-1-ynyl]-1-methyl-4-oxidanylidene-quinoline-3-carboxylic acid",
    "SMILES": "CCC1C2(C(C(C(=O)C(CC(C(C(C(C(C(=O)O1)C)OC(=O)NCCCOCCC#Cc3ccc4c(c3)N(C=C(C4=O)C(=O)O)C)C)OC5C(C(CC(O5)C)N(C)C)O)(C)OC)C)C)NC(=O)O2)C",
    "chemicalId": "A1D6G",
    "InChI": "InChI=1S/C50H72N4O15/c1-13-37-50(8)42(52-48(62)69-50)29(4)38(55)27(2)25-49(7,63-12)43(68-46-40(57)36(53(9)10)23-28(3)65-46)30(5)41(31(6)45(60)66-37)67-47(61)51-20-16-22-64-21-15-14-17-32-18-19-33-35(24-32)54(11)26-34(39(33)56)44(58)59/h18-19,24,26-31,36-37,40-43,46,57H,13,15-16,20-23,25H2,1-12H3,(H,51,61)(H,52,62)(H,58,59)/t27-,28-,29+,30+,31-,36+,37-,40-,41+,42-,43-,46+,49-,50-/m1/s1",
    "formula_weight": 0.969,
    "number_of_instances": 1,
    "InChIKey": "RMPFIFXYVGYBFO-AUSRKKLMSA-N",
    "pdbx_description": "7-[4-[3-[[(1~{S},2~{R},5~{R},6~{S},7~{S},8~{R},9~{R},11~{R},13~{R},14~{R})-8-[(2~{S},3~{R},4~{S},6~{R})-4-(dimethylamino)-6-methyl-3-oxidanyl-oxan-2-yl]oxy-2-ethyl-9-methoxy-1,5,7,9,11,13-hexamethyl-4,12,16-tris(oxidanylidene)-3,17-dioxa-15-azabicyclo[12.3.0]heptadecan-6-yl]oxycarbonylamino]propoxy]but-1-ynyl]-1-methyl-4-oxidanylidene-quinoline-3-carboxylic acid",
    "SMILES_stereo": "CC[C@@H]1[C@@]2([C@@H]([C@H](C(=O)[C@@H](C[C@@]([C@@H]([C@H]([C@@H]([C@H](C(=O)O1)C)OC(=O)NCCCOCCC#Cc3ccc4c(c3)N(C=C(C4=O)C(=O)O)C)C)O[C@H]5[C@@H]([C@H](C[C@H](O5)C)N(C)C)O)(C)OC)C)C)NC(=O)O2)C"
  },
  {
    "chemicalName": "Lefamulin",
    "SMILES": "CC1CCC23CCC(=O)C2C1(C(CC(C(C3C)O)(C)C=C)OC(=O)CSC4CCC(CC4O)N)C",
    "chemicalId": "62B",
    "InChI": "InChI=1S/C28H45NO5S/c1-6-26(4)14-22(34-23(32)15-35-21-8-7-18(29)13-20(21)31)27(5)16(2)9-11-28(17(3)25(26)33)12-10-19(30)24(27)28/h6,16-18,20-22,24-25,31,33H,1,7-15,29H2,2-5H3/t16-,17+,18-,20-,21-,22-,24+,25+,26-,27+,28+/m1/s1",
    "formula_weight": 0.508,
    "number_of_instances": 1,
    "drugbank_id": "DB12825",
    "drugbank_description": "Lefamulin is a pleuromutilin antibiotic used for the treatment of bacterial community-acquired pneumonia. A pleuromotilin is a more recently developed type of antibiotic that is derived from the fungus, Pleurotus mutilus.[A183206] Lefamulin is available in intravenous and oral preparations and was granted FDA approval in August 2019.[L8093]  This drug is the first semi-synthetic pleuromutilin that has been designed for systemic administration. Lefamulin features a novel mechanism of action that shows benefit against resistant bacteria that cause pneumonia.[A183161] The chemical structure of lefamulin contains a tricyclic mutilin core that is necessary for some of its antimicrobial activity.[A183167]",
    "InChIKey": "KPVIXBKIJXZQJX-FCEONZPQSA-N",
    "pdbx_description": "Lefamulin",
    "SMILES_stereo": "C[C@@H]1CC[C@@]23CCC(=O)[C@H]2[C@@]1([C@@H](C[C@@]([C@H]([C@@H]3C)O)(C)C=C)OC(=O)CS[C@@H]4CC[C@H](C[C@H]4O)N)C"
  },
  {
    "chemicalName": "ETHANOL",
    "SMILES": "CCO",
    "chemicalId": "EOH",
    "InChI": "InChI=1S/C2H6O/c1-2-3/h3H,2H2,1H3",
    "formula_weight": 0.046,
    "number_of_instances": 3,
    "drugbank_id": "DB00898",
    "drugbank_description": "A clear, colorless liquid rapidly absorbed from the gastrointestinal tract and distributed throughout the body. It has bactericidal activity and is used often as a topical disinfectant. It is widely used as a solvent and preservative in pharmaceutical preparations as well as serving as the primary ingredient in alcoholic beverages.",
    "InChIKey": "LFQSCWFLJHTTHZ-UHFFFAOYSA-N",
    "pdbx_description": "ETHANOL",
    "SMILES_stereo": "CCO"
  },
  {
    "chemicalName": "4-(2-HYDROXYETHYL)-1-PIPERAZINE ETHANESULFONIC ACID",
    "SMILES": "C1CN(CCN1CCO)CCS(=O)(=O)O",
    "chemicalId": "EPE",
    "InChI": "InChI=1S/C8H18N2O4S/c11-7-5-9-1-3-10(4-2-9)6-8-15(12,13)14/h11H,1-8H2,(H,12,13,14)",
    "formula_weight": 0.238,
    "number_of_instances": 1,
    "drugbank_id": "DB16872",
    "InChIKey": "JKMHFZQWWAIEOD-UHFFFAOYSA-N",
    "SMILES_stereo": "C1CN(CCN1CCO)CCS(=O)(=O)O",
    "pdbx_description": "4-(2-HYDROXYETHYL)-1-PIPERAZINE ETHANESULFONIC ACID"
  },
  {
    "chemicalName": "(3aS,4R,7R,8S,9S,10R,11R,13R,15S,15aR)-4-ethyl-11-methoxy-3a,7,9,11,13,15-hexamethyl-2,6,14-trioxo-10-{[3,4,6-trideoxy-3-(dimethylamino)-beta-D-xylo-hexopyranosyl]oxy}tetradecahydro-2H-oxacyclotetradecino[4,3-d][1,3]oxazol-8-yl (2R)-4,4-dimethyl-2-(pyridin-3-yl)pyrrolidine-1-carboxylate",
    "SMILES": "CCC1C2(C(C(C(=O)C(CC(C(C(C(C(C(=O)O1)C)OC(=O)N3CC(CC3c4cccnc4)(C)C)C)OC5C(C(CC(O5)C)N(C)C)O)(C)OC)C)C)NC(=O)O2)C",
    "chemicalId": "1F4",
    "InChI": "InChI=1S/C43H68N4O11/c1-14-31-43(10)35(45-39(51)58-43)25(4)32(48)23(2)19-42(9,53-13)36(57-38-33(49)29(46(11)12)18-24(3)54-38)26(5)34(27(6)37(50)55-31)56-40(52)47-22-41(7,8)20-30(47)28-16-15-17-44-21-28/h15-17,21,23-27,29-31,33-36,38,49H,14,18-20,22H2,1-13H3,(H,45,51)/t23-,24-,25-,26+,27-,29+,30-,31-,33-,34+,35-,36-,38+,42-,43-/m1/s1",
    "formula_weight": 0.817,
    "number_of_instances": 1,
    "InChIKey": "VHVKUBLHTMYUJJ-KYRVNRAPSA-N",
    "SMILES_stereo": "CC[C@@H]1[C@@]2([C@@H]([C@@H](C(=O)[C@@H](C[C@@]([C@@H]([C@H]([C@@H]([C@H](C(=O)O1)C)OC(=O)N3CC(C[C@@H]3c4cccnc4)(C)C)C)O[C@H]5[C@@H]([C@H](C[C@H](O5)C)N(C)C)O)(C)OC)C)C)NC(=O)O2)C",
    "pdbx_description": "(3aS,4R,7R,8S,9S,10R,11R,13R,15S,15aR)-4-ethyl-11-methoxy-3a,7,9,11,13,15-hexamethyl-2,6,14-trioxo-10-{[3,4,6-trideoxy-3-(dimethylamino)-beta-D-xylo-hexopyranosyl]oxy}tetradecahydro-2H-oxacyclotetradecino[4,3-d][1,3]oxazol-8-yl (2R)-4,4-dimethyl-2-(pyridin-3-yl)pyrrolidine-1-carboxylate"
  },
  {
    "chemicalName": "SPECTINOMYCIN",
    "SMILES": "CC1CC(=O)C2(C(O1)OC3C(C(C(C(C3O2)NC)O)NC)O)O",
    "chemicalId": "SCM",
    "InChI": "InChI=1S/C14H24N2O7/c1-5-4-6(17)14(20)13(21-5)22-12-10(19)7(15-2)9(18)8(16-3)11(12)23-14/h5,7-13,15-16,18-20H,4H2,1-3H3/t5-,7-,8+,9+,10+,11-,12-,13+,14+/m1/s1",
    "formula_weight": 0.332,
    "number_of_instances": 3,
    "drugbank_id": "DB00919",
    "drugbank_description": "An antibiotic produced by Streptomyces spectabilis. It is active against gram-negative bacteria and used for the treatment of gonorrhea.",
    "InChIKey": "UNFWWIHTNXNPBV-WXKVUWSESA-N",
    "pdbx_description": "SPECTINOMYCIN",
    "SMILES_stereo": "C[C@@H]1CC(=O)[C@]2([C@@H](O1)O[C@@H]3[C@H]([C@@H]([C@@H]([C@@H]([C@H]3O2)NC)O)NC)O)O"
  },
  {
    "chemicalName": "(1R,2R,3S,4R,6S)-4,6-diamino-2-{[3-O-(2,6-diamino-2,6-dideoxy-beta-L-idopyranosyl)-beta-D-ribofuranosyl]oxy}-3-hydroxycyclohexyl 2-amino-4,6-O-benzylidene-2-deoxy-alpha-D-glucopyranoside",
    "SMILES": "c1ccc(cc1)C2OCC3C(O2)C(C(C(O3)OC4C(CC(C(C4OC5C(C(C(O5)CO)OC6C(C(C(C(O6)CN)O)O)N)O)O)N)N)N)O",
    "chemicalId": "ON0",
    "InChI": "InChI=1S/C30H49N5O14/c31-7-13-19(38)20(39)16(34)28(43-13)48-24-14(8-36)44-30(22(24)41)49-26-18(37)11(32)6-12(33)23(26)46-29-17(35)21(40)25-15(45-29)9-42-27(47-25)10-4-2-1-3-5-10/h1-5,11-30,36-41H,6-9,31-35H2/t11-,12+,13+,14-,15-,16-,17-,18+,19-,20-,21-,22-,23-,24-,25-,26-,27-,28-,29-,30+/m1/s1",
    "formula_weight": 0.704,
    "number_of_instances": 1,
    "InChIKey": "BJNRNAHKVYQUCR-CQXNUXSXSA-N",
    "SMILES_stereo": "c1ccc(cc1)[C@@H]2OC[C@@H]3[C@@H](O2)[C@@H]([C@H]([C@H](O3)O[C@@H]4[C@H](C[C@H]([C@@H]([C@H]4O[C@H]5[C@@H]([C@@H]([C@H](O5)CO)O[C@@H]6[C@@H]([C@H]([C@@H]([C@@H](O6)CN)O)O)N)O)O)N)N)N)O",
    "pdbx_description": "(1R,2R,3S,4R,6S)-4,6-diamino-2-{[3-O-(2,6-diamino-2,6-dideoxy-beta-L-idopyranosyl)-beta-D-ribofuranosyl]oxy}-3-hydroxycyclohexyl 2-amino-4,6-O-benzylidene-2-deoxy-alpha-D-glucopyranoside"
  },
  {
    "chemicalName": "(2S,3S,4R,5R,6R)-2-(aminomethyl)-5-azanyl-6-[(2R,3S,4R,5S)-5-[(1R,2R,3S,5R,6S)-3,5-bis(azanyl)-2-[(2S,3R,4R,5S,6R)-3-azanyl-5-[(4-chlorophenyl)methoxy]-6-(hydroxymethyl)-4-oxidanyl-oxan-2-yl]oxy-6-oxidanyl-cyclohexyl]oxy-2-(hydroxymethyl)-4-oxidanyl-oxolan-3-yl]oxy-oxane-3,4-diol",
    "SMILES": "c1cc(ccc1COC2C(OC(C(C2O)N)OC3C(CC(C(C3OC4C(C(C(O4)CO)OC5C(C(C(C(O5)CN)O)O)N)O)O)N)N)CO)Cl",
    "chemicalId": "3TS",
    "InChI": "InChI=1S/C30H50ClN5O14/c31-11-3-1-10(2-4-11)9-44-25-15(7-37)46-29(18(36)22(25)42)48-24-13(34)5-12(33)19(39)27(24)50-30-23(43)26(16(8-38)47-30)49-28-17(35)21(41)20(40)14(6-32)45-28/h1-4,12-30,37-43H,5-9,32-36H2/t12-,13+,14+,15-,16-,17-,18-,19+,20-,21-,22-,23-,24-,25-,26-,27-,28-,29-,30+/m1/s1",
    "formula_weight": 0.74,
    "number_of_instances": 1,
    "InChIKey": "OUULYOBVYWOPRB-JCNXQQRHSA-N",
    "SMILES_stereo": "c1cc(ccc1CO[C@@H]2[C@H](O[C@@H]([C@@H]([C@H]2O)N)O[C@@H]3[C@H](C[C@H]([C@@H]([C@H]3O[C@H]4[C@@H]([C@@H]([C@H](O4)CO)O[C@@H]5[C@@H]([C@H]([C@@H]([C@@H](O5)CN)O)O)N)O)O)N)N)CO)Cl",
    "pdbx_description": "(2S,3S,4R,5R,6R)-2-(aminomethyl)-5-azanyl-6-[(2R,3S,4R,5S)-5-[(1R,2R,3S,5R,6S)-3,5-bis(azanyl)-2-[(2S,3R,4R,5S,6R)-3-azanyl-5-[(4-chlorophenyl)methoxy]-6-(hydroxymethyl)-4-oxidanyl-oxan-2-yl]oxy-6-oxidanyl-cyclohexyl]oxy-2-(hydroxymethyl)-4-oxidanyl-oxolan-3-yl]oxy-oxane-3,4-diol"
  },
  {
    "chemicalName": "(2S)-N-[(1R,2S,3S,4R,5S)-4-[(2R,3R,4S,5S,6R)-6-(aminomethyl)-3,4,5-tris(oxidanyl)oxan-2-yl]oxy-5-azanyl-2-[(2S,3R,4S,5S ,6R)-4-azanyl-6-(hydroxymethyl)-3,5-bis(oxidanyl)oxan-2-yl]oxy-3-oxidanyl-cyclohexyl]-4-azanyl-2-oxidanyl-butanamide",
    "SMILES": "C1C(C(C(C(C1NC(=O)C(CCN)O)OC2C(C(C(C(O2)CO)O)N)O)O)OC3C(C(C(C(O3)CN)O)O)O)N",
    "chemicalId": "AKN",
    "InChI": "InChI=1S/C22H43N5O13/c23-2-1-8(29)20(36)27-7-3-6(25)18(39-22-16(34)15(33)13(31)9(4-24)37-22)17(35)19(7)40-21-14(32)11(26)12(30)10(5-28)38-21/h6-19,21-22,28-35H,1-5,23-26H2,(H,27,36)/t6-,7+,8-,9+,10+,11-,12+,13+,14+,15-,16+,17-,18+,19-,21+,22+/m0/s1",
    "formula_weight": 0.586,
    "number_of_instances": 1,
    "drugbank_id": "DB00479",
    "drugbank_description": "Amikacin is a semi-synthetic aminoglycoside antibiotic that is derived from kanamycin A.[FDA label] Amikacin is synthesized by acylation with the l-(-)-γ-amino-α-hydroxybutyryl side chain at the C-1 amino group of the deoxystreptamine moiety of kanamycin A.[A39531]  Amikacin's unique property is that it exerts activity against more resistant gram-negative bacilli such as Acinetobacter baumanii and Pseudomonas aeruginosa. Amikacin also exerts excellent activity against most aerobic gram-negative bacilli from the Enterobacteriaceae family, including Nocardia and some Mycobacterium (M. avium-intracellulare, M. chelonae, and M. fortuitum)[L4680]. M. avium-intracellulare (MAC) is a type of nontuberculous mycobacteria (NTM) found in water and soil. Symptoms of this disease include a persistent cough, fatigue, weight loss, night sweats, and shortness of breath and the coughing up of blood.[L4680]  Several forms of amikacin are used currently, including an intravenous (IV) or intramuscular (IM) injection.[F1949] In September 2018, a liposomal inhalation suspension of this drug was approved by the FDA for the treatment of lung disease caused by Mycobacterium avium complex (MAC) bacteria in a small population of patients with the disease who do not respond to traditional treatment.[L4680,L4681]",
    "InChIKey": "LKCWBDHBTVXHDL-RMDFUYIESA-N",
    "pdbx_description": "(2S)-N-[(1R,2S,3S,4R,5S)-4-[(2R,3R,4S,5S,6R)-6-(aminomethyl)-3,4,5-tris(oxidanyl)oxan-2-yl]oxy-5-azanyl-2-[(2S,3R,4S,5S ,6R)-4-azanyl-6-(hydroxymethyl)-3,5-bis(oxidanyl)oxan-2-yl]oxy-3-oxidanyl-cyclohexyl]-4-azanyl-2-oxidanyl-butanamide",
    "SMILES_stereo": "C1[C@@H]([C@H]([C@@H]([C@H]([C@@H]1NC(=O)[C@H](CCN)O)O[C@@H]2[C@@H]([C@H]([C@@H]([C@H](O2)CO)O)N)O)O)O[C@@H]3[C@@H]([C@H]([C@@H]([C@H](O3)CN)O)O)O)N"
  },
  {
    "chemicalName": "(1S,2S,12bS,12cS)-2,4,5,7,12b,12c-hexahydro-1H-[1,3]dioxolo[4,5-j]pyrrolo[3,2,1-de]phenanthridine-1,2-diol",
    "SMILES": "c1c2c(cc3c1OCO3)C4C(C(C=C5C4N(C2)CC5)O)O",
    "chemicalId": "3KD",
    "InChI": "InChI=1S/C16H17NO4/c18-11-3-8-1-2-17-6-9-4-12-13(21-7-20-12)5-10(9)14(15(8)17)16(11)19/h3-5,11,14-16,18-19H,1-2,6-7H2/t11-,14-,15+,16+/m0/s1",
    "formula_weight": 0.287,
    "number_of_instances": 2,
    "InChIKey": "XGVJWXAYKUHDOO-DANNLKNASA-N",
    "SMILES_stereo": "c1c2c(cc3c1OCO3)[C@@H]4[C@@H]([C@H](C=C5[C@H]4N(C2)CC5)O)O",
    "pdbx_description": "(1S,2S,12bS,12cS)-2,4,5,7,12b,12c-hexahydro-1H-[1,3]dioxolo[4,5-j]pyrrolo[3,2,1-de]phenanthridine-1,2-diol"
  },
  {
    "chemicalName": "3-O-acetyl-2-O-(3-O-acetyl-6-deoxy-beta-D-glucopyranosyl)-6-deoxy-1-O-{[(2R,2'S,3a'R,4''S,5''R,6'S,7a'S)-5''-methyl-4''-{[(2E)-3-phenylprop-2-enoyl]oxy}decahydrodispiro[oxirane-2,3'-[1]benzofuran-2',2''-pyran]-6'-yl]carbonyl}-beta-D-glucopyranose",
    "SMILES": "CC1COC2(CC1OC(=O)C=Cc3ccccc3)C4(CO4)C5CCC(CC5O2)C(=O)OC6C(C(C(C(O6)C)O)OC(=O)C)OC7C(C(C(C(O7)C)O)OC(=O)C)O",
    "chemicalId": "3K5",
    "InChI": "InChI=1S/C40H52O17/c1-19-17-48-40(16-28(19)54-29(43)14-11-24-9-7-6-8-10-24)39(18-49-39)26-13-12-25(15-27(26)57-40)36(47)56-38-35(34(53-23(5)42)31(45)21(3)51-38)55-37-32(46)33(52-22(4)41)30(44)20(2)50-37/h6-11,14,19-21,25-28,30-35,37-38,44-46H,12-13,15-18H2,1-5H3/b14-11+/t19-,20-,21-,25+,26-,27+,28+,30-,31-,32-,33+,34+,35-,37+,38+,39+,40+/m1/s1",
    "formula_weight": 0.805,
    "number_of_instances": 1,
    "InChIKey": "VOTNXJVGRXZYOA-XFJWYURVSA-N",
    "SMILES_stereo": "C[C@@H]1CO[C@]2(C[C@@H]1OC(=O)/C=C/c3ccccc3)[C@]4(CO4)[C@@H]5CC[C@@H](C[C@@H]5O2)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)C)O)OC(=O)C)O[C@H]7[C@@H]([C@H]([C@@H]([C@H](O7)C)O)OC(=O)C)O",
    "pdbx_description": "3-O-acetyl-2-O-(3-O-acetyl-6-deoxy-beta-D-glucopyranosyl)-6-deoxy-1-O-{[(2R,2'S,3a'R,4''S,5''R,6'S,7a'S)-5''-methyl-4''-{[(2E)-3-phenylprop-2-enoyl]oxy}decahydrodispiro[oxirane-2,3'-[1]benzofuran-2',2''-pyran]-6'-yl]carbonyl}-beta-D-glucopyranose"
  },
  {
    "chemicalName": "1-cyclopropyl-7-(4-{4-[({[(3aR,4R,7R,8S,9S,10R,11R,13R,14E,15S,15aR)-10-{[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy}-4-ethyl-11-methoxy-14-(methoxyimino)-3a,7,9,11,13,15-hexamethyl-2,6-dioxododecahydro-2H,4H-[1,3]dioxolo[4,5-c]oxacyclotetradecin-8-yl]oxy}carbonyl)amino]butyl}piperazin-1-yl)-6-fluoro-4-oxo-1,4-dihydroquinoline-3-carboxylic acid (non-preferred name)",
    "SMILES": "CCC1C2(C(C(C(=NOC)C(CC(C(C(C(C(C(=O)O1)C)OC(=O)NCCCCN3CCN(CC3)c4cc5c(cc4F)C(=O)C(=CN5C6CC6)C(=O)O)C)OC7C(C(CC(O7)C)N(C)C)O)(C)OC)C)C)OC(=O)O2)C",
    "chemicalId": "A1AE1",
    "InChI": "InChI=1S/C54H81FN6O15/c1-13-41-54(8)47(75-52(68)76-54)31(4)42(57-70-12)29(2)27-53(7,69-11)46(74-50-44(63)40(58(9)10)24-30(3)71-50)32(5)45(33(6)49(66)72-41)73-51(67)56-18-14-15-19-59-20-22-60(23-21-59)39-26-38-35(25-37(39)55)43(62)36(48(64)65)28-61(38)34-16-17-34/h25-26,28-34,40-41,44-47,50,63H,13-24,27H2,1-12H3,(H,56,67)(H,64,65)/b57-42+/t29-,30-,31+,32+,33-,40+,41-,44-,45+,46-,47-,50+,53-,54-/m1/s1",
    "formula_weight": 1.073,
    "number_of_instances": 2,
    "InChIKey": "RVEYYYFSPNYNOZ-PXZPORDJSA-N",
    "pdbx_description": "1-cyclopropyl-7-(4-{4-[({[(3aR,4R,7R,8S,9S,10R,11R,13R,14E,15S,15aR)-10-{[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy}-4-ethyl-11-methoxy-14-(methoxyimino)-3a,7,9,11,13,15-hexamethyl-2,6-dioxododecahydro-2H,4H-[1,3]dioxolo[4,5-c]oxacyclotetradecin-8-yl]oxy}carbonyl)amino]butyl}piperazin-1-yl)-6-fluoro-4-oxo-1,4-dihydroquinoline-3-carboxylic acid (non-preferred name)",
    "SMILES_stereo": "CC[C@@H]1[C@@]2([C@@H]([C@H](/C(=N/OC)/[C@@H](C[C@@]([C@@H]([C@H]([C@@H]([C@H](C(=O)O1)C)OC(=O)NCCCCN3CCN(CC3)c4cc5c(cc4F)C(=O)C(=CN5C6CC6)C(=O)O)C)O[C@H]7[C@@H]([C@H](C[C@H](O7)C)N(C)C)O)(C)OC)C)C)OC(=O)O2)C"
  },
  {
    "chemicalName": "SPIRAMYCIN I",
    "SMILES": "CC1CC=CC=CC(C(CC(C(C(C(CC(=O)O1)O)OC)OC2C(C(C(C(O2)C)OC3CC(C(C(O3)C)O)(C)O)N(C)C)O)CC=O)C)OC4CCC(C(O4)C)N(C)C",
    "chemicalId": "SPR",
    "InChI": "InChI=1S/C43H74N2O14/c1-24-21-29(19-20-46)39(59-42-37(49)36(45(9)10)38(27(4)56-42)58-35-23-43(6,51)41(50)28(5)55-35)40(52-11)31(47)22-33(48)53-25(2)15-13-12-14-16-32(24)57-34-18-17-30(44(7)8)26(3)54-34/h12-14,16,20,24-32,34-42,47,49-51H,15,17-19,21-23H2,1-11H3/b13-12+,16-14+/t24-,25-,26-,27-,28+,29+,30+,31-,32+,34+,35+,36-,37-,38-,39+,40+,41+,42+,43-/m1/s1",
    "formula_weight": 0.843,
    "number_of_instances": 1,
    "drugbank_id": "DB06145",
    "drugbank_description": "Spiramycin is a primarily bacteriostatic macrolide antimicrobial agent with activity against Gram-positive cocci and rods, Gram-negative cocci and also Legionellae, mycoplasmas, chlamydiae, some types of spirochetes, Toxoplasma gondii and Cryptosporidium. Spiramycin is a 16-membered ring macrolide discovered in 1952 as a product of Streptomyces ambofaciens that has been available in oral formulations since 1955, and parenteral formulations since 1987. Resistant organisms include Enterobacteria, pseudomonads, and moulds.",
    "InChIKey": "ACTOXUHEUCPTEW-CEUOBAOPSA-N",
    "pdbx_description": "SPIRAMYCIN I",
    "SMILES_stereo": "C[C@@H]1CC=CC=C[C@@H]([C@@H](C[C@@H]([C@@H]([C@H]([C@@H](CC(=O)O1)O)OC)O[C@H]2[C@@H]([C@H]([C@@H]([C@H](O2)C)O[C@H]3C[C@@]([C@H]([C@@H](O3)C)O)(C)O)N(C)C)O)CC=O)C)O[C@H]4CC[C@@H]([C@H](O4)C)N(C)C"
  },
  {
    "chemicalName": "CETHROMYCIN",
    "SMILES": "CCC1C2(C(C(C(=O)C(CC(C(C(C(=O)C(C(=O)O1)C)C)OC3C(C(CC(O3)C)N(C)C)O)(C)OCC=Cc4cc5ccccc5nc4)C)C)NC(=O)O2)C",
    "chemicalId": "773",
    "InChI": "InChI=1S/C42H59N3O10/c1-11-32-42(8)36(44-40(50)55-42)25(4)33(46)23(2)21-41(7,51-18-14-15-28-20-29-16-12-13-17-30(29)43-22-28)37(26(5)34(47)27(6)38(49)53-32)54-39-35(48)31(45(9)10)19-24(3)52-39/h12-17,20,22-27,31-32,35-37,39,48H,11,18-19,21H2,1-10H3,(H,44,50)/b15-14+/t23-,24-,25+,26+,27-,31+,32-,35-,36-,37-,39+,41-,42-/m1/s1",
    "formula_weight": 0.766,
    "number_of_instances": 1,
    "InChIKey": "PENDGIOBPJLVBT-ONLVEXIXSA-N",
    "SMILES_stereo": "CC[C@@H]1[C@@]2([C@@H]([C@H](C(=O)[C@@H](C[C@@]([C@@H]([C@H](C(=O)[C@H](C(=O)O1)C)C)O[C@H]3[C@@H]([C@H](C[C@H](O3)C)N(C)C)O)(C)OCC=Cc4cc5ccccc5nc4)C)C)NC(=O)O2)C",
    "pdbx_description": "CETHROMYCIN"
  },
  {
    "chemicalName": "TETRAETHYLENE GLYCOL",
    "SMILES": "C(COCCOCCOCCO)O",
    "chemicalId": "PG4",
    "InChI": "InChI=1S/C8H18O5/c9-1-3-11-5-7-13-8-6-12-4-2-10/h9-10H,1-8H2",
    "formula_weight": 0.194,
    "number_of_instances": 7,
    "InChIKey": "UWHCKJMYHZGTIT-UHFFFAOYSA-N",
    "SMILES_stereo": "C(COCCOCCOCCO)O",
    "pdbx_description": "TETRAETHYLENE GLYCOL"
  },
  {
    "chemicalName": "DI(HYDROXYETHYL)ETHER",
    "SMILES": "C(COCCO)O",
    "chemicalId": "PEG",
    "InChI": "InChI=1S/C4H10O3/c5-1-3-7-4-2-6/h5-6H,1-4H2",
    "formula_weight": 0.106,
    "number_of_instances": 2,
    "InChIKey": "MTHSVFCYNBDYFN-UHFFFAOYSA-N",
    "pdbx_description": "DI(HYDROXYETHYL)ETHER",
    "SMILES_stereo": "C(COCCO)O"
  },
  {
    "chemicalName": "1,2-ETHANEDIOL",
    "SMILES": "C(CO)O",
    "chemicalId": "EDO",
    "InChI": "InChI=1S/C2H6O2/c3-1-2-4/h3-4H,1-2H2",
    "formula_weight": 0.062,
    "number_of_instances": 4,
    "InChIKey": "LYCAIKOWRPUZTN-UHFFFAOYSA-N",
    "SMILES_stereo": "C(CO)O",
    "pdbx_description": "1,2-ETHANEDIOL"
  },
  {
    "chemicalName": "TRIETHYLENE GLYCOL",
    "SMILES": "C(COCCOCCO)O",
    "chemicalId": "PGE",
    "InChI": "InChI=1S/C6H14O4/c7-1-3-9-5-6-10-4-2-8/h7-8H,1-6H2",
    "formula_weight": 0.15,
    "number_of_instances": 1,
    "drugbank_id": "DB02327",
    "InChIKey": "ZIBGPFATKBEMQZ-UHFFFAOYSA-N",
    "SMILES_stereo": "C(COCCOCCO)O",
    "pdbx_description": "TRIETHYLENE GLYCOL"
  },
  {
    "chemicalName": "PENTAETHYLENE GLYCOL",
    "SMILES": "C(COCCOCCOCCOCCO)O",
    "chemicalId": "1PE",
    "InChI": "InChI=1S/C10H22O6/c11-1-3-13-5-7-15-9-10-16-8-6-14-4-2-12/h11-12H,1-10H2",
    "formula_weight": 0.238,
    "number_of_instances": 2,
    "InChIKey": "JLFNLZLINWHATN-UHFFFAOYSA-N",
    "SMILES_stereo": "C(COCCOCCOCCOCCO)O",
    "pdbx_description": "PENTAETHYLENE GLYCOL"
  },
  {
    "chemicalName": "ACETIC ACID",
    "SMILES": "CC(=O)O",
    "chemicalId": "ACY",
    "InChI": "InChI=1S/C2H4O2/c1-2(3)4/h1H3,(H,3,4)",
    "formula_weight": 0.06,
    "number_of_instances": 3,
    "drugbank_id": "DB03166",
    "drugbank_description": "Acetic acid is a product of the oxidation of ethanol and of the destructive distillation of wood. It is used locally, occasionally internally, as a counterirritant and also as a reagent. (Stedman, 26th ed) Acetic acid otic (for the ear) is an antibiotic that treats infections caused by bacteria or fungus.",
    "InChIKey": "QTBSBXVTEAMEQO-UHFFFAOYSA-N",
    "SMILES_stereo": "CC(=O)O",
    "pdbx_description": "ACETIC ACID"
  },
  {
    "chemicalName": "GUANINE",
    "SMILES": "c1[nH]c2c(n1)C(=O)NC(=N2)N",
    "chemicalId": "GUN",
    "InChI": "InChI=1S/C5H5N5O/c6-5-9-3-2(4(11)10-5)7-1-8-3/h1H,(H4,6,7,8,9,10,11)",
    "formula_weight": 0.151,
    "number_of_instances": 1,
    "drugbank_id": "DB02377",
    "InChIKey": "UYTPUPDQBNUYGX-UHFFFAOYSA-N",
    "SMILES_stereo": "c1[nH]c2c(n1)C(=O)NC(=N2)N",
    "pdbx_description": "GUANINE"
  },
  {
    "chemicalName": "2-AMINO-2-HYDROXYMETHYL-PROPANE-1,3-DIOL",
    "SMILES": "C(C(CO)(CO)[NH3+])O",
    "chemicalId": "TRS",
    "InChI": "InChI=1S/C4H11NO3/c5-4(1-6,2-7)3-8/h6-8H,1-3,5H2/p+1",
    "formula_weight": 0.122,
    "number_of_instances": 1,
    "drugbank_id": "DB03754",
    "drugbank_description": "An organic amine proton acceptor. It is used in the synthesis of surface-active agents and pharmaceuticals; as an emulsifying agent for cosmetic creams and lotions, mineral oil and paraffin wax emulsions, as a biological buffer, and used as an alkalizer. (From Merck, 11th ed; Martindale, The Extra Pharmacopoeia, 30th ed, p1424)",
    "InChIKey": "LENZDBCJOHFCAS-UHFFFAOYSA-O",
    "SMILES_stereo": "C(C(CO)(CO)[NH3+])O",
    "pdbx_description": "2-AMINO-2-HYDROXYMETHYL-PROPANE-1,3-DIOL"
  },
  {
    "chemicalName": "N-[(1R,2R)-1,3-dihydroxy-1-(4-nitrophenyl)propan-2-yl]-5-(triphenyl-lambda~5~-phosphanyl)pentanamide",
    "SMILES": "c1ccc(cc1)P(CCCCC(=O)NC(CO)C(c2ccc(cc2)[N+](=O)[O-])O)(c3ccccc3)c4ccccc4",
    "chemicalId": "YXM",
    "InChI": "InChI=1S/C32H35N2O5P/c35-24-30(32(37)25-19-21-26(22-20-25)34(38)39)33-31(36)18-10-11-23-40(27-12-4-1-5-13-27,28-14-6-2-7-15-28)29-16-8-3-9-17-29/h1-9,12-17,19-22,30,32,35,37,40H,10-11,18,23-24H2,(H,33,36)/t30-,32-/m1/s1",
    "formula_weight": 0.559,
    "number_of_instances": 2,
    "InChIKey": "QTBIPHCDEMVXOU-XLJNKUFUSA-N",
    "SMILES_stereo": "c1ccc(cc1)P(CCCCC(=O)N[C@H](CO)[C@@H](c2ccc(cc2)[N+](=O)[O-])O)(c3ccccc3)c4ccccc4",
    "pdbx_description": "N-[(1R,2R)-1,3-dihydroxy-1-(4-nitrophenyl)propan-2-yl]-5-(triphenyl-lambda~5~-phosphanyl)pentanamide"
  },
  {
    "chemicalName": "(2S)-1-amino-N,N,N-trimethyl-1-oxobutan-2-aminium",
    "SMILES": "CCC(C(=O)N)[N+](C)(C)C",
    "chemicalId": "6EM",
    "InChI": "InChI=1S/C7H16N2O/c1-5-6(7(8)10)9(2,3)4/h6H,5H2,1-4H3,(H-,8,10)/p+1/t6-/m0/s1",
    "formula_weight": 0.145,
    "number_of_instances": 1,
    "InChIKey": "LPOFDMFKBRMZLU-LURJTMIESA-O",
    "SMILES_stereo": "CC[C@@H](C(=O)N)[N+](C)(C)C",
    "pdbx_description": "(2S)-1-amino-N,N,N-trimethyl-1-oxobutan-2-aminium"
  },
  {
    "chemicalName": "~{N}-[(1~{R},2~{R})-1-[(2~{R},3~{R},4~{S},5~{R},6~{R})-6-methylsulfanyl-3,4,5-tris(oxidanyl)oxan-2-yl]-2-oxidanyl-propy l]-4-nitro-benzamide",
    "SMILES": "CC(C(C1C(C(C(C(O1)SC)O)O)O)NC(=O)c2ccc(cc2)[N+](=O)[O-])O",
    "chemicalId": "95H",
    "InChI": "InChI=1S/C16H22N2O8S/c1-7(19)10(14-12(21)11(20)13(22)16(26-14)27-2)17-15(23)8-3-5-9(6-4-8)18(24)25/h3-7,10-14,16,19-22H,1-2H3,(H,17,23)/t7-,10-,11+,12-,13-,14-,16-/m1/s1",
    "formula_weight": 0.402,
    "number_of_instances": 1,
    "InChIKey": "KAMQPAUJKUPLQE-CVTPPLIDSA-N",
    "SMILES_stereo": "C[C@H]([C@H]([C@@H]1[C@@H]([C@@H]([C@H]([C@H](O1)SC)O)O)O)NC(=O)c2ccc(cc2)[N+](=O)[O-])O",
    "pdbx_description": "~{N}-[(1~{R},2~{R})-1-[(2~{R},3~{R},4~{S},5~{R},6~{R})-6-methylsulfanyl-3,4,5-tris(oxidanyl)oxan-2-yl]-2-oxidanyl-propy l]-4-nitro-benzamide"
  },
  {
    "chemicalName": "Streptothricin D",
    "SMILES": "C1C(C2C(C(=O)N1)N=C(N2)NC3C(C(C(C(O3)CO)OC(=O)N)O)NC(=O)CC(CCCNC(=O)CC(CCCNC(=O)CC(CCCN)N)N)N)O",
    "chemicalId": "OIY",
    "InChI": "InChI=1S/C31H58N12O10/c32-7-1-4-15(33)10-20(46)37-8-2-5-16(34)11-21(47)38-9-3-6-17(35)12-22(48)40-25-26(49)27(53-30(36)51)19(14-44)52-29(25)43-31-41-23-18(45)13-39-28(50)24(23)42-31/h15-19,23-27,29,44-45,49H,1-14,32-35H2,(H2,36,51)(H,37,46)(H,38,47)(H,39,50)(H,40,48)(H2,41,42,43)/t15-,16-,17-,18+,19+,23+,24-,25+,26-,27-,29+/m0/s1",
    "formula_weight": 0.759,
    "number_of_instances": 12,
    "InChIKey": "WUJTXMVGXDQPNN-OTQKCRDJSA-N",
    "pdbx_description": "Streptothricin D",
    "SMILES_stereo": "C1[C@H]([C@@H]2[C@@H](C(=O)N1)N=C(N2)N[C@H]3[C@@H]([C@@H]([C@H]([C@H](O3)CO)OC(=O)N)O)NC(=O)C[C@H](CCCNC(=O)C[C@H](CCCNC(=O)C[C@H](CCCN)N)N)N)O"
  },
  {
    "chemicalName": "amicetin",
    "SMILES": "CC1C(CCC(O1)N2C=CC(=NC2=O)NC(=O)c3ccc(cc3)NC(=O)C(C)(CO)N)OC4C(C(C(C(O4)C)N(C)C)O)O",
    "chemicalId": "FSD",
    "InChI": "InChI=1S/C29H42N6O9/c1-15-19(44-26-24(38)23(37)22(34(4)5)16(2)43-26)10-11-21(42-15)35-13-12-20(33-28(35)41)32-25(39)17-6-8-18(9-7-17)31-27(40)29(3,30)14-36/h6-9,12-13,15-16,19,21-24,26,36-38H,10-11,14,30H2,1-5H3,(H,31,40)(H,32,33,39,41)/t15-,16-,19+,21-,22-,23+,24-,26-,29+/m1/s1",
    "formula_weight": 0.619,
    "number_of_instances": 2,
    "InChIKey": "HDNVYHWHCVTDIV-ZENIWSRCSA-N",
    "SMILES_stereo": "C[C@@H]1[C@H](CC[C@@H](O1)N2C=CC(=NC2=O)NC(=O)c3ccc(cc3)NC(=O)[C@](C)(CO)N)O[C@@H]4[C@@H]([C@H]([C@@H]([C@H](O4)C)N(C)C)O)O",
    "pdbx_description": "amicetin"
  },
  {
    "chemicalName": "2-[(3~{R},4~{S},5~{S},8~{S},9~{S},10~{S},11~{R},13~{S},14~{S},16~{S})-16-acetyloxy-4,8,10,14-tetramethyl-3,11-bis(oxidanyl)-1,2,3,4,5,6,7,9,11,12,13,15,16,17-tetradecahydrocyclopenta[a]phenanthren-17-yl]-5-cyclopentyl-pentanoic acid",
    "SMILES": "CC1C2CCC3(C(C2(CCC1O)C)C(CC4C3(CC(C4C(CCCC5CCCC5)C(=O)O)OC(=O)C)C)O)C",
    "chemicalId": "WUX",
    "InChI": "InChI=1S/C33H54O6/c1-19-23-13-16-32(4)29(31(23,3)15-14-25(19)35)26(36)17-24-28(27(39-20(2)34)18-33(24,32)5)22(30(37)38)12-8-11-21-9-6-7-10-21/h19,21-29,35-36H,6-18H2,1-5H3,(H,37,38)/t19-,22-,23-,24-,25+,26+,27-,28-,29-,31-,32-,33-/m0/s1",
    "formula_weight": 0.547,
    "number_of_instances": 1,
    "InChIKey": "HKTRXHLPFUKYDU-VDIKIJNFSA-N",
    "SMILES_stereo": "C[C@H]1[C@@H]2CC[C@]3([C@H]([C@]2(CC[C@H]1O)C)[C@@H](C[C@@H]4[C@@]3(C[C@@H](C4C(CCCC5CCCC5)C(=O)O)OC(=O)C)C)O)C",
    "pdbx_description": "2-[(3~{R},4~{S},5~{S},8~{S},9~{S},10~{S},11~{R},13~{S},14~{S},16~{S})-16-acetyloxy-4,8,10,14-tetramethyl-3,11-bis(oxidanyl)-1,2,3,4,5,6,7,9,11,12,13,15,16,17-tetradecahydrocyclopenta[a]phenanthren-17-yl]-5-cyclopentyl-pentanoic acid"
  },
  {
    "chemicalName": "AZITHROMYCIN",
    "SMILES": "CCC1C(C(C(N(CC(CC(C(C(C(C(C(=O)O1)C)OC2CC(C(C(O2)C)O)(C)OC)C)OC3C(C(CC(O3)C)N(C)C)O)(C)O)C)C)C)O)(C)O",
    "chemicalId": "ZIT",
    "InChI": "InChI=1S/C38H72N2O12/c1-15-27-38(10,46)31(42)24(6)40(13)19-20(2)17-36(8,45)33(52-35-29(41)26(39(11)12)16-21(3)48-35)22(4)30(23(5)34(44)50-27)51-28-18-37(9,47-14)32(43)25(7)49-28/h20-33,35,41-43,45-46H,15-19H2,1-14H3/t20-,21-,22+,23-,24-,25+,26+,27-,28+,29-,30+,31-,32+,33-,35+,36-,37-,38-/m1/s1",
    "formula_weight": 0.749,
    "number_of_instances": 1,
    "drugbank_id": "DB00207",
    "drugbank_description": "Azithromycin is a broad-spectrum macrolide antibiotic with a long half-life and a high degree of tissue penetration [A174172]. It was initially approved by the FDA in 1991 [A174175].  It is primarily used for the treatment of respiratory, enteric and genitourinary infections and may be used instead of other macrolides for some sexually transmitted and enteric infections. It is structurally related to erythromycin [A174169].  Azithromycin [9-deoxo-9a-aza-9a-methyl-9a-homoerythromycin] is a part of the _azalide_ subclass of macrolides, and contains a 15-membered ring, with a methyl-substituted nitrogen instead of a carbonyl group at the 9a position on the aglycone ring, which allows for the prevention of its metabolism. This differentiates azithromycin from other types of macrolides [A174175].  In March 2020, a small study was funded by the French government to investigate the treatment of COVID-19 with a combination of azithromycin and the anti-malaria drug [hydroxychloroquine]. The results were positive, all patients taking the combination were virologically cured within 6 days of treatment, however, larger studies are required.[A192546]",
    "InChIKey": "MQTOSJVFKKJCRP-BICOPXKESA-N",
    "pdbx_description": "AZITHROMYCIN",
    "SMILES_stereo": "CC[C@@H]1[C@@]([C@@H]([C@H]([N@@](C[C@@H](C[C@@]([C@@H]([C@H]([C@@H]([C@H](C(=O)O1)C)O[C@H]2C[C@@]([C@H]([C@@H](O2)C)O)(C)OC)C)O[C@H]3[C@@H]([C@H](C[C@H](O3)C)N(C)C)O)(C)O)C)C)C)O)(C)O"
  },
  {
    "chemicalName": "NEGAMYCIN",
    "SMILES": "CN(CC(=O)O)NC(=O)CC(CC(CN)O)N",
    "chemicalId": "NEG",
    "InChI": "InChI=1S/C9H20N4O4/c1-13(5-9(16)17)12-8(15)3-6(11)2-7(14)4-10/h6-7,14H,2-5,10-11H2,1H3,(H,12,15)(H,16,17)/t6-,7-/m1/s1",
    "formula_weight": 0.248,
    "number_of_instances": 1,
    "InChIKey": "IKHFJPZQZVMLRH-RNFRBKRXSA-N",
    "SMILES_stereo": "C[N@@](CC(=O)O)NC(=O)C[C@@H](C[C@H](CN)O)N",
    "pdbx_description": "NEGAMYCIN"
  },
  {
    "chemicalName": "N-[(1R,2R)-1,3-dihydroxy-1-(4-nitrophenyl)propan-2-yl]-L-histidinamide",
    "SMILES": "c1cc(ccc1C(C(CO)NC(=O)C(Cc2c[nH]cn2)N)O)[N+](=O)[O-]",
    "chemicalId": "EZG",
    "InChI": "InChI=1S/C15H19N5O5/c16-12(5-10-6-17-8-18-10)15(23)19-13(7-21)14(22)9-1-3-11(4-2-9)20(24)25/h1-4,6,8,12-14,21-22H,5,7,16H2,(H,17,18)(H,19,23)/t12-,13+,14+/m0/s1",
    "formula_weight": 0.349,
    "number_of_instances": 2,
    "InChIKey": "MMDMFLDVXHCRMV-BFHYXJOUSA-N",
    "SMILES_stereo": "c1cc(ccc1[C@H]([C@@H](CO)NC(=O)[C@H](Cc2c[nH]cn2)N)O)[N+](=O)[O-]",
    "pdbx_description": "N-[(1R,2R)-1,3-dihydroxy-1-(4-nitrophenyl)propan-2-yl]-L-histidinamide"
  },
  {
    "chemicalName": "2,2-dichloro-N-({(5S)-3-[3-fluoro-4-(morpholin-4-yl)phenyl]-2-oxo-1,3-oxazolidin-5-yl}methyl)acetamide",
    "SMILES": "c1cc(c(cc1N2CC(OC2=O)CNC(=O)C(Cl)Cl)F)N3CCOCC3",
    "chemicalId": "G6V",
    "InChI": "InChI=1S/C16H18Cl2FN3O4/c17-14(18)15(23)20-8-11-9-22(16(24)26-11)10-1-2-13(12(19)7-10)21-3-5-25-6-4-21/h1-2,7,11,14H,3-6,8-9H2,(H,20,23)/t11-/m0/s1",
    "formula_weight": 0.406,
    "number_of_instances": 1,
    "InChIKey": "YEXPTKNKQPHGOQ-NSHDSACASA-N",
    "SMILES_stereo": "c1cc(c(cc1N2C[C@@H](OC2=O)CNC(=O)C(Cl)Cl)F)N3CCOCC3",
    "pdbx_description": "2,2-dichloro-N-({(5S)-3-[3-fluoro-4-(morpholin-4-yl)phenyl]-2-oxo-1,3-oxazolidin-5-yl}methyl)acetamide"
  },
  {
    "chemicalName": "2-[[[(3~{R},5~{R})-3-azanyl-6-(3-azanylpropylamino)-5-oxidanyl-hexanoyl]amino]-methyl-amino]ethanoic acid",
    "SMILES": "CN(CC(=O)O)NC(=O)CC(CC(CNCCCN)O)N",
    "chemicalId": "SY5",
    "InChI": "InChI=1S/C12H27N5O4/c1-17(8-12(20)21)16-11(19)6-9(14)5-10(18)7-15-4-2-3-13/h9-10,15,18H,2-8,13-14H2,1H3,(H,16,19)(H,20,21)/t9-,10-/m1/s1",
    "formula_weight": 0.305,
    "number_of_instances": 2,
    "InChIKey": "VBFFWDLIKBQABV-NXEZZACHSA-N",
    "SMILES_stereo": "CN(CC(=O)O)NC(=O)C[C@@H](C[C@H](CNCCCN)O)N",
    "pdbx_description": "2-[[[(3~{R},5~{R})-3-azanyl-6-(3-azanylpropylamino)-5-oxidanyl-hexanoyl]amino]-methyl-amino]ethanoic acid"
  },
  {
    "chemicalName": "1-cyclopropyl-7-{7-[({[(3aR,4R,7R,8S,9S,10R,11R,13R,14E,15S,15aR)-10-{[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy}-4-ethyl-11-methoxy-14-(methoxyimino)-3a,7,9,11,13,15-hexamethyl-2,6-dioxododecahydro-2H,4H-[1,3]dioxolo[4,5-c]oxacyclotetradecin-8-yl]oxy}carbonyl)amino]hept-1-yn-1-yl}-4-oxo-1,4-dihydroquinoline-3-carboxylic acid (non-preferred name)",
    "SMILES": "CCC1C2(C(C(C(=NOC)C(CC(C(C(C(C(C(=O)O1)C)OC(=O)NCCCCCC#Cc3ccc4c(c3)N(C=C(C4=O)C(=O)O)C5CC5)C)OC6C(C(CC(O6)C)N(C)C)O)(C)OC)C)C)OC(=O)O2)C",
    "chemicalId": "A1AE0",
    "InChI": "InChI=1S/C53H76N4O15/c1-13-40-53(8)46(71-51(64)72-53)31(4)41(55-66-12)29(2)27-52(7,65-11)45(70-49-43(59)39(56(9)10)25-30(3)67-49)32(5)44(33(6)48(62)68-40)69-50(63)54-24-18-16-14-15-17-19-34-20-23-36-38(26-34)57(35-21-22-35)28-37(42(36)58)47(60)61/h20,23,26,28-33,35,39-40,43-46,49,59H,13-16,18,21-22,24-25,27H2,1-12H3,(H,54,63)(H,60,61)/b55-41+/t29-,30-,31+,32+,33-,39+,40-,43-,44+,45-,46-,49+,52-,53-/m1/s1",
    "formula_weight": 1.009,
    "number_of_instances": 2,
    "InChIKey": "TYNGZJWSKWCGOH-NPZJNIBRSA-N",
    "pdbx_description": "1-cyclopropyl-7-{7-[({[(3aR,4R,7R,8S,9S,10R,11R,13R,14E,15S,15aR)-10-{[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy}-4-ethyl-11-methoxy-14-(methoxyimino)-3a,7,9,11,13,15-hexamethyl-2,6-dioxododecahydro-2H,4H-[1,3]dioxolo[4,5-c]oxacyclotetradecin-8-yl]oxy}carbonyl)amino]hept-1-yn-1-yl}-4-oxo-1,4-dihydroquinoline-3-carboxylic acid (non-preferred name)",
    "SMILES_stereo": "CC[C@@H]1[C@@]2([C@@H]([C@H](/C(=N/OC)/[C@@H](C[C@@]([C@@H]([C@H]([C@@H]([C@H](C(=O)O1)C)OC(=O)NCCCCCC#Cc3ccc4c(c3)N(C=C(C4=O)C(=O)O)C5CC5)C)O[C@H]6[C@@H]([C@H](C[C@H](O6)C)N(C)C)O)(C)OC)C)C)OC(=O)O2)C"
  },
  {
    "chemicalName": "OXYGEN ATOM",
    "SMILES": "O",
    "chemicalId": "O",
    "InChI": "InChI=1S/H2O/h1H2",
    "formula_weight": 0.016,
    "number_of_instances": 9,
    "InChIKey": "XLYOFNOQVPJJNP-UHFFFAOYSA-N",
    "pdbx_description": "OXYGEN ATOM",
    "SMILES_stereo": "O"
  },
  {
    "chemicalName": "N-acetyl-L-phenylalanine",
    "SMILES": "CC(=O)NC(Cc1ccccc1)C(=O)O",
    "chemicalId": "5CR",
    "InChI": "InChI=1S/C11H13NO3/c1-8(13)12-10(11(14)15)7-9-5-3-2-4-6-9/h2-6,10H,7H2,1H3,(H,12,13)(H,14,15)/t10-/m0/s1",
    "formula_weight": 0.207,
    "number_of_instances": 1,
    "InChIKey": "CBQJSKKFNMDLON-JTQLQIEISA-N",
    "pdbx_description": "N-acetyl-L-phenylalanine",
    "SMILES_stereo": "CC(=O)N[C@@H](Cc1ccccc1)C(=O)O"
  },
  {
    "chemicalName": "OCTADECATUNGSTENYL DIPHOSPHATE",
    "SMILES": "[O][W]1234O[W]567(O[W]89%10(O5[P]5%11O%12[W]%13%14(O6)(O[W]6%15(O1)(O[W]1%16%17(O6[P]6%18O2[W]2(O8)(O3)(O[W]38%19(O6[W](O3)(O1)(O[W]136(O5[W](O8)(O1)(O9)(O[W]15(O%10)(O%118[W](O7)(O%13)(O1)(O[W]8(O3)(O5)(O[W]%12(O%16)(O%14)(O6)[O])[O])[O])[O])[O])[O])(O[W]13(O%17)(O%185[W](O4)(O%15)(O1)(O[W]5(O2)(O%19)(O3)[O])[O])[O])[O])[O])[O])[O])[O])[O])[O])[O]",
    "chemicalId": "WO2",
    "InChI": "InChI=1S/2HO4P.18H2O.36O.18W/c2*1-5(2,3)4;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;/h2*5H;18*1H2;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;/q;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;18*+1/p-18",
    "formula_weight": 4.363,
    "number_of_instances": 12,
    "InChIKey": "WXCYUHHUPKCTBX-UHFFFAOYSA-A",
    "pdbx_description": "OCTADECATUNGSTENYL DIPHOSPHATE",
    "SMILES_stereo": "[O][W]1234O[W]567(O[W]89%10(O5[P]5%11O%12[W]%13%14(O6)(O[W]6%15(O1)(O[W]1%16%17(O6[P]6%18O2[W]2(O8)(O3)(O[W]38%19(O6[W](O3)(O1)(O[W]136(O5[W](O8)(O1)(O9)(O[W]15(O%10)(O%118[W](O7)(O%13)(O1)(O[W]8(O3)(O5)(O[W]%12(O%16)(O%14)(O6)[O])[O])[O])[O])[O])[O])(O[W]13(O%17)(O%185[W](O4)(O%15)(O1)(O[W]5(O2)(O%19)(O3)[O])[O])[O])[O])[O])[O])[O])[O])[O])[O])[O]"
  },
  {
    "chemicalName": "Nagilactone C",
    "SMILES": "CC(C)C1=C2C(C3C4C(C(C5C(C4(C2=CC(=O)O1)C)O5)O)(C(=O)O3)C)O",
    "chemicalId": "3J2",
    "InChI": "InChI=1S/C19H22O7/c1-6(2)11-9-7(5-8(20)24-11)18(3)14-12(10(9)21)26-17(23)19(14,4)15(22)13-16(18)25-13/h5-6,10,12-16,21-22H,1-4H3/t10-,12-,13-,14-,15+,16-,18-,19-/m1/s1",
    "formula_weight": 0.362,
    "number_of_instances": 2,
    "InChIKey": "DGNOPGIIPQKNHD-RSKPZANQSA-N",
    "SMILES_stereo": "CC(C)C1=C2[C@H]([C@@H]3[C@H]4[C@]([C@H]([C@@H]5[C@H]([C@@]4(C2=CC(=O)O1)C)O5)O)(C(=O)O3)C)O",
    "pdbx_description": "Nagilactone C"
  },
  {
    "chemicalName": "GUANOSINE-5'-MONOPHOSPHATE",
    "SMILES": "c1nc2c(n1C3C(C(C(O3)COP(=O)(O)O)O)O)N=C(NC2=O)N",
    "chemicalId": "5GP",
    "InChI": "InChI=1S/C10H14N5O8P/c11-10-13-7-4(8(18)14-10)12-2-15(7)9-6(17)5(16)3(23-9)1-22-24(19,20)21/h2-3,5-6,9,16-17H,1H2,(H2,19,20,21)(H3,11,13,14,18)/t3-,5-,6-,9-/m1/s1",
    "formula_weight": 0.363,
    "number_of_instances": 1,
    "drugbank_id": "DB01972",
    "drugbank_description": "Guanosine 5&#39;-monophosphate. A guanine nucleotide containing one phosphate group esterified to the sugar moiety and found widely in nature. [PubChem]",
    "InChIKey": "RQFCJASXJCIDSX-UUOKFMHZSA-N",
    "pdbx_description": "GUANOSINE-5'-MONOPHOSPHATE",
    "SMILES_stereo": "c1nc2c(n1[C@H]3[C@@H]([C@@H]([C@H](O3)COP(=O)(O)O)O)O)N=C(NC2=O)N"
  },
  {
    "chemicalName": "ADENOSINE-5'-MONOPHOSPHATE",
    "SMILES": "c1nc(c2c(n1)n(cn2)C3C(C(C(O3)COP(=O)(O)O)O)O)N",
    "chemicalId": "A",
    "InChI": "InChI=1S/C10H14N5O7P/c11-8-5-9(13-2-12-8)15(3-14-5)10-7(17)6(16)4(22-10)1-21-23(18,19)20/h2-4,6-7,10,16-17H,1H2,(H2,11,12,13)(H2,18,19,20)/t4-,6-,7-,10-/m1/s1",
    "formula_weight": 0.347,
    "number_of_instances": 1,
    "drugbank_id": "DB00131",
    "drugbank_description": "Adenosine phosphate, or adenylic acid, is an adenine nucleotide containing one phosphate group esterified to the sugar moiety in the 2&#39;-, 3&#39;-, or 5&#39;-position. Adenosine phosphate was withdrawn by the FDA since it was considered neither safe nor effective for its intended uses as a vasodilator and an anti-inflammatory.[L43937]",
    "InChIKey": "UDMBCSSLTHHNCD-KQYNXXCUSA-N",
    "pdbx_description": "ADENOSINE-5'-MONOPHOSPHATE",
    "SMILES_stereo": "c1nc(c2c(n1)n(cn2)[C@H]3[C@@H]([C@@H]([C@H](O3)COP(=O)(O)O)O)O)N"
  },
  {
    "chemicalName": "CYTIDINE-5'-MONOPHOSPHATE",
    "SMILES": "C1=CN(C(=O)N=C1N)C2C(C(C(O2)COP(=O)(O)O)O)O",
    "chemicalId": "C",
    "InChI": "InChI=1S/C9H14N3O8P/c10-5-1-2-12(9(15)11-5)8-7(14)6(13)4(20-8)3-19-21(16,17)18/h1-2,4,6-8,13-14H,3H2,(H2,10,11,15)(H2,16,17,18)/t4-,6-,7-,8-/m1/s1",
    "formula_weight": 0.323,
    "number_of_instances": 1,
    "drugbank_id": "DB03403",
    "drugbank_description": "A pyrimidine ribonucleoside 5'-monophosphate having cytosine as the nucleobase.",
    "InChIKey": "IERHLVCPSMICTF-XVFCMESISA-N",
    "pdbx_description": "CYTIDINE-5'-MONOPHOSPHATE",
    "SMILES_stereo": "C1=CN(C(=O)N=C1N)[C@H]2[C@@H]([C@@H]([C@H](O2)COP(=O)(O)O)O)O"
  },
  {
    "chemicalName": "emetine",
    "SMILES": "CCC1CN2CCc3cc(c(cc3C2CC1CC4c5cc(c(cc5CCN4)OC)OC)OC)OC",
    "chemicalId": "YAT",
    "InChI": "InChI=1S/C29H40N2O4/c1-6-18-17-31-10-8-20-14-27(33-3)29(35-5)16-23(20)25(31)12-21(18)11-24-22-15-28(34-4)26(32-2)13-19(22)7-9-30-24/h13-16,18,21,24-25,30H,6-12,17H2,1-5H3/t18-,21-,24+,25-/m0/s1",
    "formula_weight": 0.481,
    "number_of_instances": 1,
    "drugbank_id": "DB13393",
    "InChIKey": "AUVVAXYIELKVAI-CKBKHPSWSA-N",
    "pdbx_description": "emetine",
    "SMILES_stereo": "CC[C@H]1CN2CCc3cc(c(cc3[C@@H]2C[C@@H]1C[C@@H]4c5cc(c(cc5CCN4)OC)OC)OC)OC"
  },
  {
    "chemicalName": "(4S,5aS,8S,8aR)-4-(2-methylpropyl)-N-[(1R,5Z,7R,8R,9R,10R,11S,12R)-10,11,12-trihydroxy-7-methyl-13-oxa-2-thiabicyclo[7.3.1]tridec-5-en-8-yl]octahydro-2H-oxepino[2,3-c]pyrrole-8-carboxamide (non-preferred name)",
    "SMILES": "CC1C=CCCSC2C(C(C(C(C1NC(=O)C3C4C(CC(CCO4)CC(C)C)CN3)O2)O)O)O",
    "chemicalId": "WC9",
    "InChI": "InChI=1S/C25H42N2O6S/c1-13(2)10-15-7-8-32-22-16(11-15)12-26-18(22)24(31)27-17-14(3)6-4-5-9-34-25-21(30)19(28)20(29)23(17)33-25/h4,6,13-23,25-26,28-30H,5,7-12H2,1-3H3,(H,27,31)/b6-4-/t14-,15+,16+,17-,18+,19+,20-,21-,22-,23-,25-/m1/s1",
    "formula_weight": 0.499,
    "number_of_instances": 2,
    "InChIKey": "GMONVEGLHZWYNO-JBYNEVPESA-N",
    "SMILES_stereo": "C[C@@H]1/C=CCCS[C@@H]2[C@@H]([C@H]([C@H]([C@@H]([C@@H]1NC(=O)[C@@H]3[C@H]4[C@@H](C[C@@H](CCO4)CC(C)C)CN3)O2)O)O)O",
    "pdbx_description": "(4S,5aS,8S,8aR)-4-(2-methylpropyl)-N-[(1R,5Z,7R,8R,9R,10R,11S,12R)-10,11,12-trihydroxy-7-methyl-13-oxa-2-thiabicyclo[7.3.1]tridec-5-en-8-yl]octahydro-2H-oxepino[2,3-c]pyrrole-8-carboxamide (non-preferred name)"
  },
  {
    "chemicalName": "(2S)-4-amino-N-[(1R,2S,3S,4R,5S)-5-amino-4-{[(2S,3R)-3-amino-6-{[(2-hydroxyethyl)amino]methyl}-3,4-dihydro-2H-pyran-2-y l]oxy}-2-{[3-deoxy-4-C-methyl-3-(methylamino)-beta-L-arabinopyranosyl]oxy}-3-hydroxycyclohexyl]-2-hydroxybutanamide",
    "SMILES": "CC1(COC(C(C1NC)O)OC2C(CC(C(C2O)OC3C(CC=C(O3)CNCCO)N)N)NC(=O)C(CCN)O)O",
    "chemicalId": "EDS",
    "InChI": "InChI=1S/C25H48N6O10/c1-25(37)11-38-24(18(35)21(25)29-2)41-20-15(31-22(36)16(33)5-6-26)9-14(28)19(17(20)34)40-23-13(27)4-3-12(39-23)10-30-7-8-32/h3,13-21,23-24,29-30,32-35,37H,4-11,26-28H2,1-2H3,(H,31,36)/t13-,14+,15-,16+,17+,18-,19-,20+,21-,23-,24-,25+/m1/s1",
    "formula_weight": 0.593,
    "number_of_instances": 2,
    "drugbank_id": "DB12615",
    "drugbank_description": "Developed by Achaogen biopharmaceuticals, plazomicin is a next-generation aminoglycoside synthetically derived from [DB12604]. The structure of plazomicin was established via appending hydroxylaminobutyric acid to [DB12604] at position 1 and 2-hydroxyethyl group at position 6' [A33942]. It was designed to evade all clinically relevant aminoglycoside-modifying enzymes, which contribute to the main resistance mechanism for aminoglycoside therapy [A33942]. However, acquired resistance of aminoglycosides may arise through over expression of efflux pumps and ribosomal modification by bacteria, which results from amino acid or rRNA sequence mutations [A33942]. Like other aminoglycosides, plazomicin is ineffective against bacterial isolates that produce 16S rRNA methyltransferases [FDA Label]. Plazomicin mediates the antibacterial activity against pathogens including carbapenem-resistant (CRE) and extended-spectrum beta-lactamase (ESBL) producing _Enterobacteriaceae_. It mediates the antibacterial activity by binding to bacterial 30S ribosomal subunit and inhibiting protein synthesis [FDA Label]. On June 28th, 2018, plazomicin sulfate was approved by the FDA for use in adult patients for the treatment of complicated urinary tract infections (cUTI) including Pyelonephritis. It is marketed as Zemdri and is administered via once-daily intravenous infusion.",
    "InChIKey": "IYDYFVUFSPQPPV-PEXOCOHZSA-N",
    "pdbx_description": "(2S)-4-amino-N-[(1R,2S,3S,4R,5S)-5-amino-4-{[(2S,3R)-3-amino-6-{[(2-hydroxyethyl)amino]methyl}-3,4-dihydro-2H-pyran-2-y l]oxy}-2-{[3-deoxy-4-C-methyl-3-(methylamino)-beta-L-arabinopyranosyl]oxy}-3-hydroxycyclohexyl]-2-hydroxybutanamide",
    "SMILES_stereo": "C[C@@]1(CO[C@@H]([C@@H]([C@H]1NC)O)O[C@H]2[C@@H](C[C@@H]([C@H]([C@@H]2O)O[C@@H]3[C@@H](CC=C(O3)CNCCO)N)N)NC(=O)[C@H](CCN)O)O"
  },
  {
    "chemicalName": "SINEFUNGIN",
    "SMILES": "c1nc(c2c(n1)n(cn2)C3C(C(C(O3)CC(CCC(C(=O)O)N)N)O)O)N",
    "chemicalId": "SFG",
    "InChI": "InChI=1S/C15H23N7O5/c16-6(1-2-7(17)15(25)26)3-8-10(23)11(24)14(27-8)22-5-21-9-12(18)19-4-20-13(9)22/h4-8,10-11,14,23-24H,1-3,16-17H2,(H,25,26)(H2,18,19,20)/t6-,7-,8+,10+,11+,14+/m0/s1",
    "formula_weight": 0.381,
    "number_of_instances": 1,
    "drugbank_id": "DB01910",
    "drugbank_description": "Sinefungin is a solid. This compound belongs to the purine nucleosides and analogues. These are compounds comprising a purine base attached to a sugar. The proteins that adenosyl-ornithine target include RdmB, modification methylase TaqI, rRNA (adenine-N6-)-methyltransferase, and modification methylase RsrI.",
    "InChIKey": "LMXOHSDXUQEUSF-YECHIGJVSA-N",
    "pdbx_description": "SINEFUNGIN",
    "SMILES_stereo": "c1nc(c2c(n1)n(cn2)[C@H]3[C@@H]([C@@H]([C@H](O3)C[C@H](CC[C@@H](C(=O)O)N)N)O)O)N"
  },
  {
    "chemicalName": "VIRGINIAMYCIN M1",
    "SMILES": "CC1C=CC(=O)NCC=CC(=CC(CC(=O)Cc2nc(co2)C(=O)N3CCC=C3C(=O)OC1C(C)C)O)C",
    "chemicalId": "VIR",
    "InChI": "InChI=1S/C28H35N3O7/c1-17(2)26-19(4)9-10-24(34)29-11-5-7-18(3)13-20(32)14-21(33)15-25-30-22(16-37-25)27(35)31-12-6-8-23(31)28(36)38-26/h5,7-10,13,16-17,19-20,26,32H,6,11-12,14-15H2,1-4H3,(H,29,34)/b7-5+,10-9+,18-13+/t19-,20-,26-/m1/s1",
    "formula_weight": 0.526,
    "number_of_instances": 1,
    "drugbank_id": "DB01669",
    "drugbank_description": "Pristinamycin IIA is a macrolide antibiotic, a member of the streptogramin A group of antibiotics, and one component of pristinamycin. It is produced by Streptomyces graminofaciens and other bacteria.",
    "InChIKey": "DAIKHDNSXMZDCU-FQTGFAPKSA-N",
    "pdbx_description": "VIRGINIAMYCIN M1",
    "SMILES_stereo": "C[C@@H]1C=CC(=O)NCC=CC(=C[C@H](CC(=O)Cc2nc(co2)C(=O)N3CCC=C3C(=O)O[C@@H]1C(C)C)O)C"
  },
  {
    "chemicalName": "LINCOMYCIN",
    "SMILES": "CCCC1CC(N(C1)C)C(=O)NC(C2C(C(C(C(O2)SC)O)O)O)C(C)O",
    "chemicalId": "3QB",
    "InChI": "InChI=1S/C18H34N2O6S/c1-5-6-10-7-11(20(3)8-10)17(25)19-12(9(2)21)16-14(23)13(22)15(24)18(26-16)27-4/h9-16,18,21-24H,5-8H2,1-4H3,(H,19,25)/t9-,10-,11+,12-,13+,14-,15-,16-,18-/m1/s1",
    "formula_weight": 0.407,
    "number_of_instances": 1,
    "drugbank_id": "DB01627",
    "drugbank_description": "Lincomycin is a lincosamide antibiotic first isolated from the soil bacterium _Streptomyces lincolnensis_ in Lincoln, Nebraska.[A190621] Clinical use of lincomycin has largely been superseded by its semisynthetic derivative [clindamycin] due to its higher efficacy and a wider range of susceptible organisms, though lincomycin remains in use.[A190657, A190621]  Lincomycin was approved by the FDA on December 29, 1964.[L33214]",
    "InChIKey": "OJMMVQQUTAEWLP-KIDUDLJLSA-N",
    "pdbx_description": "LINCOMYCIN",
    "SMILES_stereo": "CCC[C@@H]1C[C@H](N(C1)C)C(=O)N[C@@H]([C@@H]2[C@@H]([C@@H]([C@H]([C@H](O2)SC)O)O)O)[C@@H](C)O"
  },
  {
    "chemicalName": "ADENOSINE MONOPHOSPHATE",
    "SMILES": "c1nc(c2c(n1)n(cn2)C3C(C(C(O3)COP(=O)(O)O)O)O)N",
    "chemicalId": "AMP",
    "InChI": "InChI=1S/C10H14N5O7P/c11-8-5-9(13-2-12-8)15(3-14-5)10-7(17)6(16)4(22-10)1-21-23(18,19)20/h2-4,6-7,10,16-17H,1H2,(H2,11,12,13)(H2,18,19,20)/t4-,6-,7-,10-/m1/s1",
    "formula_weight": 0.347,
    "number_of_instances": 1,
    "drugbank_id": "DB00131",
    "drugbank_description": "Adenosine phosphate, or adenylic acid, is an adenine nucleotide containing one phosphate group esterified to the sugar moiety in the 2&#39;-, 3&#39;-, or 5&#39;-position. Adenosine phosphate was withdrawn by the FDA since it was considered neither safe nor effective for its intended uses as a vasodilator and an anti-inflammatory.[L43937]",
    "InChIKey": "UDMBCSSLTHHNCD-KQYNXXCUSA-N",
    "pdbx_description": "ADENOSINE MONOPHOSPHATE",
    "SMILES_stereo": "c1nc(c2c(n1)n(cn2)[C@H]3[C@@H]([C@@H]([C@H](O3)COP(=O)(O)O)O)O)N"
  },
  {
    "chemicalName": "BC-3205",
    "SMILES": "CCC1(CC(C2(C(CCC3(C2C(=O)CC3)C(C1O)C)C)C)OC(=O)CSC4CCCN(C4)C(=O)C(C(C)C)N)C",
    "chemicalId": "3LK",
    "InChI": "InChI=1S/C32H54N2O5S/c1-8-30(6)16-24(31(7)20(4)11-13-32(21(5)28(30)37)14-12-23(35)27(31)32)39-25(36)18-40-22-10-9-15-34(17-22)29(38)26(33)19(2)3/h19-22,24,26-28,37H,8-18,33H2,1-7H3/t20-,21+,22+,24-,26+,27+,28+,30-,31+,32+/m1/s1",
    "formula_weight": 0.579,
    "number_of_instances": 1,
    "InChIKey": "DQQBLGJALGOFPM-JCNPUBELSA-N",
    "SMILES_stereo": "CC[C@@]1(C[C@H]([C@@]2([C@@H](CC[C@@]3([C@H]2C(=O)CC3)[C@H]([C@@H]1O)C)C)C)OC(=O)CS[C@H]4CCCN(C4)C(=O)[C@H](C(C)C)N)C",
    "pdbx_description": "BC-3205"
  },
  {
    "chemicalName": "CARBOMYCIN A",
    "SMILES": "CC1CC(C(C(C(CC(=O)OC(CC2C(O2)C=CC1=O)C)OC(=O)C)OC)OC3C(C(C(C(O3)C)OC4CC(C(C(O4)C)OC(=O)CC(C)C)(C)O)N(C)C)O)CC=O",
    "chemicalId": "CAI",
    "InChI": "InChI=1S/C42H67NO16/c1-21(2)16-32(47)57-40-25(6)53-34(20-42(40,8)50)58-37-24(5)54-41(36(49)35(37)43(9)10)59-38-27(14-15-44)17-22(3)28(46)12-13-29-30(56-29)18-23(4)52-33(48)19-31(39(38)51-11)55-26(7)45/h12-13,15,21-25,27,29-31,34-41,49-50H,14,16-20H2,1-11H3/b13-12+/t22-,23-,24-,25+,27+,29+,30+,31-,34+,35-,36-,37-,38+,39+,40+,41+,42-/m1/s1",
    "formula_weight": 0.842,
    "number_of_instances": 1,
    "drugbank_id": "DB11383",
    "drugbank_description": "Carbomycin, also called magnamycin, is crystalline macrolide antibiotic. This antibacterial is obtained from _Streptomyces halstedii_ and it presents a large inhibitory effect against Gram-positive bacteria and some Mycoplasma strains. The structure of carbomycin was generated in 1957 by Robert Woodward and later modified in 1965.",
    "InChIKey": "FQVHOULQCKDUCY-OGHXVOSASA-N",
    "pdbx_description": "CARBOMYCIN A",
    "SMILES_stereo": "C[C@@H]1C[C@@H]([C@@H]([C@H]([C@@H](CC(=O)O[C@@H](C[C@H]2[C@@H](O2)C=CC1=O)C)OC(=O)C)OC)O[C@H]3[C@@H]([C@H]([C@@H]([C@H](O3)C)O[C@H]4C[C@@]([C@H]([C@@H](O4)C)OC(=O)CC(C)C)(C)O)N(C)C)O)CC=O"
  },
  {
    "chemicalName": "Arbekacin",
    "SMILES": "C1CC(C(OC1CN)OC2C(CC(C(C2O)OC3C(C(C(C(O3)CO)O)N)O)NC(=O)C(CCN)O)N)N",
    "chemicalId": "84G",
    "InChI": "InChI=1S/C22H44N6O10/c23-4-3-12(30)20(34)28-11-5-10(26)18(37-21-9(25)2-1-8(6-24)35-21)17(33)19(11)38-22-16(32)14(27)15(31)13(7-29)36-22/h8-19,21-22,29-33H,1-7,23-27H2,(H,28,34)/t8-,9+,10-,11+,12-,13+,14-,15+,16+,17-,18+,19-,21+,22+/m0/s1",
    "formula_weight": 0.553,
    "number_of_instances": 2,
    "drugbank_id": "DB06696",
    "drugbank_description": "An semisynthetic aminoglycoside antibiotic. Often used for treatment of multi-resistant bacterial infection such as methicillin-resistant _Staphylococcus aureus_ (MRSA).",
    "InChIKey": "MKKYBZZTJQGVCD-XTCKQBCOSA-N",
    "pdbx_description": "Arbekacin",
    "SMILES_stereo": "C1C[C@H]([C@H](O[C@@H]1CN)O[C@@H]2[C@H](C[C@H]([C@@H]([C@H]2O)O[C@@H]3[C@@H]([C@H]([C@@H]([C@H](O3)CO)O)N)O)NC(=O)[C@H](CCN)O)N)N"
  },
  {
    "chemicalName": "HYGROMYCIN B VARIANT",
    "SMILES": "CNC1CC(C(C(C1O)OC2C3C(C(C(O2)CO)O)OC4(O3)C(C(C(C(O4)C(CO)N)O)O)O)O)N",
    "chemicalId": "HY0",
    "InChI": "InChI=1S/C20H37N3O13/c1-23-7-2-5(21)9(26)15(10(7)27)33-19-17-16(11(28)8(4-25)32-19)35-20(36-17)18(31)13(30)12(29)14(34-20)6(22)3-24/h5-19,23-31H,2-4,21-22H2,1H3/t5-,6+,7+,8-,9+,10-,11+,12-,13+,14-,15-,16+,17+,18-,19+,20-/m1/s1",
    "formula_weight": 0.528,
    "number_of_instances": 3,
    "InChIKey": "GRRNUXAQVGOGFE-XFOBNZBXSA-N",
    "pdbx_description": "HYGROMYCIN B VARIANT",
    "SMILES_stereo": "CN[C@H]1C[C@H]([C@@H]([C@H]([C@@H]1O)O[C@H]2[C@@H]3[C@H]([C@H]([C@H](O2)CO)O)O[C@@]4(O3)[C@@H]([C@H]([C@H]([C@H](O4)[C@H](CO)N)O)O)O)O)N"
  },
  {
    "chemicalName": "[(2~{S},3~{S},4~{S},5~{R},6~{S})-2-[(2~{R},3~{R},4~{R},5~{S})-2-[(1~{R},2~{S},3~{R},4~{R},5~{S},6~{R})-2,4-bis[[azaniumylidene(azanyl)methyl]amino]-3,5,6-tris(oxidanyl)cyclohexyl]oxy-4-[bis(oxidanyl)methyl]-5-methyl-4-oxidanyl-oxolan-3-yl]oxy-6-(hydroxymethyl)-4,5-bis(oxidanyl)oxan-3-yl]-methyl-azanium",
    "SMILES": "CC1C(C(C(O1)OC2C(C(C(C(C2O)O)NC(=[NH2+])N)O)NC(=[NH2+])N)OC3C(C(C(C(O3)CO)O)O)[NH2+]C)(C(O)O)O",
    "chemicalId": "5I0",
    "InChI": "InChI=1S/C21H41N7O13/c1-4-21(37,18(35)36)15(41-16-8(26-2)12(33)9(30)5(3-29)39-16)17(38-4)40-14-7(28-20(24)25)10(31)6(27-19(22)23)11(32)13(14)34/h4-18,26,29-37H,3H2,1-2H3,(H4,22,23,27)(H4,24,25,28)/p+3/t4-,5-,6+,7-,8-,9-,10+,11-,12-,13+,14+,15-,16-,17-,21+/m0/s1",
    "formula_weight": 0.603,
    "number_of_instances": 1,
    "InChIKey": "ATLHDHNZEMANQF-UQHZJGBMSA-Q",
    "SMILES_stereo": "C[C@H]1[C@@]([C@H]([C@@H](O1)O[C@@H]2[C@H]([C@@H]([C@H]([C@@H]([C@H]2O)O)NC(=[NH2+])N)O)NC(=[NH2+])N)O[C@H]3[C@H]([C@@H]([C@H]([C@@H](O3)CO)O)O)[NH2+]C)(C(O)O)O",
    "pdbx_description": "[(2~{S},3~{S},4~{S},5~{R},6~{S})-2-[(2~{R},3~{R},4~{R},5~{S})-2-[(1~{R},2~{S},3~{R},4~{R},5~{S},6~{R})-2,4-bis[[azaniumylidene(azanyl)methyl]amino]-3,5,6-tris(oxidanyl)cyclohexyl]oxy-4-[bis(oxidanyl)methyl]-5-methyl-4-oxidanyl-oxolan-3-yl]oxy-6-(hydroxymethyl)-4,5-bis(oxidanyl)oxan-3-yl]-methyl-azanium"
  },
  {
    "chemicalName": "(4R)-2-METHYLPENTANE-2,4-DIOL",
    "SMILES": "CC(CC(C)(C)O)O",
    "chemicalId": "MRD",
    "InChI": "InChI=1S/C6H14O2/c1-5(7)4-6(2,3)8/h5,7-8H,4H2,1-3H3/t5-/m1/s1",
    "formula_weight": 0.118,
    "number_of_instances": 1,
    "InChIKey": "SVTBMSDMJJWYQN-RXMQYKEDSA-N",
    "SMILES_stereo": "C[C@H](CC(C)(C)O)O",
    "pdbx_description": "(4R)-2-METHYLPENTANE-2,4-DIOL"
  },
  {
    "chemicalName": "Thermorubin",
    "SMILES": "COc1c2c(cc3c1c(c(c(c3)CC(=O)O)C(=O)C=C(c4ccccc4O)O)OC)cc5c(c2O)C(=O)OC(=C5)C(=O)OC",
    "chemicalId": "T8B",
    "InChI": "InChI=1S/C32H24O12/c1-41-29-24(21(35)13-20(34)18-6-4-5-7-19(18)33)17(12-23(36)37)10-15-8-14-9-16-11-22(31(39)43-3)44-32(40)26(16)28(38)25(14)30(42-2)27(15)29/h4-11,13,33-34,38H,12H2,1-3H3,(H,36,37)/b20-13-",
    "formula_weight": 0.601,
    "number_of_instances": 2,
    "InChIKey": "GGEDVBUCHDZLTH-MOSHPQCFSA-N",
    "SMILES_stereo": "COc1c2c(cc3c1c(c(c(c3)CC(=O)O)C(=O)/C=C(/c4ccccc4O)O)OC)cc5c(c2O)C(=O)OC(=C5)C(=O)OC",
    "pdbx_description": "Thermorubin"
  },
  {
    "chemicalName": "Radezolid",
    "SMILES": "CC(=O)NCC1CN(C(=O)O1)c2ccc(c(c2)F)c3ccc(cc3)CNCc4c[nH]nn4",
    "chemicalId": "RD8",
    "InChI": "InChI=1S/C22H23FN6O3/c1-14(30)25-12-19-13-29(22(31)32-19)18-6-7-20(21(23)8-18)16-4-2-15(3-5-16)9-24-10-17-11-26-28-27-17/h2-8,11,19,24H,9-10,12-13H2,1H3,(H,25,30)(H,26,27,28)/t19-/m0/s1",
    "formula_weight": 0.438,
    "number_of_instances": 1,
    "drugbank_id": "DB12339",
    "drugbank_description": "Radezolid has been used in trials studying the treatment of Abscess, Bacterial Skin Diseases, Streptococcal Infections, Infectious Skin Diseases, and Staphylococcal Skin Infections, among others.",
    "InChIKey": "BTTNOGHPGJANSW-IBGZPJMESA-N",
    "pdbx_description": "Radezolid",
    "SMILES_stereo": "CC(=O)NC[C@H]1CN(C(=O)O1)c2ccc(c(c2)F)c3ccc(cc3)CNCc4c[nH]nn4"
  },
  {
    "chemicalName": "(1S,3S,3aR,4S,4aR,7R,7aR,8aS)-8a-{[(6-deoxy-4-O-methyl-alpha-D-altropyranosyl)oxy]methyl}-4-formyl-7-methyl-3-(propan-2-yl)decahydro-1,4-methano-s-indacene-3a(1H)-carboxylate",
    "SMILES": "CC1CCC2C1CC3(C4CC(C3(C2(C4)C=O)C(=O)[O-])C(C)C)COC5C(C(C(C(O5)C)OC)O)O",
    "chemicalId": "W9C",
    "InChI": "InChI=1S/C27H42O8/c1-13(2)19-8-16-9-25(11-28)18-7-6-14(3)17(18)10-26(16,27(19,25)24(31)32)12-34-23-21(30)20(29)22(33-5)15(4)35-23/h11,13-23,29-30H,6-10,12H2,1-5H3,(H,31,32)/p-1/t14-,15-,16+,17-,18-,19+,20+,21+,22-,23+,25+,26+,27+/m1/s1",
    "formula_weight": 0.494,
    "number_of_instances": 1,
    "InChIKey": "DIBGPTPYRVEPSP-LFCZXAENSA-M",
    "SMILES_stereo": "C[C@@H]1CC[C@@H]2[C@@H]1C[C@@]3([C@H]4C[C@H]([C@@]3([C@@]2(C4)C=O)C(=O)[O-])C(C)C)CO[C@@H]5[C@H]([C@@H]([C@@H]([C@H](O5)C)OC)O)O",
    "pdbx_description": "(1S,3S,3aR,4S,4aR,7R,7aR,8aS)-8a-{[(6-deoxy-4-O-methyl-alpha-D-altropyranosyl)oxy]methyl}-4-formyl-7-methyl-3-(propan-2-yl)decahydro-1,4-methano-s-indacene-3a(1H)-carboxylate"
  },
  {
    "chemicalName": "ailanthone",
    "SMILES": "CC1CC(=O)C(C2(C1CC3C45C2C(C(C(=C)C4CC(=O)O3)O)(OC5)O)C)O",
    "chemicalId": "TIX",
    "InChI": "InChI=1S/C20H26O7/c1-8-4-12(21)16(24)18(3)10(8)5-13-19-7-26-20(25,17(18)19)15(23)9(2)11(19)6-14(22)27-13/h8,10-11,13,15-17,23-25H,2,4-7H2,1,3H3/t8-,10+,11+,13-,15-,16-,17-,18-,19-,20+/m1/s1",
    "formula_weight": 0.378,
    "number_of_instances": 2,
    "InChIKey": "DOVPXPXYKBQEAK-BJTBSANGSA-N",
    "SMILES_stereo": "C[C@@H]1CC(=O)[C@H]([C@]2([C@H]1C[C@@H]3[C@]45[C@@H]2[C@]([C@@H](C(=C)[C@@H]4CC(=O)O3)O)(OC5)O)C)O",
    "pdbx_description": "ailanthone"
  },
  {
    "chemicalName": "PHENYLALANINAL",
    "SMILES": "c1ccc(cc1)CC(C=O)N",
    "chemicalId": "PHA",
    "InChI": "InChI=1S/C9H11NO/c10-9(7-11)6-8-4-2-1-3-5-8/h1-5,7,9H,6,10H2/t9-/m0/s1",
    "formula_weight": 0.149,
    "number_of_instances": 2,
    "InChIKey": "CQIUZHAQYHXKRY-VIFPVBQESA-N",
    "SMILES_stereo": "c1ccc(cc1)C[C@@H](C=O)N",
    "pdbx_description": "PHENYLALANINAL"
  },
  {
    "chemicalName": "N-METHYL KIRROMYCIN",
    "SMILES": "CCC(C(=O)NCC=CC=C(C)C(C(C)C1C(C(C(O1)C=CC=CC=C(C)C(=O)C2=C(C=CN(C2=O)C)O)O)O)OC)C3(C(C(C(C(O3)C=CC=CC)(C)C)O)O)O",
    "chemicalId": "MAU",
    "InChI": "InChI=1S/C44H62N2O12/c1-10-12-14-22-32-43(6,7)39(51)40(52)44(55,58-32)29(11-2)41(53)45-24-18-17-20-27(4)37(56-9)28(5)38-36(50)35(49)31(57-38)21-16-13-15-19-26(3)34(48)33-30(47)23-25-46(8)42(33)54/h10,12-23,25,28-29,31-32,35-40,47,49-52,55H,11,24H2,1-9H3,(H,45,53)/b12-10-,15-13+,18-17+,21-16+,22-14+,26-19+,27-20+/t28-,29-,31-,32+,35+,36+,37-,38+,39+,40-,44-/m1/s1",
    "formula_weight": 0.811,
    "number_of_instances": 1,
    "drugbank_id": "DB04124",
    "drugbank_description": "Aurodox is an antibiotic obtained from a streptomyces variant considered as possibly effective against streptococcus pyogenes infections. It may promote growth in poultry.",
    "InChIKey": "NTAHMPNXQOYXSX-WKSONYIQSA-N",
    "pdbx_description": "N-METHYL KIRROMYCIN",
    "SMILES_stereo": "CC[C@H](C(=O)NCC=CC=C(/C)[C@H]([C@@H](C)[C@H]1[C@H]([C@H]([C@H](O1)C=CC=CC=C(/C)C(=O)C2=C(C=CN(C2=O)C)O)O)O)OC)[C@@]3([C@@H]([C@@H](C([C@@H](O3)C=CC=C/C)(C)C)O)O)O"
  },
  {
    "chemicalName": "BETA-MERCAPTOETHANOL",
    "SMILES": "C(CS)O",
    "chemicalId": "BME",
    "InChI": "InChI=1S/C2H6OS/c3-1-2-4/h3-4H,1-2H2",
    "formula_weight": 0.078,
    "number_of_instances": 1,
    "drugbank_id": "DB03345",
    "InChIKey": "DGVVWUTYPXICAM-UHFFFAOYSA-N",
    "pdbx_description": "BETA-MERCAPTOETHANOL",
    "SMILES_stereo": "C(CS)O"
  },
  {
    "chemicalName": "(3Z)-N-[(4E)-5-(4-{(5S)-5-[(acetylamino)methyl]-2-oxo-1,3-oxazolidin-3-yl}-2-fluorophenyl)pent-4-en-1-yl]-3-(4-methyl-2,6-dioxo-1,6-dihydropyrimidin-5(2H)-ylidene)propanamide",
    "SMILES": "CC1=NC(=O)NC(=O)C1=CCC(=O)NCCCC=Cc2ccc(cc2F)N3CC(OC3=O)CNC(=O)C",
    "chemicalId": "SLD",
    "InChI": "InChI=1S/C25H28FN5O6/c1-15-20(23(34)30-24(35)29-15)9-10-22(33)27-11-5-3-4-6-17-7-8-18(12-21(17)26)31-14-19(37-25(31)36)13-28-16(2)32/h4,6-9,12,19H,3,5,10-11,13-14H2,1-2H3,(H,27,33)(H,28,32)(H,30,34,35)/b6-4+,20-9-/t19-/m0/s1",
    "formula_weight": 0.514,
    "number_of_instances": 1,
    "InChIKey": "UDBPSKMSYCUBIU-MTQXBESRSA-N",
    "SMILES_stereo": "CC1=NC(=O)NC(=O)/C1=CCC(=O)NCCCC=Cc2ccc(cc2F)N3C[C@@H](OC3=O)CNC(=O)C",
    "pdbx_description": "(3Z)-N-[(4E)-5-(4-{(5S)-5-[(acetylamino)methyl]-2-oxo-1,3-oxazolidin-3-yl}-2-fluorophenyl)pent-4-en-1-yl]-3-(4-methyl-2,6-dioxo-1,6-dihydropyrimidin-5(2H)-ylidene)propanamide"
  },
  {
    "chemicalName": "TIAMULIN",
    "SMILES": "CCN(CC)CCSCC(=O)OC1CC(C(C(C23CCC(C1(C2C(=O)CC3)C)C)C)O)(C)C=C",
    "chemicalId": "MUL",
    "InChI": "InChI=1S/C28H47NO4S/c1-8-26(6)17-22(33-23(31)18-34-16-15-29(9-2)10-3)27(7)19(4)11-13-28(20(5)25(26)32)14-12-21(30)24(27)28/h8,19-20,22,24-25,32H,1,9-18H2,2-7H3/t19-,20+,22-,24+,25+,26-,27+,28+/m1/s1",
    "formula_weight": 0.494,
    "number_of_instances": 1,
    "drugbank_id": "DB11468",
    "drugbank_description": "Tiamulin is a pleuromutilin antibiotic drug that is used in veterinary medicine particularly for pigs and poultry.",
    "InChIKey": "UURAUHCOJAIIRQ-QGLSALSOSA-N",
    "pdbx_description": "TIAMULIN",
    "SMILES_stereo": "CCN(CC)CCSCC(=O)O[C@@H]1C[C@@]([C@H]([C@@H]([C@@]23CC[C@H]([C@@]1([C@@H]2C(=O)CC3)C)C)C)O)(C)C=C"
  },
  {
    "chemicalName": "(3R,5R,6S,7S,9R,11E,13S,14R)-14-ethyl-13-hydroxy-3,5,7,9,13-pentamethyl-2,4,10-trioxo-1-oxacyclotetradec-11-en-6-yl 3,4,6-trideoxy-3-(dimethylamino)-beta-D-xylo-hexopyranoside",
    "SMILES": "CCC1C(C=CC(=O)C(CC(C(C(C(=O)C(C(=O)O1)C)C)OC2C(C(CC(O2)C)N(C)C)O)C)C)(C)O",
    "chemicalId": "AQJ",
    "InChI": "InChI=1S/C28H47NO8/c1-10-22-28(7,34)12-11-21(30)15(2)13-16(3)25(18(5)23(31)19(6)26(33)36-22)37-27-24(32)20(29(8)9)14-17(4)35-27/h11-12,15-20,22,24-25,27,32,34H,10,13-14H2,1-9H3/b12-11+/t15-,16+,17-,18+,19-,20+,22-,24-,25+,27+,28+/m1/s1",
    "formula_weight": 0.526,
    "number_of_instances": 2,
    "InChIKey": "UZQBOFAUUTZOQE-VSLWXVDYSA-N",
    "SMILES_stereo": "CC[C@@H]1[C@@](/C=C/C(=O)[C@@H](C[C@@H]([C@@H]([C@H](C(=O)[C@H](C(=O)O1)C)C)O[C@H]2[C@@H]([C@H](C[C@H](O2)C)N(C)C)O)C)C)(C)O",
    "pdbx_description": "(3R,5R,6S,7S,9R,11E,13S,14R)-14-ethyl-13-hydroxy-3,5,7,9,13-pentamethyl-2,4,10-trioxo-1-oxacyclotetradec-11-en-6-yl 3,4,6-trideoxy-3-(dimethylamino)-beta-D-xylo-hexopyranoside"
  },
  {
    "chemicalName": "(2R,3S,4R,5R,7S,9S,10S,11R,12S,13R)-12-(((2R,4R,5S,6S)-4,5-dihydroxy-4,6-dimethyltetrahydro-2H-pyran-2-yl)oxy)-2-((S)-1-(((2R,3R,4R,5R,6R)-5-hydroxy-3,4-dimethoxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)propan-2-yl)-10-(((2S,3R,4R,6R)-3-hydroxy-4-(methoxyamino)-6-methyltetrahydro-2H-pyran-2-yl)oxy)-3,5,7,9,11,13-hexamethyl-7-(((2-((2-nitrophenyl)sulfonamido)ethyl)carbamoyl)oxy)-6,14-dioxooxacyclotetradecan-4-yl 3-methylbutanoate",
    "SMILES": "CC1CC(C(C(O1)OC2C(CC(C(=O)C(C(C(C(OC(=O)C(C(C2C)OC3CC(C(C(O3)C)O)(C)O)C)C(C)COC4C(C(C(C(O4)C)O)OC)OC)C)OC(=O)CC(C)C)C)(C)OC(=O)NCCNS(=O)(=O)c5ccccc5N(=O)=O)C)O)NOC",
    "chemicalId": "SJE",
    "InChI": "InChI=1S/C58H96N4O24S/c1-28(2)23-41(63)82-47-33(7)46(30(4)27-78-55-50(76-15)49(75-14)43(64)36(10)81-55)84-53(68)35(9)48(83-42-26-57(12,70)52(67)37(11)80-42)32(6)45(85-54-44(65)38(61-77-16)24-31(5)79-54)29(3)25-58(13,51(66)34(47)8)86-56(69)59-21-22-60-87(73,74)40-20-18-17-19-39(40)62(71)72/h17-20,28-38,42-50,52,54-55,60-61,64-65,67,70H,21-27H2,1-16H3,(H,59,69)/t29-,30-,31+,32+,33-,34+,35+,36+,37-,38+,42-,43+,44+,45-,46+,47+,48-,49+,50+,52-,54-,55+,57+,58-/m0/s1",
    "formula_weight": 1.265,
    "number_of_instances": 2,
    "InChIKey": "CJEOVNNONSMRPA-HVUKKSFYSA-N",
    "SMILES_stereo": "C[C@@H]1C[C@H]([C@H]([C@@H](O1)O[C@H]2[C@H](C[C@](C(=O)[C@@H]([C@@H]([C@H]([C@H](OC(=O)[C@@H]([C@H]([C@@H]2C)O[C@H]3C[C@@]([C@H]([C@@H](O3)C)O)(C)O)C)[C@@H](C)CO[C@H]4[C@@H]([C@@H]([C@@H]([C@H](O4)C)O)OC)OC)C)OC(=O)CC(C)C)C)(C)OC(=O)NCCNS(=O)(=O)c5ccccc5N(=O)=O)C)O)NOC",
    "pdbx_description": "(2R,3S,4R,5R,7S,9S,10S,11R,12S,13R)-12-(((2R,4R,5S,6S)-4,5-dihydroxy-4,6-dimethyltetrahydro-2H-pyran-2-yl)oxy)-2-((S)-1-(((2R,3R,4R,5R,6R)-5-hydroxy-3,4-dimethoxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)propan-2-yl)-10-(((2S,3R,4R,6R)-3-hydroxy-4-(methoxyamino)-6-methyltetrahydro-2H-pyran-2-yl)oxy)-3,5,7,9,11,13-hexamethyl-7-(((2-((2-nitrophenyl)sulfonamido)ethyl)carbamoyl)oxy)-6,14-dioxooxacyclotetradecan-4-yl 3-methylbutanoate"
  },
  {
    "chemicalName": "Cisplatin",
    "SMILES": "[NH3][Pt]([NH3])(Cl)Cl",
    "chemicalId": "CPT",
    "InChI": "InChI=1S/2ClH.2H3N.Pt/h2*1H;2*1H3;/q;;;;+2/p-2",
    "formula_weight": 0.3,
    "number_of_instances": 16,
    "drugbank_id": "DB00515",
    "drugbank_description": "Cisplatin, cisplatinum or cis-diamminedichloroplatinum(II) (CDDP) is a platinum-based chemotherapy drug used to treat various types of cancers, including sarcomas, some carcinomas (e.g. small cell lung cancer, and ovarian cancer), lymphomas and germ cell tumors. It was the first member of its class, which now also includes carboplatin and oxaliplatin.",
    "InChIKey": "LXZZYRPGZAFOLE-UHFFFAOYSA-L",
    "SMILES_stereo": "[NH3][Pt]([NH3])(Cl)Cl",
    "pdbx_description": "Cisplatin"
  },
  {
    "chemicalName": "(2S)-2-[2-[4-[[(2R,3S,4S)-3-acetyloxy-4-oxidanyl-pyrrolidin-2-yl]methyl]phenoxy]ethanoylamino]-6-azanyl-hexanoic acid",
    "SMILES": "CC(=O)OC1C(CNC1Cc2ccc(cc2)OCC(=O)NC(CCCCN)C(=O)O)O",
    "chemicalId": "A1H4F",
    "InChI": "InChI=1S/C21H31N3O7/c1-13(25)31-20-17(23-11-18(20)26)10-14-5-7-15(8-6-14)30-12-19(27)24-16(21(28)29)4-2-3-9-22/h5-8,16-18,20,23,26H,2-4,9-12,22H2,1H3,(H,24,27)(H,28,29)/t16-,17+,18-,20-/m0/s1",
    "formula_weight": 0.437,
    "number_of_instances": 1,
    "InChIKey": "IZMYQNBWNCVEHB-DMUMMCEESA-N",
    "pdbx_description": "(2S)-2-[2-[4-[[(2R,3S,4S)-3-acetyloxy-4-oxidanyl-pyrrolidin-2-yl]methyl]phenoxy]ethanoylamino]-6-azanyl-hexanoic acid",
    "SMILES_stereo": "CC(=O)O[C@@H]1[C@H](CN[C@@H]1Cc2ccc(cc2)OCC(=O)N[C@@H](CCCCN)C(=O)O)O"
  },
  {
    "chemicalName": "6-AMINOHEXANOIC ACID",
    "SMILES": "C(CCC(=O)O)CCN",
    "chemicalId": "ACA",
    "InChI": "InChI=1S/C6H13NO2/c7-5-3-1-2-4-6(8)9/h1-5,7H2,(H,8,9)",
    "formula_weight": 0.131,
    "number_of_instances": 1,
    "drugbank_id": "DB00513",
    "drugbank_description": "An antifibrinolytic agent that acts by inhibiting plasminogen activators which have fibrinolytic properties.",
    "InChIKey": "SLXKOJJOQWFEFD-UHFFFAOYSA-N",
    "SMILES_stereo": "C(CCC(=O)O)CCN",
    "pdbx_description": "6-AMINOHEXANOIC ACID"
  },
  {
    "chemicalName": "Amicoumacin A",
    "SMILES": "CC(C)CC(C1Cc2cccc(c2C(=O)O1)O)NC(=O)C(C(C(CC(=O)N)N)O)O",
    "chemicalId": "UAM",
    "InChI": "InChI=1S/C20H29N3O7/c1-9(2)6-12(23-19(28)18(27)17(26)11(21)8-15(22)25)14-7-10-4-3-5-13(24)16(10)20(29)30-14/h3-5,9,11-12,14,17-18,24,26-27H,6-8,21H2,1-2H3,(H2,22,25)(H,23,28)/t11-,12-,14-,17-,18-/m0/s1",
    "formula_weight": 0.423,
    "number_of_instances": 1,
    "InChIKey": "DCPWYLSPIAHJFU-YKRRISCLSA-N",
    "SMILES_stereo": "CC(C)C[C@@H]([C@@H]1Cc2cccc(c2C(=O)O1)O)NC(=O)[C@H]([C@H]([C@H](CC(=O)N)N)O)O",
    "pdbx_description": "Amicoumacin A"
  },
  {
    "chemicalName": "Tedizolid",
    "SMILES": "Cn1nc(nn1)c2ccc(cn2)c3ccc(cc3F)N4CC(OC4=O)CO",
    "chemicalId": "U7V",
    "InChI": "InChI=1S/C17H15FN6O3/c1-23-21-16(20-22-23)15-5-2-10(7-19-15)13-4-3-11(6-14(13)18)24-8-12(9-25)27-17(24)26/h2-7,12,25H,8-9H2,1H3/t12-/m1/s1",
    "formula_weight": 0.37,
    "number_of_instances": 1,
    "drugbank_id": "DB14569",
    "drugbank_description": "Drug-resistant bacteria, such as methicillin-resistant _Staphylococcus aureus_, vancomycin-resistant _Enterococcus faecium_, and penicillin-resistant _Streptococcus penumoniae_, represent a massive public health threat.[A199086, A199131] Tedizolid is a member of the oxazolidinone class of antibiotics, which includes the previously approved [linezolid] and is generally effective against multidrug-resistant Gram-positive bacteria. Tedizolid is indicated for the treatment of acute bacterial skin and skin structure infections (ABSSSI) and is generally more effective and more tolerable than [linezolid].[L11232, A199086, A199050]  Tedizolid was approved by the FDA on June 20, 2014, for sale by Cubist Pharmaceuticals as tedizolid phosphate (SIVEXTRO®). This product is currently available as both an oral tablet and as a powder for intravenous injection.[L11232]",
    "InChIKey": "XFALPSLJIHVRKE-GFCCVEGCSA-N",
    "pdbx_description": "Tedizolid",
    "SMILES_stereo": "Cn1nc(nn1)c2ccc(cn2)c3ccc(cc3F)N4C[C@@H](OC4=O)CO"
  },
  {
    "chemicalName": "S-[2-({N-[(2R)-2-hydroxy-3,3-dimethyl-4-(phosphonooxy)butanoyl]-beta-alanyl}amino)ethyl] dodecanethioate",
    "SMILES": "CCCCCCCCCCCC(=O)SCCNC(=O)CCNC(=O)C(C(C)(C)COP(=O)(O)O)O",
    "chemicalId": "8Q1",
    "InChI": "InChI=1S/C23H45N2O8PS/c1-4-5-6-7-8-9-10-11-12-13-20(27)35-17-16-24-19(26)14-15-25-22(29)21(28)23(2,3)18-33-34(30,31)32/h21,28H,4-18H2,1-3H3,(H,24,26)(H,25,29)(H2,30,31,32)/t21-/m0/s1",
    "formula_weight": 0.541,
    "number_of_instances": 1,
    "InChIKey": "MVHUOSAYFQKAMT-NRFANRHFSA-N",
    "SMILES_stereo": "CCCCCCCCCCCC(=O)SCCNC(=O)CCNC(=O)[C@@H](C(C)(C)COP(=O)(O)O)O",
    "pdbx_description": "S-[2-({N-[(2R)-2-hydroxy-3,3-dimethyl-4-(phosphonooxy)butanoyl]-beta-alanyl}amino)ethyl] dodecanethioate"
  },
  {
    "chemicalName": "Sequanamycin 9",
    "SMILES": "CC1CC(OC(CN1C)C)OC2C(C(C(CC(C(=O)C(C(C(C(OC(=O)C2C)C(C)COC3C(C(C(C(O3)C)O)OC)OC)C)OC(=O)CC(C)C)C)(C)OC(=O)NC(C)(C)CNS(=O)(=O)c4ccccc4)C)OC5C(C(=NOC)CC(O5)C)O)C",
    "chemicalId": "WDP",
    "InChI": "InChI=1S/C61H102N4O20S/c1-32(2)25-45(66)81-51-39(9)50(34(4)30-77-58-54(75-18)53(74-17)47(67)42(12)80-58)83-56(70)41(11)52(82-46-26-35(5)65(16)29-37(7)78-46)38(8)49(84-57-48(68)44(64-76-19)27-36(6)79-57)33(3)28-61(15,55(69)40(51)10)85-59(71)63-60(13,14)31-62-86(72,73)43-23-21-20-22-24-43/h20-24,32-42,46-54,57-58,62,67-68H,25-31H2,1-19H3,(H,63,71)/b64-44+/t33-,34-,35+,36+,37-,38+,39-,40+,41+,42+,46-,47+,48+,49-,50+,51+,52-,53+,54+,57-,58+,61-/m0/s1",
    "formula_weight": 1.244,
    "number_of_instances": 1,
    "InChIKey": "IXJRUHKGLMWLLP-XMRFQGNKSA-N",
    "SMILES_stereo": "C[C@@H]1C[C@@H](O[C@H](CN1C)C)O[C@H]2[C@@H]([C@H]([C@H](C[C@](C(=O)[C@@H]([C@@H]([C@H]([C@H](OC(=O)[C@@H]2C)[C@@H](C)CO[C@H]3[C@@H]([C@@H]([C@@H]([C@H](O3)C)O)OC)OC)C)OC(=O)CC(C)C)C)(C)OC(=O)NC(C)(C)CNS(=O)(=O)c4ccccc4)C)O[C@H]5[C@@H](C(=NOC)C[C@H](O5)C)O)C",
    "pdbx_description": "Sequanamycin 9"
  },
  {
    "chemicalName": "URIDINE-5'-MONOPHOSPHATE",
    "SMILES": "C1=CN(C(=O)NC1=O)C2C(C(C(O2)COP(=O)(O)O)O)O",
    "chemicalId": "U",
    "InChI": "InChI=1S/C9H13N2O9P/c12-5-1-2-11(9(15)10-5)8-7(14)6(13)4(20-8)3-19-21(16,17)18/h1-2,4,6-8,13-14H,3H2,(H,10,12,15)(H2,16,17,18)/t4-,6-,7-,8-/m1/s1",
    "formula_weight": 0.324,
    "number_of_instances": 2,
    "drugbank_id": "DB03685",
    "drugbank_description": "5'-Uridylic acid. A uracil nucleotide containing one phosphate group esterified to the sugar moiety in the 2', 3' or 5' position.",
    "InChIKey": "DJJCXFVJDGTHFX-XVFCMESISA-N",
    "pdbx_description": "URIDINE-5'-MONOPHOSPHATE",
    "SMILES_stereo": "C1=CN(C(=O)NC1=O)[C@H]2[C@@H]([C@@H]([C@H](O2)COP(=O)(O)O)O)O"
  },
  {
    "chemicalName": "O2'-METHYLGUANOSINE-5'-MONOPHOSPHATE",
    "SMILES": "COC1C(C(OC1n2cnc3c2N=C(NC3=O)N)COP(=O)(O)O)O",
    "chemicalId": "OMG",
    "InChI": "InChI=1S/C11H16N5O8P/c1-22-7-6(17)4(2-23-25(19,20)21)24-10(7)16-3-13-5-8(16)14-11(12)15-9(5)18/h3-4,6-7,10,17H,2H2,1H3,(H2,19,20,21)(H3,12,14,15,18)/t4-,6-,7-,10-/m1/s1",
    "formula_weight": 0.377,
    "number_of_instances": 1,
    "InChIKey": "YPMKZCOIEXUDSS-KQYNXXCUSA-N",
    "SMILES_stereo": "CO[C@@H]1[C@@H]([C@H](O[C@H]1n2cnc3c2N=C(NC3=O)N)COP(=O)(O)O)O",
    "pdbx_description": "O2'-METHYLGUANOSINE-5'-MONOPHOSPHATE"
  },
  {
    "chemicalName": "GUANOSINE-5'-MONOPHOSPHATE",
    "SMILES": "c1nc2c(n1C3C(C(C(O3)COP(=O)(O)O)O)O)N=C(NC2=O)N",
    "chemicalId": "G",
    "InChI": "InChI=1S/C10H14N5O8P/c11-10-13-7-4(8(18)14-10)12-2-15(7)9-6(17)5(16)3(23-9)1-22-24(19,20)21/h2-3,5-6,9,16-17H,1H2,(H2,19,20,21)(H3,11,13,14,18)/t3-,5-,6-,9-/m1/s1",
    "formula_weight": 0.363,
    "number_of_instances": 1,
    "drugbank_id": "DB01972",
    "drugbank_description": "Guanosine 5&#39;-monophosphate. A guanine nucleotide containing one phosphate group esterified to the sugar moiety and found widely in nature. [PubChem]",
    "InChIKey": "RQFCJASXJCIDSX-UUOKFMHZSA-N",
    "pdbx_description": "GUANOSINE-5'-MONOPHOSPHATE",
    "SMILES_stereo": "c1nc2c(n1[C@H]3[C@@H]([C@@H]([C@H](O3)COP(=O)(O)O)O)O)N=C(NC2=O)N"
  },
  {
    "chemicalName": "PSEUDOURIDINE-5'-MONOPHOSPHATE",
    "SMILES": "C1=C(C(=O)NC(=O)N1)C2C(C(C(O2)COP(=O)(O)O)O)O",
    "chemicalId": "PSU",
    "InChI": "InChI=1S/C9H13N2O9P/c12-5-4(2-19-21(16,17)18)20-7(6(5)13)3-1-10-9(15)11-8(3)14/h1,4-7,12-13H,2H2,(H2,16,17,18)(H2,10,11,14,15)/t4-,5-,6-,7+/m1/s1",
    "formula_weight": 0.324,
    "number_of_instances": 1,
    "drugbank_id": "DB03829",
    "InChIKey": "MOBMOJGXNHLLIR-GBNDHIKLSA-N",
    "SMILES_stereo": "C1=C(C(=O)NC(=O)N1)[C@H]2[C@@H]([C@@H]([C@H](O2)COP(=O)(O)O)O)O",
    "pdbx_description": "PSEUDOURIDINE-5'-MONOPHOSPHATE"
  },
  {
    "chemicalName": "methyl (5beta,7alpha,9beta,10alpha,11alpha,12alpha,13beta,15alpha)-15-{[(2E)-3,4-dimethylpent-2-enoyl]oxy}-3,11,12-trihydroxy-2,16-dioxo-13,20-epoxypicras-3-en-21-oate",
    "SMILES": "CC1=C(C(=O)CC2(C1CC3C45C2C(C(C(C4C(C(=O)O3)OC(=O)C=C(C)C(C)C)(OC5)C(=O)OC)O)O)C)O",
    "chemicalId": "WIN",
    "InChI": "InChI=1S/C28H36O11/c1-11(2)12(3)7-17(30)39-20-22-27-10-37-28(22,25(35)36-6)23(33)19(32)21(27)26(5)9-15(29)18(31)13(4)14(26)8-16(27)38-24(20)34/h7,11,14,16,19-23,31-33H,8-10H2,1-6H3/b12-7+/t14-,16+,19+,20+,21+,22+,23-,26-,27+,28-/m0/s1",
    "formula_weight": 0.549,
    "number_of_instances": 1,
    "InChIKey": "IRQXZTBHNKVIRL-GOTQHHPNSA-N",
    "SMILES_stereo": "CC1=C(C(=O)C[C@]2([C@H]1C[C@@H]3[C@]45[C@@H]2[C@H]([C@@H]([C@]([C@@H]4[C@H](C(=O)O3)OC(=O)/C=C(C)/C(C)C)(OC5)C(=O)OC)O)O)C)O",
    "pdbx_description": "methyl (5beta,7alpha,9beta,10alpha,11alpha,12alpha,13beta,15alpha)-15-{[(2E)-3,4-dimethylpent-2-enoyl]oxy}-3,11,12-trihydroxy-2,16-dioxo-13,20-epoxypicras-3-en-21-oate"
  },
  {
    "chemicalName": "(3R,4S,5S,7R,9E,11S,12R)-12-ethyl-11-hydroxy-3,5,7,11-tetramethyl-2,8-dioxooxacyclododec-9-en-4-yl 3,4,6-trideoxy-3-(dimethylamino)-beta-D-xylo-hexopyranoside",
    "SMILES": "CCC1C(C=CC(=O)C(CC(C(C(C(=O)O1)C)OC2C(C(CC(O2)C)N(C)C)O)C)C)(C)O",
    "chemicalId": "MT9",
    "InChI": "InChI=1S/C25H43NO7/c1-9-20-25(6,30)11-10-19(27)14(2)12-15(3)22(17(5)23(29)32-20)33-24-21(28)18(26(7)8)13-16(4)31-24/h10-11,14-18,20-22,24,28,30H,9,12-13H2,1-8H3/b11-10+/t14-,15+,16-,17-,18+,20-,21-,22+,24+,25+/m1/s1",
    "formula_weight": 0.47,
    "number_of_instances": 2,
    "InChIKey": "HUKYPYXOBINMND-HYUJHOPRSA-N",
    "SMILES_stereo": "CC[C@@H]1[C@@](C=CC(=O)[C@@H](C[C@@H]([C@@H]([C@H](C(=O)O1)C)O[C@H]2[C@@H]([C@H](C[C@H](O2)C)N(C)C)O)C)C)(C)O",
    "pdbx_description": "(3R,4S,5S,7R,9E,11S,12R)-12-ethyl-11-hydroxy-3,5,7,11-tetramethyl-2,8-dioxooxacyclododec-9-en-4-yl 3,4,6-trideoxy-3-(dimethylamino)-beta-D-xylo-hexopyranoside"
  },
  {
    "chemicalName": "ADENOSINE-3'-5'-DIPHOSPHATE",
    "SMILES": "c1nc(c2c(n1)n(cn2)C3C(C(C(O3)COP(=O)(O)O)OP(=O)(O)O)O)N",
    "chemicalId": "A3P",
    "InChI": "InChI=1S/C10H15N5O10P2/c11-8-5-9(13-2-12-8)15(3-14-5)10-6(16)7(25-27(20,21)22)4(24-10)1-23-26(17,18)19/h2-4,6-7,10,16H,1H2,(H2,11,12,13)(H2,17,18,19)(H2,20,21,22)/t4-,6-,7-,10-/m1/s1",
    "formula_weight": 0.427,
    "number_of_instances": 2,
    "drugbank_id": "DB01812",
    "InChIKey": "WHTCPDAXWFLDIH-KQYNXXCUSA-N",
    "pdbx_description": "ADENOSINE-3'-5'-DIPHOSPHATE",
    "SMILES_stereo": "c1nc(c2c(n1)n(cn2)[C@H]3[C@@H]([C@@H]([C@H](O3)COP(=O)(O)O)OP(=O)(O)O)O)N"
  },
  {
    "chemicalName": "2-AMINO-BENZAMIDE",
    "SMILES": "c1ccc(c(c1)C(=O)N)N",
    "chemicalId": "2AE",
    "InChI": "InChI=1S/C7H8N2O/c8-6-4-2-1-3-5(6)7(9)10/h1-4H,8H2,(H2,9,10)",
    "formula_weight": 0.136,
    "number_of_instances": 1,
    "InChIKey": "PXBFMLJZNCDSMP-UHFFFAOYSA-N",
    "SMILES_stereo": "c1ccc(c(c1)C(=O)N)N",
    "pdbx_description": "2-AMINO-BENZAMIDE"
  },
  {
    "chemicalName": "beta-D-glucopyranose",
    "chemicalId": "BGC",
    "formula_weight": 0.18,
    "number_of_instances": 1,
    "drugbank_id": "DB02379",
    "drugbank_description": "A primary source of energy for living organisms. It is naturally occurring and is found in fruits and other parts of plants in its free state. It is used therapeutically in fluid and nutrient replacement.",
    "pdbx_description": "beta-D-glucopyranose"
  },
  {
    "chemicalName": "Bactobolin A",
    "SMILES": "CC1CC(=C2C(C1O)C(C(OC2=O)(C)C(Cl)Cl)NC(=O)C(C)N)O",
    "chemicalId": "3V6",
    "InChI": "InChI=1S/C15H22Cl2N2O5/c1-5-4-7(20)8-9(10(5)21)11(19-12(22)6(2)18)15(3,14(16)17)24-13(8)23/h5-6,9-11,14,20-21H,4,18H2,1-3H3,(H,19,22)/t5-,6+,9+,10+,11-,15+/m1/s1",
    "formula_weight": 0.381,
    "number_of_instances": 2,
    "InChIKey": "RREHSYIRMHYJHY-RQGKCFPDSA-N",
    "SMILES_stereo": "C[C@@H]1CC(=C2[C@@H]([C@H]1O)[C@H]([C@@](OC2=O)(C)C(Cl)Cl)NC(=O)[C@H](C)N)O",
    "pdbx_description": "Bactobolin A"
  },
  {
    "chemicalName": "(2R,3S,4R,6S)-4-hydroxy-6-{[(2R,3aR,4R,4'R,5'S,6S,6'R,7aR)-4'-hydroxy-6-{[(2S,3R,4R,5S,6R)-3-hydroxy-2-{[(2R,3S,4S,5S,6S)-4-hydroxy-6-({(2R,3aS,3a'R,6S,6'R,7R,7'R,7aR,7a'R)-7'-hydroxy-7'-[(1S)-1-hydroxyethyl]-6'-methyl-7-[(2-methylpropanoyl)oxy]octahydro-4H-2,4'-spirobi[[1,3]dioxolo[4,5-c]pyran]-6-yl}oxy)-5-methoxy-2-(methoxymethyl)tetrahydro-2H-pyran-3-yl]oxy}-5-methoxy-6-methyltetrahydro-2H-pyran-4-yl]oxy}-4,6',7a-trimethyloctahydro-4H-spiro[1,3-dioxolo[4,5-c]pyran-2,2'-pyran]-5'-yl]oxy}-2-methyltetrahydro-2H-pyran-3-yl 3,5-dichloro-4-hydroxy-2-methoxy-6-methylbenzoate (non-preferred name)",
    "SMILES": "Cc1c(c(c(c(c1Cl)O)Cl)OC)C(=O)OC2C(OC(CC2O)OC3C(OC4(CC3O)OC5C(OC(CC5(O4)C)OC6C(C(OC(C6OC)C)OC7C(OC(C(C7O)OC)OC8C(C9C(CO8)OC1(O9)C2C(C(C(O1)C)(C(C)O)O)OCO2)OC(=O)C(C)C)COC)O)C)C)C",
    "chemicalId": "6UQ",
    "InChI": "InChI=1S/C61H90Cl2O32/c1-21(2)53(70)87-49-45-32(92-61(93-45)52-51(78-20-79-52)60(72,27(8)64)28(9)91-61)19-77-56(49)89-57-48(76-14)39(68)44(31(83-57)18-73-11)88-55-40(69)47(43(74-12)24(5)82-55)85-34-17-58(10)50(26(7)81-34)94-59(95-58)16-30(66)42(25(6)90-59)84-33-15-29(65)41(23(4)80-33)86-54(71)35-22(3)36(62)38(67)37(63)46(35)75-13/h21,23-34,39-45,47-52,55-57,64-69,72H,15-20H2,1-14H3/t23-,24-,25-,26-,27+,28-,29-,30-,31-,32+,33+,34+,39+,40-,41-,42-,43+,44-,45-,47-,48+,49-,50-,51-,52-,55+,56+,57+,58-,59-,60-,61-/m1/s1",
    "formula_weight": 1.406,
    "number_of_instances": 1,
    "InChIKey": "AEIFATUAVHHRBC-JOYRSTEWSA-N",
    "SMILES_stereo": "Cc1c(c(c(c(c1Cl)O)Cl)OC)C(=O)O[C@@H]2[C@H](O[C@H](C[C@H]2O)O[C@@H]3[C@H](O[C@]4(C[C@H]3O)O[C@@H]5[C@H](O[C@H](C[C@]5(O4)C)O[C@@H]6[C@H]([C@@H](O[C@@H]([C@@H]6OC)C)O[C@@H]7[C@H](O[C@H]([C@H]([C@H]7O)OC)O[C@H]8[C@@H]([C@H]9[C@H](CO8)O[C@@]1(O9)[C@H]2[C@H]([C@]([C@H](O1)C)([C@H](C)O)O)OCO2)OC(=O)C(C)C)COC)O)C)C)C",
    "pdbx_description": "(2R,3S,4R,6S)-4-hydroxy-6-{[(2R,3aR,4R,4'R,5'S,6S,6'R,7aR)-4'-hydroxy-6-{[(2S,3R,4R,5S,6R)-3-hydroxy-2-{[(2R,3S,4S,5S,6S)-4-hydroxy-6-({(2R,3aS,3a'R,6S,6'R,7R,7'R,7aR,7a'R)-7'-hydroxy-7'-[(1S)-1-hydroxyethyl]-6'-methyl-7-[(2-methylpropanoyl)oxy]octahydro-4H-2,4'-spirobi[[1,3]dioxolo[4,5-c]pyran]-6-yl}oxy)-5-methoxy-2-(methoxymethyl)tetrahydro-2H-pyran-3-yl]oxy}-5-methoxy-6-methyltetrahydro-2H-pyran-4-yl]oxy}-4,6',7a-trimethyloctahydro-4H-spiro[1,3-dioxolo[4,5-c]pyran-2,2'-pyran]-5'-yl]oxy}-2-methyltetrahydro-2H-pyran-3-yl 3,5-dichloro-4-hydroxy-2-methoxy-6-methylbenzoate (non-preferred name)"
  },
  {
    "chemicalName": "Agelastatin A",
    "SMILES": "CN1C(=O)NC2C1(CC3C2NC(=O)c4n3c(cc4)Br)O",
    "chemicalId": "7MB",
    "InChI": "InChI=1S/C12H13BrN4O3/c1-16-11(19)15-9-8-6(4-12(9,16)20)17-5(10(18)14-8)2-3-7(17)13/h2-3,6,8-9,20H,4H2,1H3,(H,14,18)(H,15,19)/t6-,8-,9+,12+/m1/s1",
    "formula_weight": 0.341,
    "number_of_instances": 2,
    "InChIKey": "MPASKXAEPUAMBS-WJOUQXRDSA-N",
    "SMILES_stereo": "CN1C(=O)N[C@@H]2[C@]1(C[C@@H]3[C@H]2NC(=O)c4n3c(cc4)Br)O",
    "pdbx_description": "Agelastatin A"
  },
  {
    "chemicalName": "Chlorolissoclimide",
    "SMILES": "CC1(CC(CC2(C1CC(C(=C)C2CC(C3CC(=O)NC3=O)O)O)C)Cl)C",
    "chemicalId": "7AL",
    "InChI": "InChI=1S/C20H30ClNO4/c1-10-13(6-15(24)12-5-17(25)22-18(12)26)20(4)9-11(21)8-19(2,3)16(20)7-14(10)23/h11-16,23-24H,1,5-9H2,2-4H3,(H,22,25,26)/t11-,12+,13-,14-,15-,16-,20+/m0/s1",
    "formula_weight": 0.384,
    "number_of_instances": 2,
    "InChIKey": "LCBZIVZSFYGPBC-LWHFJPTFSA-N",
    "pdbx_description": "Chlorolissoclimide",
    "SMILES_stereo": "C[C@]12C[C@H](CC([C@@H]1C[C@@H](C(=C)[C@@H]2C[C@@H]([C@H]3CC(=O)NC3=O)O)O)(C)C)Cl"
  },
  {
    "chemicalName": "13-DEOXYTEDANOLIDE",
    "SMILES": "CC=CC(C)C1C(O1)(C)C(C2COC(=O)C(C(C(C(=O)C(C(C(=CC(C(=O)CCC(C2=O)C)C)C)O)C)C)OC)O)O",
    "chemicalId": "13T",
    "InChI": "InChI=1S/C32H50O10/c1-10-11-17(3)30-32(8,42-30)29(38)22-15-41-31(39)27(37)28(40-9)21(7)26(36)20(6)24(34)19(5)14-18(4)23(33)13-12-16(2)25(22)35/h10-11,14,16-18,20-22,24,27-30,34,37-38H,12-13,15H2,1-9H3/b11-10-,19-14+/t16-,17+,18+,20-,21-,22+,24+,27-,28+,29+,30-,32-/m1/s1",
    "formula_weight": 0.595,
    "number_of_instances": 1,
    "InChIKey": "YTOSLGBJMGPGPA-AYJAMTIUSA-N",
    "pdbx_description": "13-DEOXYTEDANOLIDE",
    "SMILES_stereo": "CC=C/[C@H](C)[C@@H]1[C@@](O1)(C)[C@H]([C@H]2COC(=O)[C@@H]([C@H]([C@@H](C(=O)[C@@H]([C@H](/C(=C/[C@@H](C(=O)CC[C@H](C2=O)C)C)/C)O)C)C)OC)O)O"
  },
  {
    "chemicalName": "Retapamulin",
    "SMILES": "CC1CCC23CCC(=O)C2C1(C(CC(C(C3C)O)(C)C=C)OC(=O)CSC4CC5CCC(C4)N5C)C",
    "chemicalId": "G34",
    "InChI": "InChI=1S/C30H47NO4S/c1-7-28(4)16-24(35-25(33)17-36-22-14-20-8-9-21(15-22)31(20)6)29(5)18(2)10-12-30(19(3)27(28)34)13-11-23(32)26(29)30/h7,18-22,24,26-27,34H,1,8-17H2,2-6H3/t18-,19+,20-,21+,22-,24-,26+,27+,28-,29+,30+/m1/s1",
    "formula_weight": 0.518,
    "number_of_instances": 1,
    "drugbank_id": "DB01256",
    "drugbank_description": "Retapamulin, marketed by GlaxoSmithKline as the ointment Altabax, is an antibiotic for skin infections like impetigo. It was approved by the FDA in April 2007.",
    "InChIKey": "STZYTFJPGGDRJD-NHUWBDDWSA-N",
    "pdbx_description": "Retapamulin",
    "SMILES_stereo": "C[C@@H]1CC[C@@]23CCC(=O)[C@H]2[C@@]1([C@@H](C[C@@]([C@H]([C@@H]3C)O)(C)C=C)OC(=O)CSC4C[C@H]5CC[C@@H](C4)N5C)C"
  },
  {
    "chemicalName": "Avilamycin",
    "SMILES": "Cc1c(c(c(c(c1Cl)O)Cl)OC)C(=O)OC2C(OC(CC2O)OC3C(OC4(CC3O)OC5C(OC(CC5(O4)C)OC6C(C(OC(C6OC)C)OC7C(OC(C(C7O)OC)OC8C(C9C(CO8)OC1(O9)C2C(C(C(O1)C)(C(=O)C)O)OCO2)OC(=O)C(C)C)COC)O)C)C)C",
    "chemicalId": "6NO",
    "InChI": "InChI=1S/C61H88Cl2O32/c1-21(2)53(70)87-49-45-32(92-61(93-45)52-51(78-20-79-52)60(72,27(8)64)28(9)91-61)19-77-56(49)89-57-48(76-14)39(68)44(31(83-57)18-73-11)88-55-40(69)47(43(74-12)24(5)82-55)85-34-17-58(10)50(26(7)81-34)94-59(95-58)16-30(66)42(25(6)90-59)84-33-15-29(65)41(23(4)80-33)86-54(71)35-22(3)36(62)38(67)37(63)46(35)75-13/h21,23-26,28-34,39-45,47-52,55-57,65-69,72H,15-20H2,1-14H3/t23-,24-,25-,26-,28-,29-,30-,31-,32+,33+,34+,39+,40-,41-,42-,43+,44-,45-,47-,48+,49-,50-,51-,52-,55+,56+,57+,58-,59-,60+,61-/m1/s1",
    "formula_weight": 1.404,
    "number_of_instances": 1,
    "InChIKey": "XIRGHRXBGGPPKY-GMJOKQQKSA-N",
    "SMILES_stereo": "Cc1c(c(c(c(c1Cl)O)Cl)OC)C(=O)O[C@@H]2[C@H](O[C@H](C[C@H]2O)O[C@@H]3[C@H](O[C@]4(C[C@H]3O)O[C@@H]5[C@H](O[C@H](C[C@]5(O4)C)O[C@@H]6[C@H]([C@@H](O[C@@H]([C@@H]6OC)C)O[C@@H]7[C@H](O[C@H]([C@H]([C@H]7O)OC)O[C@H]8[C@@H]([C@H]9[C@H](CO8)O[C@@]1(O9)[C@H]2[C@H]([C@@]([C@H](O1)C)(C(=O)C)O)OCO2)OC(=O)C(C)C)COC)O)C)C)C",
    "pdbx_description": "Avilamycin"
  },
  {
    "chemicalName": "(3aS,4R,7R,8S,9S,10R,11R,13R,15R,15aR)-4-ethyl-11-methoxy-3a,7,9,11,13,15-hexamethyl-2,6,14-trioxo-10-{[3,4,6-trideoxy-3-(dimethylamino)-beta-D-xylo-hexopyranosyl]oxy}tetradecahydro-2H-oxacyclotetradecino[4,3-d][1,3]oxazol-8-yl (2R)-2-(pyridin-3-yl)pyrrolidine-1-carboxylate",
    "SMILES": "CCC1C2(C(C(C(=O)C(CC(C(C(C(C(C(=O)O1)C)OC(=O)N3CCCC3c4cccnc4)C)OC5C(C(CC(O5)C)N(C)C)O)(C)OC)C)C)NC(=O)O2)C",
    "chemicalId": "1F2",
    "InChI": "InChI=1S/C41H64N4O11/c1-12-30-41(8)34(43-38(49)56-41)24(4)31(46)22(2)20-40(7,51-11)35(55-37-32(47)29(44(9)10)19-23(3)52-37)25(5)33(26(6)36(48)53-30)54-39(50)45-18-14-16-28(45)27-15-13-17-42-21-27/h13,15,17,21-26,28-30,32-35,37,47H,12,14,16,18-20H2,1-11H3,(H,43,49)/t22-,23-,24+,25+,26-,28-,29+,30-,32-,33+,34-,35-,37+,40-,41-/m1/s1",
    "formula_weight": 0.789,
    "number_of_instances": 1,
    "InChIKey": "QMAYKVIDQIRQBR-XPYOOJRRSA-N",
    "SMILES_stereo": "CC[C@@H]1[C@@]2([C@@H]([C@H](C(=O)[C@@H](C[C@@]([C@@H]([C@H]([C@@H]([C@H](C(=O)O1)C)OC(=O)N3CCC[C@@H]3c4cccnc4)C)O[C@H]5[C@@H]([C@H](C[C@H](O5)C)N(C)C)O)(C)OC)C)C)NC(=O)O2)C",
    "pdbx_description": "(3aS,4R,7R,8S,9S,10R,11R,13R,15R,15aR)-4-ethyl-11-methoxy-3a,7,9,11,13,15-hexamethyl-2,6,14-trioxo-10-{[3,4,6-trideoxy-3-(dimethylamino)-beta-D-xylo-hexopyranosyl]oxy}tetradecahydro-2H-oxacyclotetradecino[4,3-d][1,3]oxazol-8-yl (2R)-2-(pyridin-3-yl)pyrrolidine-1-carboxylate"
  },
  {
    "chemicalName": "(3aS,4R,7R,8S,9S,10R,11R,13R,15R,15aR)-4-ethyl-11-methoxy-3a,7,9,11,13,15-hexamethyl-2,6,14-trioxo-10-{[3,4,6-trideoxy-3-(dimethylamino)-beta-D-xylo-hexopyranosyl]oxy}tetradecahydro-2H-oxacyclotetradecino[4,3-d][1,3]oxazol-8-yl (2R)-2-[4-(acetylamino)phenyl]-2,3-dihydro-1H-pyrrole-1-carboxylate",
    "SMILES": "CCC1C2(C(C(C(=O)C(CC(C(C(C(C(C(=O)O1)C)OC(=O)N3C=CCC3c4ccc(cc4)NC(=O)C)C)OC5C(C(CC(O5)C)N(C)C)O)(C)OC)C)C)NC(=O)O2)C",
    "chemicalId": "1F3",
    "InChI": "InChI=1S/C44H66N4O12/c1-13-33-44(9)37(46-41(53)60-44)25(4)34(50)23(2)22-43(8,55-12)38(59-40-35(51)32(47(10)11)21-24(3)56-40)26(5)36(27(6)39(52)57-33)58-42(54)48-20-14-15-31(48)29-16-18-30(19-17-29)45-28(7)49/h14,16-20,23-27,31-33,35-38,40,51H,13,15,21-22H2,1-12H3,(H,45,49)(H,46,53)/t23-,24-,25+,26+,27-,31-,32+,33-,35-,36+,37-,38-,40+,43-,44-/m1/s1",
    "formula_weight": 0.843,
    "number_of_instances": 1,
    "InChIKey": "ZKTKUJCCBJLCJA-RDDSPYQVSA-N",
    "SMILES_stereo": "CC[C@@H]1[C@@]2([C@@H]([C@H](C(=O)[C@@H](C[C@@]([C@@H]([C@H]([C@@H]([C@H](C(=O)O1)C)OC(=O)N3C=CC[C@@H]3c4ccc(cc4)NC(=O)C)C)O[C@H]5[C@@H]([C@H](C[C@H](O5)C)N(C)C)O)(C)OC)C)C)NC(=O)O2)C",
    "pdbx_description": "(3aS,4R,7R,8S,9S,10R,11R,13R,15R,15aR)-4-ethyl-11-methoxy-3a,7,9,11,13,15-hexamethyl-2,6,14-trioxo-10-{[3,4,6-trideoxy-3-(dimethylamino)-beta-D-xylo-hexopyranosyl]oxy}tetradecahydro-2H-oxacyclotetradecino[4,3-d][1,3]oxazol-8-yl (2R)-2-[4-(acetylamino)phenyl]-2,3-dihydro-1H-pyrrole-1-carboxylate"
  },
  {
    "chemicalName": "Sarecycline",
    "SMILES": "CN(C)C1C2CC3Cc4c(ccc(c4C(=O)C3=C(C2(C(=O)C(=C1O)C(=O)N)O)O)O)CN(C)OC",
    "chemicalId": "V7A",
    "InChI": "InChI=1S/C24H29N3O8/c1-26(2)18-13-8-11-7-12-10(9-27(3)35-4)5-6-14(28)16(12)19(29)15(11)21(31)24(13,34)22(32)17(20(18)30)23(25)33/h5-6,11,13,18,28,30-31,34H,7-9H2,1-4H3,(H2,25,33)/t11-,13-,18-,24-/m0/s1",
    "formula_weight": 0.488,
    "number_of_instances": 2,
    "drugbank_id": "DB12035",
    "drugbank_description": "Sarecycline is a semi-synthetic derivative of tetracycline that was initially discovered by Paratek Pharmaceuticals from Boston, MA but then licensed to Warner Chilcott of Rockaway, NJ in July of 2007 [A40005]. After completing various phase-II and phase-III trials demonstrating its effectiveness in treating moderate to severe facial acne vulgaris [A39993, A39994] the US Food and Drug Administration approved Barcelona based Almirall, S.A.'s Seysara (sarecylcine) as a new first in class narrow spectrum tetracycline derived oral antibiotic for the treatment of inflammatory lesions of non-nodular moderate to severe acne vulgaris in patients nine years of age and older [L4814]. Seysara (sarecycline) was originally part of Allergan's US Medical Dermatology portfolio, before Almirall acquired the portfolio in the second half of 2018 as a means of consolidating and reinforcing the dermatology-focused pharmaceutical company's presence in the United States [L4815].  Acne vulgaris itself is a common chronic skin condition associated with the blockage and/or inflammation of hair follicles and their accompanying sebaceous glands [L4814]. The acne often presents physically as a mixture of non-inflammatory and inflammatory lesions mainly on the face but on the back and chest as well [L4814]. Based upon data from Global Burden of Disease studies, the acne vulgaris condition affects up to 85% of young adults aged 12 to 25 years globally - with the possibility of permanent physical and mental scarring resulting from cases of severe acne [L4814].  Subsequently, while a number of first line tetracycline therapies like doxycycline and minocycline do exist for treating acne vulgaris, sarecycline presents a new and innovative therapy choice because it exhibits the necessary antibacterial activity against relevant pathogens that cause acne vulgaris but also possesses a low propensity for resistance development in such pathogens and a narrower, more specific spectrum of antibacterial activity, resulting in fewer off-target antibacterial effects on endogenous intestinal flora and consequently fewer resultant adverse effects associated with diarrhea, fungal overgrowth, etc.",
    "InChIKey": "PQJQFLNBMSCUSH-SBAJWEJLSA-N",
    "pdbx_description": "Sarecycline",
    "SMILES_stereo": "CN(C)[C@H]1[C@@H]2C[C@@H]3Cc4c(ccc(c4C(=O)C3=C([C@@]2(C(=O)C(=C1O)C(=O)N)O)O)O)CN(C)OC"
  },
  {
    "chemicalName": "SPERMINE (FULLY PROTONATED FORM)",
    "SMILES": "C(CC[NH2+]CCC[NH3+])C[NH2+]CCC[NH3+]",
    "chemicalId": "SPK",
    "InChI": "InChI=1S/C10H26N4/c11-5-3-9-13-7-1-2-8-14-10-4-6-12/h13-14H,1-12H2/p+4",
    "formula_weight": 0.206,
    "number_of_instances": 1,
    "InChIKey": "PFNFFQXMRSDOHW-UHFFFAOYSA-R",
    "SMILES_stereo": "C(CC[NH2+]CCC[NH3+])C[NH2+]CCC[NH3+]",
    "pdbx_description": "SPERMINE (FULLY PROTONATED FORM)"
  },
  {
    "chemicalName": "Cephaeline",
    "SMILES": "CCC1CN2CCc3cc(c(cc3C2CC1CC4c5cc(c(cc5CCN4)O)OC)OC)OC",
    "chemicalId": "K16",
    "InChI": "InChI=1S/C28H38N2O4/c1-5-17-16-30-9-7-19-13-27(33-3)28(34-4)15-22(19)24(30)11-20(17)10-23-21-14-26(32-2)25(31)12-18(21)6-8-29-23/h12-15,17,20,23-24,29,31H,5-11,16H2,1-4H3/t17-,20-,23+,24-/m0/s1",
    "formula_weight": 0.467,
    "number_of_instances": 3,
    "InChIKey": "DTGZHCFJNDAHEN-OZEXIGSWSA-N",
    "SMILES_stereo": "CC[C@H]1CN2CCc3cc(c(cc3[C@@H]2C[C@@H]1C[C@@H]4c5cc(c(cc5CCN4)O)OC)OC)OC",
    "pdbx_description": "Cephaeline"
  },
  {
    "chemicalName": "PUROMYCIN-5'-MONOPHOSPHATE",
    "SMILES": "CN(C)c1c2c(ncn1)n(cn2)C3C(C(C(O3)COP(=O)(O)O)NC(=O)C(Cc4ccc(cc4)OC)N)O",
    "chemicalId": "PPU",
    "InChI": "InChI=1S/C22H30N7O8P/c1-28(2)19-17-20(25-10-24-19)29(11-26-17)22-18(30)16(15(37-22)9-36-38(32,33)34)27-21(31)14(23)8-12-4-6-13(35-3)7-5-12/h4-7,10-11,14-16,18,22,30H,8-9,23H2,1-3H3,(H,27,31)(H2,32,33,34)/t14-,15+,16+,18+,22+/m0/s1",
    "formula_weight": 0.551,
    "number_of_instances": 1,
    "InChIKey": "NYICMZBLMICLBS-NVWDDTSBSA-N",
    "SMILES_stereo": "CN(C)c1c2c(ncn1)n(cn2)[C@H]3[C@@H]([C@@H]([C@H](O3)COP(=O)(O)O)NC(=O)[C@H](Cc4ccc(cc4)OC)N)O",
    "pdbx_description": "PUROMYCIN-5'-MONOPHOSPHATE"
  },
  {
    "chemicalName": "(3beta,7alpha)-3,7,15-trihydroxy-12,13-epoxytrichothec-9-en-8-one",
    "SMILES": "CC1=CC2C(C(C1=O)O)(C3(CC(C(C34CO4)O2)O)C)CO",
    "chemicalId": "3J6",
    "InChI": "InChI=1S/C15H20O6/c1-7-3-9-14(5-16,11(19)10(7)18)13(2)4-8(17)12(21-9)15(13)6-20-15/h3,8-9,11-12,16-17,19H,4-6H2,1-2H3/t8-,9-,11-,12-,13-,14-,15+/m1/s1",
    "formula_weight": 0.296,
    "number_of_instances": 2,
    "InChIKey": "LINOMUASTDIRTM-QGRHZQQGSA-N",
    "SMILES_stereo": "CC1=C[C@@H]2[C@]([C@@H](C1=O)O)([C@]3(C[C@H]([C@H]([C@@]34CO4)O2)O)C)CO",
    "pdbx_description": "(3beta,7alpha)-3,7,15-trihydroxy-12,13-epoxytrichothec-9-en-8-one"
  },
  {
    "chemicalName": "(2R,3R,4R,6S)-6-{[(2R,3aR,4R,4'R,5'S,6S,6'R,7S,7aR)-6-{[(2S,3R,4R,5S,6R)-2-{[(2R,3S,4S,5S,6S)-6-({(2R,3aS,3a'R,6S,7R,7'R,7aS,7a'S)-7'-[(2,4-dihydroxy-6-methylbenzoyl)oxy]-7-hydroxyoctahydro-4H-2,4'-spirobi[[1,3]dioxolo[4,5-c]pyran]-6-yl}oxy)-4-hydroxy-5-methoxy-2-(methoxymethyl)tetrahydro-2H-pyran-3-yl]oxy}-3-hydroxy-5-methoxy-6-methyltetrahydro-2H-pyran-4-yl]oxy}-4',7-dihydroxy-4,6',7a-trimethyloctahydro-4H-spiro[1,3-dioxolo[4,5-c]pyran-2,2'-pyran]-5'-yl]oxy}-4-{[(2R,4S,5R,6S)-5-methoxy-4,6-dimethyl-4-nitrotetrahydro-2H-pyran-2-yl]oxy}-2-methyltetrahydro-2H-pyran-3-yl 3,5-dichloro-4-hydroxy-2-methoxy-6-methylbenzoate (non-preferred name)",
    "SMILES": "Cc1cc(cc(c1C(=O)OC2COC3(C4C2OCO4)OC5COC(C(C5O3)O)OC6C(C(C(C(O6)COC)OC7C(C(C(C(O7)C)OC)OC8C(C9(C(C(O8)C)OC1(O9)CC(C(C(O1)C)OC1CC(C(C(O1)C)OC(=O)c1c(c(c(c(c1OC)Cl)O)Cl)C)OC1CC(C(C(O1)C)OC)(C)[N+](=O)[O-])O)C)O)O)O)OC)O)O",
    "chemicalId": "EVN",
    "InChI": "InChI=1S/C70H97Cl2NO38/c1-24-15-31(74)16-32(75)40(24)61(82)100-36-22-94-70(60-53(36)92-23-93-60)108-37-21-91-63(46(79)52(37)109-70)106-65-56(89-13)45(78)51(35(101-65)20-86-10)104-64-47(80)55(50(87-11)27(4)97-64)105-66-57(81)68(9)59(30(7)98-66)110-69(111-68)18-33(76)48(28(5)107-69)102-38-17-34(99-39-19-67(8,73(84)85)58(90-14)29(6)96-39)49(26(3)95-38)103-62(83)41-25(2)42(71)44(77)43(72)54(41)88-12/h15-16,26-30,33-39,45-53,55-60,63-66,74-81H,17-23H2,1-14H3/t26-,27-,28-,29+,30-,33-,34-,35-,36-,37+,38+,39-,45+,46-,47-,48-,49-,50+,51-,52-,53+,55-,56+,57-,58+,59-,60-,63+,64+,65+,66+,67+,68-,69-,70-/m1/s1",
    "formula_weight": 1.631,
    "number_of_instances": 1,
    "InChIKey": "UPADRKHAIMTUCC-LRNXXXSBSA-N",
    "SMILES_stereo": "Cc1cc(cc(c1C(=O)O[C@@H]2CO[C@]3([C@H]4[C@H]2OCO4)O[C@H]5CO[C@H]([C@@H]([C@@H]5O3)O)O[C@H]6[C@H]([C@H]([C@@H]([C@H](O6)COC)O[C@H]7[C@@H]([C@H]([C@H]([C@H](O7)C)OC)O[C@H]8[C@H]([C@@]9([C@@H]([C@H](O8)C)O[C@@]1(O9)C[C@H]([C@@H]([C@H](O1)C)O[C@H]1C[C@H]([C@@H]([C@H](O1)C)OC(=O)c1c(c(c(c(c1OC)Cl)O)Cl)C)O[C@@H]1C[C@]([C@H]([C@@H](O1)C)OC)(C)[N+](=O)[O-])O)C)O)O)O)OC)O)O",
    "pdbx_description": "(2R,3R,4R,6S)-6-{[(2R,3aR,4R,4'R,5'S,6S,6'R,7S,7aR)-6-{[(2S,3R,4R,5S,6R)-2-{[(2R,3S,4S,5S,6S)-6-({(2R,3aS,3a'R,6S,7R,7'R,7aS,7a'S)-7'-[(2,4-dihydroxy-6-methylbenzoyl)oxy]-7-hydroxyoctahydro-4H-2,4'-spirobi[[1,3]dioxolo[4,5-c]pyran]-6-yl}oxy)-4-hydroxy-5-methoxy-2-(methoxymethyl)tetrahydro-2H-pyran-3-yl]oxy}-3-hydroxy-5-methoxy-6-methyltetrahydro-2H-pyran-4-yl]oxy}-4',7-dihydroxy-4,6',7a-trimethyloctahydro-4H-spiro[1,3-dioxolo[4,5-c]pyran-2,2'-pyran]-5'-yl]oxy}-4-{[(2R,4S,5R,6S)-5-methoxy-4,6-dimethyl-4-nitrotetrahydro-2H-pyran-2-yl]oxy}-2-methyltetrahydro-2H-pyran-3-yl 3,5-dichloro-4-hydroxy-2-methoxy-6-methylbenzoate (non-preferred name)"
  },
  {
    "chemicalName": "ANY 5'-MONOPHOSPHATE NUCLEOTIDE",
    "SMILES": "C1C(C(C(O1)COP(=O)(O)O)O)O",
    "chemicalId": "N",
    "InChI": "InChI=1S/C5H11O7P/c6-3-1-11-4(5(3)7)2-12-13(8,9)10/h3-7H,1-2H2,(H2,8,9,10)/t3-,4+,5-/m0/s1",
    "formula_weight": 0.214,
    "number_of_instances": 1,
    "InChIKey": "CYZZKTRFOOKUMT-LMVFSUKVSA-N",
    "pdbx_description": "ANY 5'-MONOPHOSPHATE NUCLEOTIDE",
    "SMILES_stereo": "C1[C@@H]([C@@H]([C@H](O1)COP(=O)(O)O)O)O"
  },
  {
    "chemicalName": "(14aR)-2,3,6-trimethoxy-11,12,13,14,14a,15-hexahydro-9H-dibenzo[f,h]pyrido[1,2-b]isoquinoline",
    "SMILES": "COc1ccc2c(c1)c3cc(c(cc3c4c2CN5CCCCC5C4)OC)OC",
    "chemicalId": "3K8",
    "InChI": "InChI=1S/C24H27NO3/c1-26-16-7-8-17-19(11-16)21-13-24(28-3)23(27-2)12-20(21)18-10-15-6-4-5-9-25(15)14-22(17)18/h7-8,11-13,15H,4-6,9-10,14H2,1-3H3/t15-/m1/s1",
    "formula_weight": 0.377,
    "number_of_instances": 2,
    "InChIKey": "RSHYSOGXGSUUIJ-OAHLLOKOSA-N",
    "SMILES_stereo": "COc1ccc2c(c1)c3cc(c(cc3c4c2CN5CCCC[C@@H]5C4)OC)OC",
    "pdbx_description": "(14aR)-2,3,6-trimethoxy-11,12,13,14,14a,15-hexahydro-9H-dibenzo[f,h]pyrido[1,2-b]isoquinoline"
  },
  {
    "chemicalName": "3'-deoxy-3'-{[(2E)-3-(4-{[(4Z)-6-O-(6-deoxy-3,4-di-O-methyl-alpha-D-mannopyranosyl)-5-O-methyl-alpha-D-threo-hex-4-enofuranosyl]oxy}phenyl)-2-methylprop-2-enoyl]amino}-N,N-dimethyladenosine",
    "SMILES": "CC1C(C(C(C(O1)OCC(=C2C(C(C(O2)Oc3ccc(cc3)C=C(C)C(=O)NC4C(OC(C4O)n5cnc6c5ncnc6N(C)C)CO)O)O)OC)O)OC)OC",
    "chemicalId": "4M2",
    "InChI": "InChI=1S/C37H50N6O14/c1-17(34(49)41-23-21(13-44)56-35(25(23)45)43-16-40-24-32(42(3)4)38-15-39-33(24)43)12-19-8-10-20(11-9-19)55-37-27(47)26(46)30(57-37)22(50-5)14-53-36-28(48)31(52-7)29(51-6)18(2)54-36/h8-12,15-16,18,21,23,25-29,31,35-37,44-48H,13-14H2,1-7H3,(H,41,49)/b17-12+,30-22-/t18-,21-,23-,25-,26+,27+,28+,29-,31-,35-,36+,37+/m1/s1",
    "formula_weight": 0.803,
    "number_of_instances": 2,
    "InChIKey": "HELPZWNRUYNCJQ-NADCVASFSA-N",
    "SMILES_stereo": "C[C@@H]1[C@H]([C@@H]([C@@H]([C@H](O1)OC/C(=C/2[C@H]([C@@H]([C@H](O2)Oc3ccc(cc3)/C=C(C)/C(=O)N[C@@H]4[C@H](O[C@H]([C@@H]4O)n5cnc6c5ncnc6N(C)C)CO)O)O)/OC)O)OC)OC",
    "pdbx_description": "3'-deoxy-3'-{[(2E)-3-(4-{[(4Z)-6-O-(6-deoxy-3,4-di-O-methyl-alpha-D-mannopyranosyl)-5-O-methyl-alpha-D-threo-hex-4-enofuranosyl]oxy}phenyl)-2-methylprop-2-enoyl]amino}-N,N-dimethyladenosine"
  },
  {
    "chemicalName": "GLYCEROL",
    "SMILES": "C(C(CO)O)O",
    "chemicalId": "GOL",
    "InChI": "InChI=1S/C3H8O3/c4-1-3(6)2-5/h3-6H,1-2H2",
    "formula_weight": 0.092,
    "number_of_instances": 3,
    "drugbank_id": "DB09462",
    "drugbank_description": "A trihydroxy sugar alcohol that is an intermediate in carbohydrate and lipid metabolism.",
    "InChIKey": "PEDCQBHIVMGVHV-UHFFFAOYSA-N",
    "SMILES_stereo": "C(C(CO)O)O",
    "pdbx_description": "GLYCEROL"
  },
  {
    "chemicalName": "(4S,4aS,5aR,12aS)-4-(diethylamino)-3,10,12,12a-tetrahydroxy-1,11-dioxo-8-[(2S)-pyrrolidin-2-yl]-7-(trifluoromethyl)-1,4,4a,5,5a,6,11,12a-octahydrotetracene-2-carboxamide",
    "SMILES": "CCN(CC)C1C2CC3Cc4c(c(cc(c4C(F)(F)F)C5CCCN5)O)C(=O)C3=C(C2(C(=O)C(=C1O)C(=O)N)O)O",
    "chemicalId": "80P",
    "InChI": "InChI=1S/C28H32F3N3O7/c1-3-34(4-2)21-14-9-11-8-13-18(16(35)10-12(15-6-5-7-33-15)20(13)28(29,30)31)22(36)17(11)24(38)27(14,41)25(39)19(23(21)37)26(32)40/h10-11,14-15,21,33,35,37-38,41H,3-9H2,1-2H3,(H2,32,40)/t11-,14-,15-,21-,27-/m0/s1",
    "formula_weight": 0.58,
    "number_of_instances": 3,
    "InChIKey": "IDWTZCZXXFOLNV-DOYYSQEVSA-N",
    "SMILES_stereo": "CCN(CC)[C@H]1[C@@H]2C[C@@H]3Cc4c(c(cc(c4C(F)(F)F)[C@@H]5CCCN5)O)C(=O)C3=C([C@@]2(C(=O)C(=C1O)C(=O)N)O)O",
    "pdbx_description": "(4S,4aS,5aR,12aS)-4-(diethylamino)-3,10,12,12a-tetrahydroxy-1,11-dioxo-8-[(2S)-pyrrolidin-2-yl]-7-(trifluoromethyl)-1,4,4a,5,5a,6,11,12a-octahydrotetracene-2-carboxamide"
  },
  {
    "chemicalName": "N-({(5S)-2-oxo-3-[4-(1,3-thiazol-5-yl)phenyl]-1,3-oxazolidin-5-yl}methyl)acetamide",
    "SMILES": "CC(=O)NCC1CN(C(=O)O1)c2ccc(cc2)c3cncs3",
    "chemicalId": "917",
    "InChI": "InChI=1S/C15H15N3O3S/c1-10(19)17-6-13-8-18(15(20)21-13)12-4-2-11(3-5-12)14-7-16-9-22-14/h2-5,7,9,13H,6,8H2,1H3,(H,17,19)/t13-/m0/s1",
    "formula_weight": 0.317,
    "number_of_instances": 1,
    "InChIKey": "WTZZWIUUAPRUHM-ZDUSSCGKSA-N",
    "SMILES_stereo": "CC(=O)NC[C@H]1CN(C(=O)O1)c2ccc(cc2)c3cncs3",
    "pdbx_description": "N-({(5S)-2-oxo-3-[4-(1,3-thiazol-5-yl)phenyl]-1,3-oxazolidin-5-yl}methyl)acetamide"
  },
  {
    "chemicalName": "Evernimicin",
    "SMILES": "Cc1cc(cc(c1C(=O)OC2COC3(C4C2OCO4)OC5COC(C(C5O3)O)OC6C(C(C(C(O6)COC)OC7C(C(C(C(O7)C)OC)OC8C(C9(C(C(O8)C)OC1(O9)CC(C(C(O1)C)OC1CC(C(C(O1)C)OC(=O)c1c(c(c(c(c1OC)Cl)O)Cl)C)OC1CC(C(C(O1)C)OC)(C)[N+](=O)[O-])O)C)O)O)O)OC)O)O",
    "chemicalId": "6O1",
    "InChI": "InChI=1S/C70H97Cl2NO38/c1-24-15-31(74)16-32(75)40(24)61(82)100-36-22-94-70(60-53(36)92-23-93-60)108-37-21-91-63(46(79)52(37)109-70)106-65-56(89-13)45(78)51(35(101-65)20-86-10)104-64-47(80)55(50(87-11)27(4)97-64)105-66-57(81)68(9)59(30(7)98-66)110-69(111-68)18-33(76)48(28(5)107-69)102-38-17-34(99-39-19-67(8,73(84)85)58(90-14)29(6)96-39)49(26(3)95-38)103-62(83)41-25(2)42(71)44(77)43(72)54(41)88-12/h15-16,26-30,33-39,45-53,55-60,63-66,74-81H,17-23H2,1-14H3/t26-,27-,28-,29?,30-,33-,34-,35-,36-,37+,38+,39-,45+,46-,47-,48-,49-,50+,51-,52-,53+,55-,56+,57-,58?,59-,60-,63+,64+,65+,66+,67-,68-,69-,70-/m1/s1",
    "formula_weight": 1.631,
    "number_of_instances": 1,
    "InChIKey": "UPADRKHAIMTUCC-PPTKMMIPSA-N",
    "SMILES_stereo": "Cc1cc(cc(c1C(=O)O[C@@H]2CO[C@]3([C@H]4[C@H]2OCO4)O[C@H]5CO[C@H]([C@@H]([C@@H]5O3)O)O[C@H]6[C@H]([C@H]([C@@H]([C@H](O6)COC)O[C@H]7[C@@H]([C@H]([C@H]([C@H](O7)C)OC)O[C@H]8[C@H]([C@@]9([C@@H]([C@H](O8)C)O[C@@]1(O9)C[C@H]([C@@H]([C@H](O1)C)O[C@H]1C[C@H]([C@@H]([C@H](O1)C)OC(=O)c1c(c(c(c(c1OC)Cl)O)Cl)C)O[C@@H]1C[C@@](C(C(O1)C)OC)(C)[N+](=O)[O-])O)C)O)O)O)OC)O)O",
    "pdbx_description": "Evernimicin"
  },
  {
    "chemicalName": "N-[(1R,2S,3S,4R,5S)-5-amino-4-{[(2S,3R)-3-amino-6-(aminomethyl)-3,4-dihydro-2H-pyran-2-yl]oxy}-2-{[3-deoxy-4-C-methyl-3-(methylamino)-beta-L-arabinopyranosyl]oxy}-3-hydroxycyclohexyl]methanesulfonamide",
    "SMILES": "CC1(COC(C(C1NC)O)OC2C(CC(C(C2O)OC3C(CC=C(O3)CN)N)N)NS(=O)(=O)C)O",
    "chemicalId": "EUS",
    "InChI": "InChI=1S/C20H39N5O9S/c1-20(28)8-31-19(14(27)17(20)24-2)34-16-12(25-35(3,29)30)6-11(23)15(13(16)26)33-18-10(22)5-4-9(7-21)32-18/h4,10-19,24-28H,5-8,21-23H2,1-3H3/t10-,11+,12-,13+,14-,15-,16+,17-,18-,19-,20+/m1/s1",
    "formula_weight": 0.526,
    "number_of_instances": 1,
    "InChIKey": "YMZLOLIFCOUGLA-CPIRLDNISA-N",
    "SMILES_stereo": "C[C@@]1(CO[C@@H]([C@@H]([C@H]1NC)O)O[C@H]2[C@@H](C[C@@H]([C@H]([C@@H]2O)O[C@@H]3[C@@H](CC=C(O3)CN)N)N)NS(=O)(=O)C)O",
    "pdbx_description": "N-[(1R,2S,3S,4R,5S)-5-amino-4-{[(2S,3R)-3-amino-6-(aminomethyl)-3,4-dihydro-2H-pyran-2-yl]oxy}-2-{[3-deoxy-4-C-methyl-3-(methylamino)-beta-L-arabinopyranosyl]oxy}-3-hydroxycyclohexyl]methanesulfonamide"
  },
  {
    "chemicalName": "(2R,3S,4R,5R,7S,9S,10S,11R,12S,13R)-12-(((2R,4R,5S,6S)-4,5-dihydroxy-4,6-dimethyltetrahydro-2H-pyran-2-yl)oxy)-2-((S)-1-(((2R,3R,4R,5R,6R)-5-hydroxy-3,4-dimethoxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)propan-2-yl)-10-(((2S,3R,6R,E)-3-hydroxy-4-(methoxyimino)-6-methyltetrahydro-2H-pyran-2-yl)oxy)-3,5,7,9,11,13-hexamethyl-7-(((2-(2-methyl-5-nitro-1H-imidazol-1-yl)ethyl)carbamoyl)oxy)-6,14-dioxooxacyclotetradecan-4-yl 3-methylbutanoate",
    "SMILES": "Cc1ncc(n1CCNC(=O)OC2(CC(C(C(C(C(C(=O)OC(C(C(C(C2=O)C)OC(=O)CC(C)C)C)C(C)COC3C(C(C(C(O3)C)O)OC)OC)C)OC4CC(C(C(O4)C)O)(C)O)C)OC5C(C(=NOC)CC(O5)C)O)C)C)[N+](=O)[O-]",
    "chemicalId": "SJH",
    "InChI": "InChI=1S/C56H93N5O22/c1-26(2)20-39(62)79-45-31(7)44(28(4)25-75-53-48(73-16)47(72-15)41(63)34(10)78-53)81-51(67)33(9)46(80-40-23-55(13,69)50(66)35(11)77-40)30(6)43(82-52-42(64)37(59-74-17)21-29(5)76-52)27(3)22-56(14,49(65)32(45)8)83-54(68)57-18-19-60-36(12)58-24-38(60)61(70)71/h24,26-35,40-48,50,52-53,63-64,66,69H,18-23,25H2,1-17H3,(H,57,68)/b59-37+/t27-,28-,29+,30+,31-,32+,33+,34+,35-,40-,41+,42+,43-,44+,45+,46-,47+,48+,50-,52-,53+,55+,56-/m0/s1",
    "formula_weight": 1.188,
    "number_of_instances": 2,
    "InChIKey": "WIXZUCMALGKNIO-BQELURNMSA-N",
    "SMILES_stereo": "Cc1ncc(n1CCNC(=O)O[C@]2(C[C@@H]([C@@H]([C@H]([C@@H]([C@H](C(=O)O[C@@H]([C@@H]([C@H]([C@H](C2=O)C)OC(=O)CC(C)C)C)[C@@H](C)CO[C@H]3[C@@H]([C@@H]([C@@H]([C@H](O3)C)O)OC)OC)C)O[C@H]4C[C@@]([C@H]([C@@H](O4)C)O)(C)O)C)O[C@H]5[C@@H](/C(=N/OC)/C[C@H](O5)C)O)C)C)[N+](=O)[O-]",
    "pdbx_description": "(2R,3S,4R,5R,7S,9S,10S,11R,12S,13R)-12-(((2R,4R,5S,6S)-4,5-dihydroxy-4,6-dimethyltetrahydro-2H-pyran-2-yl)oxy)-2-((S)-1-(((2R,3R,4R,5R,6R)-5-hydroxy-3,4-dimethoxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)propan-2-yl)-10-(((2S,3R,6R,E)-3-hydroxy-4-(methoxyimino)-6-methyltetrahydro-2H-pyran-2-yl)oxy)-3,5,7,9,11,13-hexamethyl-7-(((2-(2-methyl-5-nitro-1H-imidazol-1-yl)ethyl)carbamoyl)oxy)-6,14-dioxooxacyclotetradecan-4-yl 3-methylbutanoate"
  },
  {
    "chemicalName": "plitidepsin",
    "SMILES": "CCC(C)C1C(CC(=O)OC(C(=O)C(C(=O)NC(C(=O)N2CCCC2C(=O)N(C(C(=O)OC(C(C(=O)N1)NC(=O)C(CC(C)C)N(C)C(=O)C3CCCN3C(=O)C(=O)C)C)Cc4ccc(cc4)OC)C)CC(C)C)C)C(C)C)O",
    "chemicalId": "ZIY",
    "InChI": "InChI=1S/C57H87N7O15/c1-15-33(8)46-44(66)29-45(67)79-49(32(6)7)48(68)34(9)50(69)58-39(26-30(2)3)54(73)64-25-17-19-41(64)56(75)62(13)43(28-37-20-22-38(77-14)23-21-37)57(76)78-36(11)47(52(71)59-46)60-51(70)42(27-31(4)5)61(12)55(74)40-18-16-24-63(40)53(72)35(10)65/h20-23,30-34,36,39-44,46-47,49,66H,15-19,24-29H2,1-14H3,(H,58,69)(H,59,71)(H,60,70)/t33-,34-,36+,39-,40-,41-,42+,43-,44-,46+,47-,49-/m0/s1",
    "formula_weight": 1.11,
    "number_of_instances": 1,
    "drugbank_id": "DB04977",
    "drugbank_description": "Aplidine is a peptide found in tunicates which shows promise in shrinking tumors in pancreatic, stomach, bladder, and prostate cancers. The specific marine organism is _Aplidium albicans_. Aplidine is also of interest as a potential treatment for some leukemias.",
    "InChIKey": "UUSZLLQJYRSZIS-LXNNNBEUSA-N",
    "pdbx_description": "plitidepsin",
    "SMILES_stereo": "CC[C@H](C)[C@@H]1C(CC(=O)O[C@H](C(=O)[C@@H](C(=O)N[C@H](C(=O)N2CCC[C@H]2C(=O)N([C@H](C(=O)O[C@@H]([C@@H](C(=O)N1)NC(=O)[C@@H](CC(C)C)N(C)C(=O)[C@@H]3CCCN3C(=O)C(=O)C)C)Cc4ccc(cc4)OC)C)CC(C)C)C)C(C)C)O"
  },
  {
    "chemicalName": "Madumycin II",
    "SMILES": "CC1C=CC(=O)NCC=CC(=CC(CC(Cc2nc(co2)C(=O)NC(C(=O)OC1C(C)C)C)O)O)C",
    "chemicalId": "M2D",
    "InChI": "InChI=1S/C26H37N3O7/c1-15(2)24-17(4)8-9-22(32)27-10-6-7-16(3)11-19(30)12-20(31)13-23-29-21(14-35-23)25(33)28-18(5)26(34)36-24/h6-9,11,14-15,17-20,24,30-31H,10,12-13H2,1-5H3,(H,27,32)(H,28,33)/b7-6-,9-8+,16-11+/t17-,18-,19-,20+,24-/m1/s1",
    "formula_weight": 0.504,
    "number_of_instances": 2,
    "InChIKey": "SAQNYTQFLPVTNJ-YHZICBGDSA-N",
    "SMILES_stereo": "C[C@@H]1/C=C/C(=O)NC/C=CC(=C[C@H](C[C@@H](Cc2nc(co2)C(=O)N[C@@H](C(=O)O[C@@H]1C(C)C)C)O)O)C",
    "pdbx_description": "Madumycin II"
  },
  {
    "chemicalName": "(3aS,4R,7S,9R,10R,11R,13R,15R,15aR)-1-{4-[4-(3-aminophenyl)-1H-1,2,3-triazol-1-yl]butyl}-4-ethyl-7-fluoro-11-methoxy-3a ,7,9,11,13,15-hexamethyl-2,6,8,14-tetraoxotetradecahydro-2H-oxacyclotetradecino[4,3-d][1,3]oxazol-10-yl 3,4,6-trideoxy-3-(dimethylamino)-beta-D-xylo-hexopyranoside",
    "SMILES": "CCC1C2(C(C(C(=O)C(CC(C(C(C(=O)C(C(=O)O1)(C)F)C)OC3C(C(CC(O3)C)N(C)C)O)(C)OC)C)C)N(C(=O)O2)CCCCn4cc(nn4)c5cccc(c5)N)C",
    "chemicalId": "EM1",
    "InChI": "InChI=1S/C43H65FN6O10/c1-12-32-43(8)35(50(40(55)60-43)19-14-13-18-49-23-30(46-47-49)28-16-15-17-29(45)21-28)26(4)33(51)24(2)22-41(6,56-11)37(27(5)36(53)42(7,44)39(54)58-32)59-38-34(52)31(48(9)10)20-25(3)57-38/h15-17,21,23-27,31-32,34-35,37-38,52H,12-14,18-20,22,45H2,1-11H3/t24-,25-,26+,27+,31+,32-,34-,35-,37-,38+,41-,42+,43-/m1/s1",
    "formula_weight": 0.845,
    "number_of_instances": 1,
    "drugbank_id": "DB09308",
    "drugbank_description": "Solithromycin is a ketolide antibiotic undergoing clinical development for the treatment of community-acquired pneumonia (CAP) and other infections.",
    "InChIKey": "IXXFZUPTQVDPPK-ZAWHAJPISA-N",
    "pdbx_description": "(3aS,4R,7S,9R,10R,11R,13R,15R,15aR)-1-{4-[4-(3-aminophenyl)-1H-1,2,3-triazol-1-yl]butyl}-4-ethyl-7-fluoro-11-methoxy-3a ,7,9,11,13,15-hexamethyl-2,6,8,14-tetraoxotetradecahydro-2H-oxacyclotetradecino[4,3-d][1,3]oxazol-10-yl 3,4,6-trideoxy-3-(dimethylamino)-beta-D-xylo-hexopyranoside",
    "SMILES_stereo": "CC[C@@H]1[C@@]2([C@@H]([C@H](C(=O)[C@@H](C[C@@]([C@@H]([C@H](C(=O)[C@](C(=O)O1)(C)F)C)O[C@H]3[C@@H]([C@H](C[C@H](O3)C)N(C)C)O)(C)OC)C)C)N(C(=O)O2)CCCCn4cc(nn4)c5cccc(c5)N)C"
  },
  {
    "chemicalName": "LEUCINE",
    "SMILES": "CC(C)CC(C(=O)O)N",
    "chemicalId": "LEU",
    "InChI": "InChI=1S/C6H13NO2/c1-4(2)3-5(7)6(8)9/h4-5H,3,7H2,1-2H3,(H,8,9)/t5-/m0/s1",
    "formula_weight": 0.131,
    "number_of_instances": 2,
    "drugbank_id": "DB00149",
    "drugbank_description": "An essential branched-chain amino acid important for hemoglobin formation.",
    "InChIKey": "ROHFNLRQFUQHCH-YFKPBYRVSA-N",
    "SMILES_stereo": "CC(C)C[C@@H](C(=O)O)N",
    "pdbx_description": "LEUCINE"
  },
  {
    "chemicalName": "2-acetamido-2-deoxy-alpha-D-galactopyranose",
    "SMILES": "CC(=O)NC1C(C(C(OC1O)CO)O)O",
    "chemicalId": "A2G",
    "InChI": "InChI=1S/C8H15NO6/c1-3(11)9-5-7(13)6(12)4(2-10)15-8(5)14/h4-8,10,12-14H,2H2,1H3,(H,9,11)/t4-,5-,6+,7-,8+/m1/s1",
    "formula_weight": 0.221,
    "number_of_instances": 1,
    "drugbank_id": "DB03567",
    "drugbank_description": "The N-acetyl derivative of galactosamine. [PubChem]",
    "InChIKey": "OVRNDRQMDRJTHS-CBQIKETKSA-N",
    "SMILES_stereo": "CC(=O)N[C@@H]1[C@H]([C@H]([C@H](O[C@@H]1O)CO)O)O",
    "pdbx_description": "2-acetamido-2-deoxy-alpha-D-galactopyranose"
  },
  {
    "chemicalName": "L-ornithine",
    "SMILES": "C(CC(C(=O)O)N)CN",
    "chemicalId": "ORN",
    "InChI": "InChI=1S/C5H12N2O2/c6-3-1-2-4(7)5(8)9/h4H,1-3,6-7H2,(H,8,9)/t4-/m0/s1",
    "formula_weight": 0.132,
    "number_of_instances": 1,
    "drugbank_id": "DB00129",
    "drugbank_description": "Produced during the urea cycle, ornithine is an amino acid produced from the splitting off of urea from arginine. L-Ornithine allows for the disposal of excess nitrogen and acts as a precursor of citrulline and arginine.",
    "InChIKey": "AHLPHDHHMVZTML-BYPYZUCNSA-N",
    "SMILES_stereo": "C(C[C@@H](C(=O)O)N)CN",
    "pdbx_description": "L-ornithine"
  },
  {
    "chemicalName": "N-[(1R,2R,3R,4S,5S)-4-[(2R,3R,6S)-6-(aminomethyl)-3-azanyl-oxan-2-yl]oxy-5-azanyl-2-[(2R,3R,4R)-5-methyl-4-(methylamino)-3,5-bis(oxidanyl)oxan-2-yl]oxy-3-oxidanyl-cyclohexyl]ethanamide",
    "SMILES": "CC(=O)NC1CC(C(C(C1OC2C(C(C(CO2)(C)O)NC)O)O)OC3C(CCC(O3)CN)N)N",
    "chemicalId": "HJO",
    "InChI": "InChI=1S/C21H41N5O8/c1-9(27)26-13-6-12(24)16(33-19-11(23)5-4-10(7-22)32-19)14(28)17(13)34-20-15(29)18(25-3)21(2,30)8-31-20/h10-20,25,28-30H,4-8,22-24H2,1-3H3,(H,26,27)/t10-,11+,12-,13+,14+,15+,16-,17+,18+,19+,20+,21-/m0/s1",
    "formula_weight": 0.492,
    "number_of_instances": 1,
    "InChIKey": "NVWHEJSLTXSZGG-RKWCMCGNSA-N",
    "SMILES_stereo": "CC(=O)N[C@@H]1C[C@@H]([C@@H]([C@H]([C@@H]1O[C@@H]2[C@@H]([C@H](C(CO2)(C)O)NC)O)O)O[C@@H]3[C@@H](CC[C@H](O3)CN)N)N",
    "pdbx_description": "N-[(1R,2R,3R,4S,5S)-4-[(2R,3R,6S)-6-(aminomethyl)-3-azanyl-oxan-2-yl]oxy-5-azanyl-2-[(2R,3R,4R)-5-methyl-4-(methylamino)-3,5-bis(oxidanyl)oxan-2-yl]oxy-3-oxidanyl-cyclohexyl]ethanamide"
  },
  {
    "chemicalName": "(1S)-2-{[(2-AMINOETHOXY)(HYDROXY)PHOSPHORYL]OXY}-1-[(PALMITOYLOXY)METHYL]ETHYL STEARATE",
    "SMILES": "CCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCCCC)COP(=O)(O)OCCN",
    "chemicalId": "PEV",
    "InChI": "InChI=1S/C39H78NO8P/c1-3-5-7-9-11-13-15-17-18-20-22-24-26-28-30-32-39(42)48-37(36-47-49(43,44)46-34-33-40)35-45-38(41)31-29-27-25-23-21-19-16-14-12-10-8-6-4-2/h37H,3-36,40H2,1-2H3,(H,43,44)/t37-/m0/s1",
    "formula_weight": 0.72,
    "number_of_instances": 101,
    "InChIKey": "RPJZYOHZALDGKI-QNGWXLTQSA-N",
    "SMILES_stereo": "CCCCCCCCCCCCCCCCCC(=O)O[C@@H](COC(=O)CCCCCCCCCCCCCCC)CO[P@@](=O)(O)OCCN",
    "pdbx_description": "(1S)-2-{[(2-AMINOETHOXY)(HYDROXY)PHOSPHORYL]OXY}-1-[(PALMITOYLOXY)METHYL]ETHYL STEARATE"
  },
  {
    "chemicalName": "(1R)-2-{[{[(2S)-2,3-DIHYDROXYPROPYL]OXY}(HYDROXY)PHOSPHORYL]OXY}-1-[(PALMITOYLOXY)METHYL]ETHYL (11E)-OCTADEC-11-ENOATE",
    "SMILES": "CCCCCCCCCCCCCCCC(=O)OCC(COP(=O)(O)OCC(CO)O)OC(=O)CCCCCCCCCC=CCCCCCC",
    "chemicalId": "PGV",
    "InChI": "InChI=1S/C40H77O10P/c1-3-5-7-9-11-13-15-17-18-20-22-24-26-28-30-32-40(44)50-38(36-49-51(45,46)48-34-37(42)33-41)35-47-39(43)31-29-27-25-23-21-19-16-14-12-10-8-6-4-2/h13,15,37-38,41-42H,3-12,14,16-36H2,1-2H3,(H,45,46)/b15-13-/t37-,38+/m0/s1",
    "formula_weight": 0.749,
    "number_of_instances": 32,
    "InChIKey": "ADYWCMPUNIVOEA-GPJPVTGXSA-N",
    "SMILES_stereo": "CCCCCCCCCCCCCCCC(=O)OC[C@H](CO[P@](=O)(O)OC[C@H](CO)O)OC(=O)CCCCCCCCCC=C/CCCCCC",
    "pdbx_description": "(1R)-2-{[{[(2S)-2,3-DIHYDROXYPROPYL]OXY}(HYDROXY)PHOSPHORYL]OXY}-1-[(PALMITOYLOXY)METHYL]ETHYL (11E)-OCTADEC-11-ENOATE"
  },
  {
    "chemicalName": "(2S,4S,4AR,5AS,6S,11R,11AS,12R,12AR)-7-CHLORO-4-(DIMETHYLAMINO)-6,10,11,12-TETRAHYDROXY-1,3-DIOXO-1,2,3,4,4A,5,5A,6,11,11A,12,12A-DODECAHYDROTETRACENE-2-CARBOXAMIDE",
    "SMILES": "CN(C)C1C2CC3C(c4c(ccc(c4C(C3C(C2C(=O)C(C1=O)C(=O)N)O)O)O)Cl)O",
    "chemicalId": "D2C",
    "InChI": "InChI=1S/C21H25ClN2O7/c1-24(2)15-6-5-7-11(17(27)10(6)19(29)14(20(15)30)21(23)31)18(28)13-9(25)4-3-8(22)12(13)16(7)26/h3-4,6-7,10-11,14-18,25-28H,5H2,1-2H3,(H2,23,31)/t6-,7+,10-,11+,14+,15+,16+,17+,18-/m1/s1",
    "formula_weight": 0.453,
    "number_of_instances": 1,
    "InChIKey": "DMSXRSJJYGANOR-VAVXRSHRSA-N",
    "SMILES_stereo": "CN(C)[C@H]1[C@@H]2C[C@@H]3[C@@H](c4c(ccc(c4C(C3C([C@@H]2C(=O)C(C1=O)C(=O)N)O)O)O)Cl)O",
    "pdbx_description": "(2S,4S,4AR,5AS,6S,11R,11AS,12R,12AR)-7-CHLORO-4-(DIMETHYLAMINO)-6,10,11,12-TETRAHYDROXY-1,3-DIOXO-1,2,3,4,4A,5,5A,6,11,11A,12,12A-DODECAHYDROTETRACENE-2-CARBOXAMIDE"
  },
  {
    "chemicalName": "(2R)-4-AMINO-N-{(1R,2S,3R,4R,5S)-5-AMINO-2-{2-[(2-AMINOETHYL)AMINO]ETHOXY}-4-[(2,6-DIAMINO-2,6-DIDEOXY-ALPHA-D-GLUCOPYRANOSYL)OXY]-3-HYDROXYCYCLOHEXYL}-2-HYDROXYBUTANAMIDE",
    "SMILES": "C1C(C(C(C(C1NC(=O)C(CCN)O)OCCNCCN)O)OC2C(C(C(C(O2)CN)O)O)N)N",
    "chemicalId": "AB9",
    "InChI": "InChI=1S/C20H43N7O8/c21-2-1-11(28)19(32)27-10-7-9(24)17(16(31)18(10)33-6-5-26-4-3-22)35-20-13(25)15(30)14(29)12(8-23)34-20/h9-18,20,26,28-31H,1-8,21-25H2,(H,27,32)/t9-,10+,11+,12+,13+,14+,15+,16-,17+,18-,20+/m0/s1",
    "formula_weight": 0.51,
    "number_of_instances": 1,
    "InChIKey": "OGRDTONULPXNRP-HSDDYVLRSA-N",
    "SMILES_stereo": "C1[C@@H]([C@H]([C@@H]([C@H]([C@@H]1NC(=O)[C@@H](CCN)O)OCCNCCN)O)O[C@@H]2[C@@H]([C@H]([C@@H]([C@H](O2)CN)O)O)N)N",
    "pdbx_description": "(2R)-4-AMINO-N-{(1R,2S,3R,4R,5S)-5-AMINO-2-{2-[(2-AMINOETHYL)AMINO]ETHOXY}-4-[(2,6-DIAMINO-2,6-DIDEOXY-ALPHA-D-GLUCOPYRANOSYL)OXY]-3-HYDROXYCYCLOHEXYL}-2-HYDROXYBUTANAMIDE"
  },
  {
    "chemicalName": "3-aminobenzamide",
    "SMILES": "c1cc(cc(c1)N)C(=O)N",
    "chemicalId": "3AB",
    "InChI": "InChI=1S/C7H8N2O/c8-6-3-1-2-5(4-6)7(9)10/h1-4H,8H2,(H2,9,10)",
    "formula_weight": 0.136,
    "number_of_instances": 1,
    "InChIKey": "GSCPDZHWVNUUFI-UHFFFAOYSA-N",
    "SMILES_stereo": "c1cc(cc(c1)N)C(=O)N",
    "pdbx_description": "3-aminobenzamide"
  },
  {
    "chemicalName": "TROLEANDOMYCIN",
    "SMILES": "CC1CC(C(C(O1)OC2C(CC3(CO3)C(=O)C(C(C(C(OC(=O)C(C(C2C)OC4CC(C(C(O4)C)OC(=O)C)OC)C)C)C)OC(=O)C)C)C)OC(=O)C)N(C)C",
    "chemicalId": "TAO",
    "InChI": "InChI=1S/C41H67NO15/c1-19-17-41(18-49-41)38(46)23(5)34(53-27(9)43)21(3)25(7)52-39(47)24(6)35(56-32-16-31(48-14)36(26(8)51-32)54-28(10)44)22(4)33(19)57-40-37(55-29(11)45)30(42(12)13)15-20(2)50-40/h19-26,30-37,40H,15-18H2,1-14H3/t19-,20-,21+,22-,23-,24-,25-,26+,30+,31+,32+,33+,34-,35+,36+,37-,40+,41-/m1/s1",
    "formula_weight": 0.814,
    "number_of_instances": 1,
    "drugbank_id": "DB13179",
    "drugbank_description": "A macrolide antibiotic that is similar to erythromycin.",
    "InChIKey": "LQCLVBQBTUVCEQ-CLPGKMRCSA-N",
    "pdbx_description": "TROLEANDOMYCIN",
    "SMILES_stereo": "C[C@@H]1C[C@@H]([C@H]([C@@H](O1)O[C@H]2[C@@H](C[C@@]3(CO3)C(=O)[C@@H]([C@@H]([C@H]([C@H](OC(=O)[C@@H]([C@H]([C@@H]2C)O[C@H]4C[C@@H]([C@H]([C@@H](O4)C)OC(=O)C)OC)C)C)C)OC(=O)C)C)C)OC(=O)C)N(C)C"
  },
  {
    "chemicalName": "(1R,2R,3S,4R,6S)-4,6-diamino-2-{[3-O-(2,6-diamino-2,6-dideoxy-beta-L-idopyranosyl)-beta-D-ribofuranosyl]oxy}-3-hydroxycyclohexyl 2-amino-4-O-benzyl-2-deoxy-alpha-D-glucopyranoside",
    "SMILES": "c1ccc(cc1)COC2C(OC(C(C2O)N)OC3C(CC(C(C3OC4C(C(C(O4)CO)OC5C(C(C(C(O5)CN)O)O)N)O)O)N)N)CO",
    "chemicalId": "RPO",
    "InChI": "InChI=1S/C30H51N5O14/c31-7-14-20(39)21(40)17(34)28(44-14)48-26-16(9-37)46-30(23(26)42)49-27-19(38)12(32)6-13(33)24(27)47-29-18(35)22(41)25(15(8-36)45-29)43-10-11-4-2-1-3-5-11/h1-5,12-30,36-42H,6-10,31-35H2/t12-,13+,14+,15-,16-,17-,18-,19+,20-,21-,22-,23-,24-,25-,26-,27-,28-,29-,30+/m1/s1",
    "formula_weight": 0.706,
    "number_of_instances": 1,
    "InChIKey": "DRHDMQJFWDZMND-JCNXQQRHSA-N",
    "SMILES_stereo": "c1ccc(cc1)CO[C@@H]2[C@H](O[C@@H]([C@@H]([C@H]2O)N)O[C@@H]3[C@H](C[C@H]([C@@H]([C@H]3O[C@H]4[C@@H]([C@@H]([C@H](O4)CO)O[C@@H]5[C@@H]([C@H]([C@@H]([C@@H](O5)CN)O)O)N)O)O)N)N)CO",
    "pdbx_description": "(1R,2R,3S,4R,6S)-4,6-diamino-2-{[3-O-(2,6-diamino-2,6-dideoxy-beta-L-idopyranosyl)-beta-D-ribofuranosyl]oxy}-3-hydroxycyclohexyl 2-amino-4-O-benzyl-2-deoxy-alpha-D-glucopyranoside"
  },
  {
    "chemicalName": "(2R,4R,4aS,5aR,6S,7S,8R,9S,9aR,10aS)-2-methyl-6,8-bis(methylamino)-4-({[2-(oxan-4-yl)ethyl]amino}methyl)octahydro-2H-pyrano[2,3-b][1,4]benzodioxine-4,4a,7,9(10aH)-tetrol",
    "SMILES": "CC1CC(C2(C(O1)OC3C(C(C(C(C3O2)NC)O)NC)O)O)(CNCCC4CCOCC4)O",
    "chemicalId": "Y7K",
    "InChI": "InChI=1S/C22H41N3O8/c1-12-10-21(28,11-25-7-4-13-5-8-30-9-6-13)22(29)20(31-12)32-19-17(27)14(23-2)16(26)15(24-3)18(19)33-22/h12-20,23-29H,4-11H2,1-3H3/t12-,14-,15+,16+,17+,18-,19-,20+,21-,22-/m1/s1",
    "formula_weight": 0.476,
    "number_of_instances": 2,
    "InChIKey": "LKCDGONKFJKONL-WUYRLSBSSA-N",
    "SMILES_stereo": "C[C@@H]1C[C@]([C@]2([C@@H](O1)O[C@@H]3[C@H]([C@@H]([C@@H]([C@@H]([C@H]3O2)NC)O)NC)O)O)(CNCCC4CCOCC4)O",
    "pdbx_description": "(2R,4R,4aS,5aR,6S,7S,8R,9S,9aR,10aS)-2-methyl-6,8-bis(methylamino)-4-({[2-(oxan-4-yl)ethyl]amino}methyl)octahydro-2H-pyrano[2,3-b][1,4]benzodioxine-4,4a,7,9(10aH)-tetrol"
  },
  {
    "chemicalName": "4-(hydroxymethyl)-3-methyl-1H-indole-2-carboxylic acid",
    "SMILES": "Cc1c2c(cccc2[nH]c1C(=O)O)CO",
    "chemicalId": "NO1",
    "InChI": "InChI=1S/C11H11NO3/c1-6-9-7(5-13)3-2-4-8(9)12-10(6)11(14)15/h2-4,12-13H,5H2,1H3,(H,14,15)",
    "formula_weight": 0.205,
    "number_of_instances": 1,
    "InChIKey": "BSECKLZXEJBFRE-UHFFFAOYSA-N",
    "SMILES_stereo": "Cc1c2c(cccc2[nH]c1C(=O)O)CO",
    "pdbx_description": "4-(hydroxymethyl)-3-methyl-1H-indole-2-carboxylic acid"
  },
  {
    "chemicalName": "N-[(1R,2R)-1,3-dihydroxy-1-(4-nitrophenyl)propan-2-yl]-D-histidinamide",
    "SMILES": "c1cc(ccc1C(C(CO)NC(=O)C(Cc2c[nH]cn2)N)O)N(=O)=O",
    "chemicalId": "EZP",
    "InChI": "InChI=1S/C15H19N5O5/c16-12(5-10-6-17-8-18-10)15(23)19-13(7-21)14(22)9-1-3-11(4-2-9)20(24)25/h1-4,6,8,12-14,21-22H,5,7,16H2,(H,17,18)(H,19,23)/t12-,13-,14-/m1/s1",
    "formula_weight": 0.349,
    "number_of_instances": 2,
    "InChIKey": "MMDMFLDVXHCRMV-MGPQQGTHSA-N",
    "SMILES_stereo": "c1cc(ccc1[C@H]([C@@H](CO)NC(=O)[C@@H](Cc2c[nH]cn2)N)O)N(=O)=O",
    "pdbx_description": "N-[(1R,2R)-1,3-dihydroxy-1-(4-nitrophenyl)propan-2-yl]-D-histidinamide"
  },
  {
    "chemicalName": "methyl 7-chloro-6,7,8-trideoxy-6-{[(4S,5aS,8S,8aR)-4-(2-methylpropyl)octahydro-2H-oxepino[2,3-c]pyrrole-8-carbonyl]amino}-1-thio-L-threo-alpha-D-galacto-octopyranoside",
    "SMILES": "CC(C)CC1CCOC2C(C1)CNC2C(=O)NC(C3C(C(C(C(O3)SC)O)O)O)C(C)Cl",
    "chemicalId": "6IF",
    "InChI": "InChI=1S/C22H39ClN2O6S/c1-10(2)7-12-5-6-30-19-13(8-12)9-24-15(19)21(29)25-14(11(3)23)20-17(27)16(26)18(28)22(31-20)32-4/h10-20,22,24,26-28H,5-9H2,1-4H3,(H,25,29)/t11-,12-,13-,14+,15-,16-,17+,18+,19+,20+,22+/m0/s1",
    "formula_weight": 0.495,
    "number_of_instances": 2,
    "InChIKey": "JPCLUJPDWMBCAA-SUTQZAMLSA-N",
    "SMILES_stereo": "C[C@@H]([C@H]([C@@H]1[C@@H]([C@@H]([C@H]([C@H](O1)SC)O)O)O)NC(=O)[C@@H]2[C@H]3[C@@H](C[C@@H](CCO3)CC(C)C)CN2)Cl",
    "pdbx_description": "methyl 7-chloro-6,7,8-trideoxy-6-{[(4S,5aS,8S,8aR)-4-(2-methylpropyl)octahydro-2H-oxepino[2,3-c]pyrrole-8-carbonyl]amino}-1-thio-L-threo-alpha-D-galacto-octopyranoside"
  },
  {
    "chemicalName": "13-(2-{[(1R,2R)-1,3-dihydroxy-1-(4-nitrophenyl)propan-2-yl]amino}-2-oxoethyl)-9,10-dimethoxy-5,6-dihydro-2H-[1,3]dioxolo[4,5-g]isoquinolino[3,2-a]isoquinolin-7-ium",
    "SMILES": "COc1ccc2c(c1OC)c[n+]3c(c2CC(=O)NC(CO)C(c4ccc(cc4)[N+](=O)[O-])O)-c5cc6c(cc5CC3)OCO6",
    "chemicalId": "A1AIX",
    "InChI": "InChI=1S/C31H29N3O9/c1-40-25-8-7-20-22(13-28(36)32-24(15-35)30(37)17-3-5-19(6-4-17)34(38)39)29-21-12-27-26(42-16-43-27)11-18(21)9-10-33(29)14-23(20)31(25)41-2/h3-8,11-12,14,24,30,35,37H,9-10,13,15-16H2,1-2H3/p+1/t24-,30-/m1/s1",
    "formula_weight": 0.589,
    "number_of_instances": 2,
    "InChIKey": "UZHFALJZQVUPGZ-AYWVHJORSA-O",
    "pdbx_description": "13-(2-{[(1R,2R)-1,3-dihydroxy-1-(4-nitrophenyl)propan-2-yl]amino}-2-oxoethyl)-9,10-dimethoxy-5,6-dihydro-2H-[1,3]dioxolo[4,5-g]isoquinolino[3,2-a]isoquinolin-7-ium",
    "SMILES_stereo": "COc1ccc2c(c1OC)c[n+]3c(c2CC(=O)N[C@H](CO)[C@@H](c4ccc(cc4)[N+](=O)[O-])O)-c5cc6c(cc5CC3)OCO6"
  },
  {
    "chemicalName": "2-chloro-N-({(5S)-3-[3-fluoro-4-(morpholin-4-yl)phenyl]-2-oxo-1,3-oxazolidin-5-yl}methyl)acetamide",
    "SMILES": "c1cc(c(cc1N2CC(OC2=O)CNC(=O)CCl)F)N3CCOCC3",
    "chemicalId": "G6M",
    "InChI": "InChI=1S/C16H19ClFN3O4/c17-8-15(22)19-9-12-10-21(16(23)25-12)11-1-2-14(13(18)7-11)20-3-5-24-6-4-20/h1-2,7,12H,3-6,8-10H2,(H,19,22)/t12-/m0/s1",
    "formula_weight": 0.372,
    "number_of_instances": 1,
    "InChIKey": "BLEAWUVPPDXJFJ-LBPRGKRZSA-N",
    "SMILES_stereo": "c1cc(c(cc1N2C[C@@H](OC2=O)CNC(=O)CCl)F)N3CCOCC3",
    "pdbx_description": "2-chloro-N-({(5S)-3-[3-fluoro-4-(morpholin-4-yl)phenyl]-2-oxo-1,3-oxazolidin-5-yl}methyl)acetamide"
  },
  {
    "chemicalName": "(2S,3R,4S,4aR)-2,3,4,7-tetrahydroxy-3,4,4a,5-tetrahydro[1,3]dioxolo[4,5-j]phenanthridin-6(2H)-one",
    "SMILES": "c1c2c(c(c3c1OCO3)O)C(=O)NC4C2=CC(C(C4O)O)O",
    "chemicalId": "3KF",
    "InChI": "InChI=1S/C14H13NO7/c16-6-1-5-4-2-7-13(22-3-21-7)11(18)8(4)14(20)15-9(5)12(19)10(6)17/h1-2,6,9-10,12,16-19H,3H2,(H,15,20)/t6-,9+,10+,12-/m0/s1",
    "formula_weight": 0.307,
    "number_of_instances": 2,
    "InChIKey": "LZAZURSABQIKGB-AEKGRLRDSA-N",
    "SMILES_stereo": "c1c2c(c(c3c1OCO3)O)C(=O)N[C@@H]4C2=C[C@@H]([C@H]([C@H]4O)O)O",
    "pdbx_description": "(2S,3R,4S,4aR)-2,3,4,7-tetrahydroxy-3,4,4a,5-tetrahydro[1,3]dioxolo[4,5-j]phenanthridin-6(2H)-one"
  },
  {
    "chemicalName": "Tetracenomycin X",
    "SMILES": "Cc1c2c(cc3c(c2O)C(=O)C4(C(=O)C=C(C(C4(C3=O)O)O)OC)OC)cc(c1C(=O)OC)OC",
    "chemicalId": "OCW",
    "InChI": "InChI=1S/C24H22O11/c1-9-15-10(7-12(32-2)16(9)22(30)34-4)6-11-17(18(15)26)21(29)24(35-5)14(25)8-13(33-3)20(28)23(24,31)19(11)27/h6-8,20,26,28,31H,1-5H3/t20-,23-,24-/m1/s1",
    "formula_weight": 0.486,
    "number_of_instances": 1,
    "InChIKey": "QSPIPUXWSNFXCK-AGILITTLSA-N",
    "pdbx_description": "Tetracenomycin X",
    "SMILES_stereo": "Cc1c2c(cc3c(c2O)C(=O)[C@@]4(C(=O)C=C([C@H]([C@@]4(C3=O)O)O)OC)OC)cc(c1C(=O)OC)OC"
  },
  {
    "chemicalName": "N-[(1R,2R)-1,3-dihydroxy-1-(4-nitrophenyl)propan-2-yl]-L-lysinamide",
    "SMILES": "c1cc(ccc1C(C(CO)NC(=O)C(CCCCN)N)O)[N+](=O)[O-]",
    "chemicalId": "EZM",
    "InChI": "InChI=1S/C15H24N4O5/c16-8-2-1-3-12(17)15(22)18-13(9-20)14(21)10-4-6-11(7-5-10)19(23)24/h4-7,12-14,20-21H,1-3,8-9,16-17H2,(H,18,22)/t12-,13+,14+/m0/s1",
    "formula_weight": 0.34,
    "number_of_instances": 2,
    "InChIKey": "LSXOPXJWOLKWDK-BFHYXJOUSA-N",
    "SMILES_stereo": "c1cc(ccc1[C@H]([C@@H](CO)NC(=O)[C@H](CCCCN)N)O)[N+](=O)[O-]",
    "pdbx_description": "N-[(1R,2R)-1,3-dihydroxy-1-(4-nitrophenyl)propan-2-yl]-L-lysinamide"
  },
  {
    "chemicalName": "N-[(1R,2R,3R,4S,5R)-4-[(2R,6S)-6-(aminomethyl)oxan-2-yl]oxy-5-azanyl-2-[(2R,4S,5R}-5-methyl-4-(methylamino)-5-oxidanyl-oxan-2-yl]oxy-3-oxidanyl-cyclohexyl]-1,1,1-tris(fluoranyl)methanesulfonamide",
    "SMILES": "CC1(COC(CC1NC)OC2C(CC(C(C2O)OC3CCCC(O3)CN)N)NS(=O)(=O)C(F)(F)F)O",
    "chemicalId": "HJR",
    "InChI": "InChI=1S/C20H37F3N4O8S/c1-19(29)9-32-15(7-13(19)26-2)35-18-12(27-36(30,31)20(21,22)23)6-11(25)17(16(18)28)34-14-5-3-4-10(8-24)33-14/h10-18,26-29H,3-9,24-25H2,1-2H3/t10-,11+,12+,13-,14+,15+,16+,17-,18+,19-/m0/s1",
    "formula_weight": 0.551,
    "number_of_instances": 1,
    "InChIKey": "KKFADIKIUKLKMG-OOFUMXBDSA-N",
    "SMILES_stereo": "C[C@@]1(CO[C@@H](C[C@@H]1NC)O[C@@H]2[C@@H](C[C@H]([C@@H]([C@H]2O)O[C@@H]3CCC[C@H](O3)CN)N)NS(=O)(=O)C(F)(F)F)O",
    "pdbx_description": "N-[(1R,2R,3R,4S,5R)-4-[(2R,6S)-6-(aminomethyl)oxan-2-yl]oxy-5-azanyl-2-[(2R,4S,5R}-5-methyl-4-(methylamino)-5-oxidanyl-oxan-2-yl]oxy-3-oxidanyl-cyclohexyl]-1,1,1-tris(fluoranyl)methanesulfonamide"
  },
  {
    "chemicalName": "KANAMYCIN A",
    "SMILES": "C1C(C(C(C(C1N)OC2C(C(C(C(O2)CN)O)O)O)O)OC3C(C(C(C(O3)CO)O)N)O)N",
    "chemicalId": "KAN",
    "InChI": "InChI=1S/C18H36N4O11/c19-2-6-10(25)12(27)13(28)18(30-6)33-16-5(21)1-4(20)15(14(16)29)32-17-11(26)8(22)9(24)7(3-23)31-17/h4-18,23-29H,1-3,19-22H2/t4-,5+,6-,7-,8+,9-,10-,11-,12+,13-,14-,15+,16-,17-,18-/m1/s1",
    "formula_weight": 0.484,
    "number_of_instances": 7,
    "drugbank_id": "DB01172",
    "drugbank_description": "Kanamycin (also known as kanamycin A) is an aminoglycoside bacteriocidal antibiotic, available in oral, intravenous, and intramuscular forms, and used to treat a wide variety of infections. Kanamycin is isolated from the bacterium Streptomyces kanamyceticus and its most commonly used form is kanamycin sulfate.",
    "InChIKey": "SBUJHOSQTJFQJX-NOAMYHISSA-N",
    "pdbx_description": "KANAMYCIN A",
    "SMILES_stereo": "C1[C@H]([C@@H]([C@H]([C@@H]([C@H]1N)O[C@@H]2[C@@H]([C@H]([C@@H]([C@H](O2)CN)O)O)O)O)O[C@@H]3[C@@H]([C@H]([C@@H]([C@H](O3)CO)O)N)O)N"
  },
  {
    "chemicalName": "12,13-Epoxytrichothec-9-ene-3,4,8,15-tetrol-4,15-diacetate-8-isovalerate",
    "SMILES": "CC1=CC2C(CC1OC(=O)CC(=C)C)(C3(C(C(C(C34CO4)O2)O)OC(=O)C)C)COC(=O)C",
    "chemicalId": "ZBA",
    "InChI": "InChI=1S/C24H32O9/c1-12(2)7-18(27)32-16-9-23(10-29-14(4)25)17(8-13(16)3)33-21-19(28)20(31-15(5)26)22(23,6)24(21)11-30-24/h8,16-17,19-21,28H,1,7,9-11H2,2-6H3/t16-,17+,19+,20+,21+,22+,23+,24-/m0/s1",
    "formula_weight": 0.465,
    "number_of_instances": 2,
    "InChIKey": "JESYGVLQSIZOBZ-QYWOHJEZSA-N",
    "SMILES_stereo": "CC1=C[C@@H]2[C@](C[C@@H]1OC(=O)CC(=C)C)([C@]3([C@@H]([C@H]([C@H]([C@@]34CO4)O2)O)OC(=O)C)C)COC(=O)C",
    "pdbx_description": "12,13-Epoxytrichothec-9-ene-3,4,8,15-tetrol-4,15-diacetate-8-isovalerate"
  },
  {
    "chemicalName": "Argyrin B",
    "SMILES": "CCC1C(=O)NC(=C)C(=O)N(CC(=O)NC(c2nc(cs2)C(=O)NC(C(=O)NC(C(=O)NCC(=O)N1)Cc3c[nH]c4c3c(ccc4)OC)Cc5c[nH]c6c5cccc6)C)C",
    "chemicalId": "1I7",
    "InChI": "InChI=1S/C41H46N10O8S/c1-6-26-37(55)46-22(3)41(58)51(4)19-34(53)45-21(2)40-50-31(20-60-40)39(57)49-30(14-23-16-42-27-11-8-7-10-25(23)27)38(56)48-29(36(54)44-18-33(52)47-26)15-24-17-43-28-12-9-13-32(59-5)35(24)28/h7-13,16-17,20-21,26,29-30,42-43H,3,6,14-15,18-19H2,1-2,4-5H3,(H,44,54)(H,45,53)(H,46,55)(H,47,52)(H,48,56)(H,49,57)/t21-,26-,29+,30+/m1/s1",
    "formula_weight": 0.839,
    "number_of_instances": 1,
    "InChIKey": "OVJDNZFLEREPKG-VPMCBBNJSA-N",
    "SMILES_stereo": "CC[C@@H]1C(=O)NC(=C)C(=O)N(CC(=O)N[C@@H](c2nc(cs2)C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N1)Cc3c[nH]c4c3c(ccc4)OC)Cc5c[nH]c6c5cccc6)C)C",
    "pdbx_description": "Argyrin B"
  },
  {
    "chemicalName": "CLARITHROMYCIN",
    "SMILES": "CCC1C(C(C(C(=O)C(CC(C(C(C(C(C(=O)O1)C)OC2CC(C(C(O2)C)O)(C)OC)C)OC3C(C(CC(O3)C)N(C)C)O)(C)OC)C)C)O)(C)O",
    "chemicalId": "CTY",
    "InChI": "InChI=1S/C38H69NO13/c1-15-26-38(10,45)31(42)21(4)28(40)19(2)17-37(9,47-14)33(52-35-29(41)25(39(11)12)16-20(3)48-35)22(5)30(23(6)34(44)50-26)51-27-18-36(8,46-13)32(43)24(7)49-27/h19-27,29-33,35,41-43,45H,15-18H2,1-14H3/t19-,20-,21+,22+,23-,24+,25+,26-,27+,29-,30+,31-,32+,33-,35+,36-,37-,38-/m1/s1",
    "formula_weight": 0.748,
    "number_of_instances": 1,
    "drugbank_id": "DB01211",
    "drugbank_description": "Clarithromycin, a semisynthetic macrolide antibiotic derived from erythromycin, inhibits bacterial protein synthesis by binding to the bacterial 50S ribosomal subunit. Binding inhibits peptidyl transferase activity and interferes with amino acid translocation during the translation and protein assembly process. Clarithromycin may be bacteriostatic or bactericidal depending on the organism and drug concentration.",
    "InChIKey": "AGOYDEPGAOXOCK-KCBOHYOISA-N",
    "pdbx_description": "CLARITHROMYCIN",
    "SMILES_stereo": "CC[C@@H]1[C@@]([C@@H]([C@H](C(=O)[C@@H](C[C@@]([C@@H]([C@H]([C@@H]([C@H](C(=O)O1)C)O[C@H]2C[C@@]([C@H]([C@@H](O2)C)O)(C)OC)C)O[C@H]3[C@@H]([C@H](C[C@H](O3)C)N(C)C)O)(C)OC)C)C)O)(C)O"
  },
  {
    "chemicalName": "BIOTIN",
    "SMILES": "C1C2C(C(S1)CCCCC(=O)O)NC(=O)N2",
    "chemicalId": "BTN",
    "InChI": "InChI=1S/C10H16N2O3S/c13-8(14)4-2-1-3-7-9-6(5-16-7)11-10(15)12-9/h6-7,9H,1-5H2,(H,13,14)(H2,11,12,15)/t6-,7-,9-/m0/s1",
    "formula_weight": 0.244,
    "number_of_instances": 1,
    "drugbank_id": "DB00121",
    "drugbank_description": "A water-soluble, enzyme co-factor present in minute amounts in every living cell. It occurs mainly bound to proteins or polypeptides and is abundant in liver, kidney, pancreas, yeast, and milk.",
    "InChIKey": "YBJHBAHKTGYVGT-ZKWXMUAHSA-N",
    "pdbx_description": "BIOTIN",
    "SMILES_stereo": "C1[C@H]2[C@@H]([C@@H](S1)CCCCC(=O)O)NC(=O)N2"
  },
  {
    "chemicalName": "TOBRAMYCIN",
    "SMILES": "C1C(C(C(C(C1N)OC2C(C(C(C(O2)CO)O)N)O)O)OC3C(CC(C(O3)CN)O)N)N",
    "chemicalId": "TOY",
    "InChI": "InChI=1S/C18H37N5O9/c19-3-9-8(25)2-7(22)17(29-9)31-15-5(20)1-6(21)16(14(15)28)32-18-13(27)11(23)12(26)10(4-24)30-18/h5-18,24-28H,1-4,19-23H2/t5-,6+,7+,8-,9+,10+,11-,12+,13+,14-,15+,16-,17+,18+/m0/s1",
    "formula_weight": 0.468,
    "number_of_instances": 1,
    "drugbank_id": "DB00684",
    "drugbank_description": "Aminoglycosides, many of which are derived directly from _Streptomyces_ spp., are concentration-dependent bactericidal antibiotics with a broad spectrum of activity against Gram-positive and Gram-negative organisms.[A232294] Inhaled tobramycin is notable for its use in treating chronic _Pseudomonas aeruginosa_ infections in cystic fibrosis patients, as _P. aeruginosa_ is notoriously inherently resistant to many antibiotics.[A232294, A232299, L32739] However, tobramycin can also be administered intravenously and topically to treat a variety of infections caused by susceptible bacteria.[L32744, L32749] Its use is limited in some cases by characteristic toxicities such as nephrotoxicity and ototoxicity, yet it remains a valuable option in the face of growing resistance to front-line antibiotics such as β-lactams and cephalosporins.[A232294, A232349, L32739, L32749]  Tobramycin was approved by the FDA in 1975 and is currently available in a variety of forms for administration by inhalation, injection, and external application to the eye (ophthalmic).[L32739, L32744, L32749]",
    "InChIKey": "NLVFBUXFDBBNBW-PBSUHMDJSA-N",
    "pdbx_description": "TOBRAMYCIN",
    "SMILES_stereo": "C1[C@@H]([C@H]([C@@H]([C@H]([C@@H]1N)O[C@@H]2[C@@H]([C@H]([C@@H]([C@H](O2)CO)O)N)O)O)O[C@@H]3[C@@H](C[C@@H]([C@H](O3)CN)O)N)N"
  },
  {
    "chemicalName": "(2R,3S,4R,5R,8R,10R,11R,12S,13S,14R)-2-ethyl-3,4,10-trihydroxy-3,5,6,8,10,12,14-heptamethyl-15-oxo-11-[(3,4,6-trideoxy-3-{[3-(1-{(1S,2R)-1-(fluoromethyl)-2-hydroxy-2-[4-(methylsulfonyl)phenyl]ethyl}-1H-1,2,3-triazol-4-yl)propyl](methyl)amino}-beta-D-xylo-hexopyranosyl)oxy]-1-oxa-6-azacyclopentadecan-13-yl 2,6-dideoxy-3-C-methyl-3-O-methyl-alpha-L-ribo-hexopyranoside",
    "SMILES": "CCC1C(C(C(N(CC(CC(C(C(C(C(C(=O)O1)C)OC2CC(C(C(O2)C)O)(C)OC)C)OC3C(C(CC(O3)C)N(C)CCCc4cn(nn4)C(CF)C(c5ccc(cc5)S(=O)(=O)C)O)O)(C)O)C)C)C)O)(C)O",
    "chemicalId": "EMK",
    "InChI": "InChI=1S/C52H88FN5O15S/c1-15-40-52(10,65)45(61)33(6)57(12)27-29(2)24-50(8,64)47(31(4)44(32(5)48(63)71-40)72-41-25-51(9,68-13)46(62)34(7)70-41)73-49-43(60)38(23-30(3)69-49)56(11)22-16-17-36-28-58(55-54-36)39(26-53)42(59)35-18-20-37(21-19-35)74(14,66)67/h18-21,28-34,38-47,49,59-62,64-65H,15-17,22-27H2,1-14H3/t29-,30-,31+,32-,33-,34+,38+,39-,40-,41+,42-,43-,44+,45-,46+,47-,49+,50-,51-,52-/m1/s1",
    "formula_weight": 1.074,
    "number_of_instances": 1,
    "InChIKey": "YWHOXJJBJDOIMO-BOBSHVDTSA-N",
    "SMILES_stereo": "CC[C@@H]1[C@@]([C@@H]([C@H]([N@](C[C@@H](C[C@@]([C@@H]([C@H]([C@@H]([C@H](C(=O)O1)C)O[C@H]2C[C@@]([C@H]([C@@H](O2)C)O)(C)OC)C)O[C@H]3[C@@H]([C@H](C[C@H](O3)C)[N@](C)CCCc4cn(nn4)[C@H](CF)[C@@H](c5ccc(cc5)S(=O)(=O)C)O)O)(C)O)C)C)C)O)(C)O",
    "pdbx_description": "(2R,3S,4R,5R,8R,10R,11R,12S,13S,14R)-2-ethyl-3,4,10-trihydroxy-3,5,6,8,10,12,14-heptamethyl-15-oxo-11-[(3,4,6-trideoxy-3-{[3-(1-{(1S,2R)-1-(fluoromethyl)-2-hydroxy-2-[4-(methylsulfonyl)phenyl]ethyl}-1H-1,2,3-triazol-4-yl)propyl](methyl)amino}-beta-D-xylo-hexopyranosyl)oxy]-1-oxa-6-azacyclopentadecan-13-yl 2,6-dideoxy-3-C-methyl-3-O-methyl-alpha-L-ribo-hexopyranoside"
  },
  {
    "chemicalName": "4-amino-N-[5-(4-ethynylphenyl)-1,3,4-oxadiazol-2-yl]benzamide",
    "SMILES": "C#Cc1ccc(cc1)c2nnc(o2)NC(=O)c3ccc(cc3)N",
    "chemicalId": "KKL",
    "InChI": "InChI=1S/C17H12N4O2/c1-2-11-3-5-13(6-4-11)16-20-21-17(23-16)19-15(22)12-7-9-14(18)10-8-12/h1,3-10H,18H2,(H,19,21,22)",
    "formula_weight": 0.304,
    "number_of_instances": 1,
    "InChIKey": "FIEDYLNUYGEAJG-UHFFFAOYSA-N",
    "SMILES_stereo": "C#Cc1ccc(cc1)c2nnc(o2)NC(=O)c3ccc(cc3)N",
    "pdbx_description": "4-amino-N-[5-(4-ethynylphenyl)-1,3,4-oxadiazol-2-yl]benzamide"
  },
  {
    "chemicalName": "Haemanthamine",
    "SMILES": "COC1CC2C3(C=C1)c4cc5c(cc4CN2CC3O)OCO5",
    "chemicalId": "HN8",
    "InChI": "InChI=1S/C17H19NO4/c1-20-11-2-3-17-12-6-14-13(21-9-22-14)4-10(12)7-18(8-16(17)19)15(17)5-11/h2-4,6,11,15-16,19H,5,7-9H2,1H3/t11-,15+,16+,17+/m1/s1",
    "formula_weight": 0.301,
    "number_of_instances": 2,
    "InChIKey": "YGPRSGKVLATIHT-HSHDSVGOSA-N",
    "SMILES_stereo": "CO[C@H]1C[C@H]2[C@]3(C=C1)c4cc5c(cc4CN2C[C@@H]3O)OCO5",
    "pdbx_description": "Haemanthamine"
  },
  {
    "chemicalName": "THERMINE",
    "SMILES": "C(CN)CNCCCNCCCN",
    "chemicalId": "SPE",
    "InChI": "InChI=1S/C9H24N4/c10-4-1-6-12-8-3-9-13-7-2-5-11/h12-13H,1-11H2",
    "formula_weight": 0.188,
    "number_of_instances": 5,
    "InChIKey": "ZAXCZCOUDLENMH-UHFFFAOYSA-N",
    "SMILES_stereo": "C(CN)CNCCCNCCCN",
    "pdbx_description": "THERMINE"
  },
  {
    "chemicalName": "Pentacycline",
    "SMILES": "CN(C)C1C2CC3Cc4cc5ccc(cc5c(c4C(=O)C3=C(C2(C(=O)C(=C1O)C(=O)N)O)O)O)CN6CC(C6)F",
    "chemicalId": "P8F",
    "InChI": "InChI=1S/C29H30FN3O7/c1-32(2)22-18-8-15-7-14-6-13-4-3-12(9-33-10-16(30)11-33)5-17(13)23(34)19(14)24(35)20(15)26(37)29(18,40)27(38)21(25(22)36)28(31)39/h3-6,15-16,18,22,34,36-37,40H,7-11H2,1-2H3,(H2,31,39)/t15-,18-,22-,29-/m0/s1",
    "formula_weight": 0.552,
    "number_of_instances": 2,
    "InChIKey": "DAUIQSOIFWOKJQ-MGVDVOGZSA-N",
    "SMILES_stereo": "CN(C)[C@H]1[C@@H]2C[C@@H]3Cc4cc5ccc(cc5c(c4C(=O)C3=C([C@@]2(C(=O)C(=C1O)C(=O)N)O)O)O)CN6CC(C6)F",
    "pdbx_description": "Pentacycline"
  },
  {
    "chemicalName": "Virginiamycin M",
    "SMILES": "CC1C=CC(=O)NCC=CC(=CC(CC(=O)Cc2nc(co2)C(=O)n3cccc3C(=O)OC1C(C)C)O)C",
    "chemicalId": "H8T",
    "InChI": "InChI=1S/C28H33N3O7/c1-17(2)26-19(4)9-10-24(34)29-11-5-7-18(3)13-20(32)14-21(33)15-25-30-22(16-37-25)27(35)31-12-6-8-23(31)28(36)38-26/h5-10,12-13,16-17,19-20,26,32H,11,14-15H2,1-4H3,(H,29,34)/b7-5+,10-9+,18-13+/t19-,20-,26-/m1/s1",
    "formula_weight": 0.524,
    "number_of_instances": 1,
    "InChIKey": "CNTGCXRBDCXZRN-FQTGFAPKSA-N",
    "pdbx_description": "Virginiamycin M",
    "SMILES_stereo": "C[C@@H]1/C=C/C(=O)NC/C=C/C(=C/[C@H](CC(=O)Cc2nc(co2)C(=O)n3cccc3C(=O)O[C@@H]1C(C)C)O)/C"
  },
  {
    "chemicalName": "CYSTEINE",
    "SMILES": "C(C(C(=O)O)N)S",
    "chemicalId": "CYS",
    "InChI": "InChI=1S/C3H7NO2S/c4-2(1-7)3(5)6/h2,7H,1,4H2,(H,5,6)/t2-/m0/s1",
    "formula_weight": 0.121,
    "number_of_instances": 1,
    "drugbank_id": "DB00151",
    "drugbank_description": "A thiol-containing non-essential amino acid that is oxidized to form cystine.",
    "InChIKey": "XUJNEKJLAYXESH-REOHCLBHSA-N",
    "SMILES_stereo": "C([C@@H](C(=O)O)N)S",
    "pdbx_description": "CYSTEINE"
  },
  {
    "chemicalName": "GLUTAMINE",
    "SMILES": "C(CC(=O)N)C(C(=O)O)N",
    "chemicalId": "GLN",
    "InChI": "InChI=1S/C5H10N2O3/c6-3(5(9)10)1-2-4(7)8/h3H,1-2,6H2,(H2,7,8)(H,9,10)/t3-/m0/s1",
    "formula_weight": 0.146,
    "number_of_instances": 1,
    "drugbank_id": "DB00130",
    "drugbank_description": "A non-essential amino acid present abundantly throughout the body and is involved in many metabolic processes. It is synthesized from glutamic acid and ammonia. It is the principal carrier of nitrogen in the body and is an important energy source for many cells. An oral formulation of L-glutamine was approved by the FDA in July 2017 for use in sickle cell disease [L892]. This oral formulation is marketed under the tradename Endari by Emmaus Medical.",
    "InChIKey": "ZDXPYRJPNDTMRX-VKHMYHEASA-N",
    "SMILES_stereo": "C(CC(=O)N)[C@@H](C(=O)O)N",
    "pdbx_description": "GLUTAMINE"
  },
  {
    "chemicalName": "GIRODAZOLE",
    "SMILES": "c1c([nH]c(n1)N)C(C(CN)Cl)O",
    "chemicalId": "GIR",
    "InChI": "InChI=1S/C6H11ClN4O/c7-3(1-8)5(12)4-2-10-6(9)11-4/h2-3,5,12H,1,8H2,(H3,9,10,11)/t3-,5+/m0/s1",
    "formula_weight": 0.191,
    "number_of_instances": 1,
    "InChIKey": "YILCGOCHVFQMTC-WVZVXSGGSA-N",
    "pdbx_description": "GIRODAZOLE",
    "SMILES_stereo": "c1c([nH]c(n1)N)[C@@H]([C@H](CN)Cl)O"
  },
  {
    "chemicalName": "1-CYCLOPROPYL-6-FLUORO-4-OXO-7-PIPERAZIN-1-YL-1,4-DIHYDROQUINOLINE-3-CARBOXYLIC ACID",
    "SMILES": "c1c2c(cc(c1F)N3CCNCC3)N(C=C(C2=O)C(=O)O)C4CC4",
    "chemicalId": "CPF",
    "InChI": "InChI=1S/C17H18FN3O3/c18-13-7-11-14(8-15(13)20-5-3-19-4-6-20)21(10-1-2-10)9-12(16(11)22)17(23)24/h7-10,19H,1-6H2,(H,23,24)",
    "formula_weight": 0.331,
    "number_of_instances": 2,
    "drugbank_id": "DB00537",
    "drugbank_description": "Ciprofloxacin is a second generation fluoroquinolone that has spawned many derivative antibiotics.[A178870] It is formulated for oral, intravenous, intratympanic, ophthalmic, and otic administration for a number of bacterial infections.[L6469,L6472,L6475,L6478,L6481,L6484,L6487,L6490,L6493]  The first ciprofloxacin containing product was FDA approved on 22 October 1987.[L6463]",
    "InChIKey": "MYSWGUAQZAJSOK-UHFFFAOYSA-N",
    "pdbx_description": "1-CYCLOPROPYL-6-FLUORO-4-OXO-7-PIPERAZIN-1-YL-1,4-DIHYDROQUINOLINE-3-CARBOXYLIC ACID",
    "SMILES_stereo": "c1c2c(cc(c1F)N3CCNCC3)N(C=C(C2=O)C(=O)O)C4CC4"
  },
  {
    "chemicalName": "UNKNOWN LIGAND",
    "chemicalId": "UNL",
    "number_of_instances": 1,
    "pdbx_description": "UNKNOWN LIGAND"
  },
  {
    "chemicalName": "DIHYDROFLAVINE-ADENINE DINUCLEOTIDE",
    "SMILES": "Cc1cc2c(cc1C)N(C3=C(N2)C(=O)NC(=O)N3)CC(C(C(COP(=O)(O)OP(=O)(O)OCC4C(C(C(O4)n5cnc6c5ncnc6N)O)O)O)O)O",
    "chemicalId": "FDA",
    "InChI": "InChI=1S/C27H35N9O15P2/c1-10-3-12-13(4-11(10)2)35(24-18(32-12)25(42)34-27(43)33-24)5-14(37)19(39)15(38)6-48-52(44,45)51-53(46,47)49-7-16-20(40)21(41)26(50-16)36-9-31-17-22(28)29-8-30-23(17)36/h3-4,8-9,14-16,19-21,26,32,37-41H,5-7H2,1-2H3,(H,44,45)(H,46,47)(H2,28,29,30)(H2,33,34,42,43)/t14-,15+,16+,19-,20+,21+,26+/m0/s1",
    "formula_weight": 0.788,
    "number_of_instances": 1,
    "InChIKey": "YPZRHBJKEMOYQH-UYBVJOGSSA-N",
    "SMILES_stereo": "Cc1cc2c(cc1C)N(C3=C(N2)C(=O)NC(=O)N3)C[C@@H]([C@@H]([C@@H](CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@@H]4[C@H]([C@H]([C@@H](O4)n5cnc6c5ncnc6N)O)O)O)O)O",
    "pdbx_description": "DIHYDROFLAVINE-ADENINE DINUCLEOTIDE"
  },
  {
    "chemicalName": "[(2~{R},3~{S},4~{R},5~{R})-5-(6-aminopurin-9-yl)-4-oxidanyl-2-(phosphonooxymethyl)oxolan-3-yl] (2~{S})-2-azanyl-4-methylsulfanyl-butanoate",
    "SMILES": "CSCCC(C(=O)OC1C(OC(C1O)n2cnc3c2ncnc3N)COP(=O)(O)O)N",
    "chemicalId": "7NO",
    "InChI": "InChI=1S/C15H23N6O8PS/c1-31-3-2-7(16)15(23)29-11-8(4-27-30(24,25)26)28-14(10(11)22)21-6-20-9-12(17)18-5-19-13(9)21/h5-8,10-11,14,22H,2-4,16H2,1H3,(H2,17,18,19)(H2,24,25,26)/t7-,8+,10+,11+,14+/m0/s1",
    "formula_weight": 0.478,
    "number_of_instances": 1,
    "InChIKey": "QTJGZHBCXHRMIV-TWBCTODHSA-N",
    "SMILES_stereo": "CSCC[C@@H](C(=O)O[C@@H]1[C@H](O[C@H]([C@@H]1O)n2cnc3c2ncnc3N)COP(=O)(O)O)N",
    "pdbx_description": "[(2~{R},3~{S},4~{R},5~{R})-5-(6-aminopurin-9-yl)-4-oxidanyl-2-(phosphonooxymethyl)oxolan-3-yl] (2~{S})-2-azanyl-4-methylsulfanyl-butanoate"
  },
  {
    "chemicalName": "3'-O-(N-methylanthraniloyl)-beta:gamma-imidoguanosine-5'-triphosphate",
    "SMILES": "CNc1ccccc1C(=O)OC2C(OC(C2O)n3cnc4c3N=C(NC4=O)N)COP(=O)(O)OP(=O)(NP(=O)(O)O)O",
    "chemicalId": "GGM",
    "InChI": "InChI=1S/C18H24N7O14P3/c1-20-9-5-3-2-4-8(9)17(28)38-13-10(6-36-42(34,35)39-41(32,33)24-40(29,30)31)37-16(12(13)26)25-7-21-11-14(25)22-18(19)23-15(11)27/h2-5,7,10,12-13,16,20,26H,6H2,1H3,(H,34,35)(H3,19,22,23,27)(H4,24,29,30,31,32,33)/t10-,12-,13-,16-/m1/s1",
    "formula_weight": 0.655,
    "number_of_instances": 1,
    "InChIKey": "ZGTKZICAFACDSP-XNIJJKJLSA-N",
    "SMILES_stereo": "CNc1ccccc1C(=O)O[C@@H]2[C@H](O[C@H]([C@@H]2O)n3cnc4c3N=C(NC4=O)N)CO[P@](=O)(O)O[P@](=O)(NP(=O)(O)O)O",
    "pdbx_description": "3'-O-(N-methylanthraniloyl)-beta:gamma-imidoguanosine-5'-triphosphate"
  },
  {
    "chemicalName": "Tedizolid isomer",
    "SMILES": "Cn1c(nnn1)c2ccc(cn2)c3ccc(cc3F)N4CC(OC4=O)CO",
    "chemicalId": "U7Y",
    "InChI": "InChI=1S/C17H15FN6O3/c1-23-16(20-21-22-23)15-5-2-10(7-19-15)13-4-3-11(6-14(13)18)24-8-12(9-25)27-17(24)26/h2-7,12,25H,8-9H2,1H3/t12-/m1/s1",
    "formula_weight": 0.37,
    "number_of_instances": 1,
    "InChIKey": "WFAZKGCKGCUHAN-GFCCVEGCSA-N",
    "pdbx_description": "Tedizolid isomer",
    "SMILES_stereo": "Cn1c(nnn1)c2ccc(cn2)c3ccc(cc3F)N4C[C@@H](OC4=O)CO"
  },
  {
    "chemicalName": "8-fluoro-6-methoxy-3-methyl-1-(3-methylpyridin-4-yl)-3H-pyrazolo[3,4-c]cinnoline",
    "SMILES": "Cc1cnccc1c2c3c4cc(cc(c4nnc3n(n2)C)OC)F",
    "chemicalId": "JY7",
    "InChI": "InChI=1S/C17H14FN5O/c1-9-8-19-5-4-11(9)16-14-12-6-10(18)7-13(24-3)15(12)20-21-17(14)23(2)22-16/h4-8H,1-3H3",
    "formula_weight": 0.323,
    "number_of_instances": 2,
    "InChIKey": "BEHIYTQDLXFKJV-UHFFFAOYSA-N",
    "SMILES_stereo": "Cc1cnccc1c2c3c4cc(cc(c4nnc3n(n2)C)OC)F",
    "pdbx_description": "8-fluoro-6-methoxy-3-methyl-1-(3-methylpyridin-4-yl)-3H-pyrazolo[3,4-c]cinnoline"
  },
  {
    "chemicalName": "N-[4-[(4R)-1,4-dimethyl-6-oxidanylidene-4,5-dihydropyridazin-3-yl]phenyl]-5,7-dihydropyrrolo[3,4-b]pyridine-6-carboxamide",
    "SMILES": "CC1CC(=O)N(N=C1c2ccc(cc2)NC(=O)N3Cc4cccnc4C3)C",
    "chemicalId": "7YT",
    "InChI": "InChI=1S/C20H21N5O2/c1-13-10-18(26)24(2)23-19(13)14-5-7-16(8-6-14)22-20(27)25-11-15-4-3-9-21-17(15)12-25/h3-9,13H,10-12H2,1-2H3,(H,22,27)/t13-/m1/s1",
    "formula_weight": 0.363,
    "number_of_instances": 2,
    "InChIKey": "IJKUAZSSMFHECB-CYBMUJFWSA-N",
    "SMILES_stereo": "C[C@@H]1CC(=O)N(N=C1c2ccc(cc2)NC(=O)N3Cc4cccnc4C3)C",
    "pdbx_description": "N-[4-[(4R)-1,4-dimethyl-6-oxidanylidene-4,5-dihydropyridazin-3-yl]phenyl]-5,7-dihydropyrrolo[3,4-b]pyridine-6-carboxamide"
  },
  {
    "chemicalName": "(4S,5aS,8S,8aR)-N-[(1R,4R,6Z,8R,9R,10R,11R,12S,13R)-4-fluoro-11,12,13-trihydroxy-8-methyl-14-oxa-2-thiabicyclo[8.3.1]tetradec-6-en-9-yl]-4-(2-methylpropyl)octahydro-2H-oxepino[2,3-c]pyrrole-8-carboxamide (non-preferred name)",
    "SMILES": "CC1C=CCC(CSC2C(C(C(C(C1NC(=O)C3C4C(CC(CCO4)CC(C)C)CN3)O2)O)O)O)F",
    "chemicalId": "A1A1L",
    "InChI": "InChI=1S/C26H43FN2O6S/c1-13(2)9-15-7-8-34-23-16(10-15)11-28-19(23)25(33)29-18-14(3)5-4-6-17(27)12-36-26-22(32)20(30)21(31)24(18)35-26/h4-5,13-24,26,28,30-32H,6-12H2,1-3H3,(H,29,33)/b5-4-/t14-,15+,16+,17-,18-,19+,20+,21-,22-,23-,24-,26-/m1/s1",
    "formula_weight": 0.531,
    "number_of_instances": 2,
    "InChIKey": "GLEYKIFUQKWPHN-JPYIKDSJSA-N",
    "pdbx_description": "(4S,5aS,8S,8aR)-N-[(1R,4R,6Z,8R,9R,10R,11R,12S,13R)-4-fluoro-11,12,13-trihydroxy-8-methyl-14-oxa-2-thiabicyclo[8.3.1]tetradec-6-en-9-yl]-4-(2-methylpropyl)octahydro-2H-oxepino[2,3-c]pyrrole-8-carboxamide (non-preferred name)",
    "SMILES_stereo": "C[C@@H]1/C=CC[C@H](CS[C@@H]2[C@@H]([C@H]([C@H]([C@@H]([C@@H]1NC(=O)[C@@H]3[C@H]4[C@@H](C[C@@H](CCO4)CC(C)C)CN3)O2)O)O)O)F"
  }
]
